|
|
·|û¡Ghung120110149413 µoªí®É¶¡:2020/6/24 ¤U¤È 02:11:23
|
¥«³õº¨£·sÃÄ(¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸) Àø®Ä¤ÀªR p=0.009 6634 ªYÄ£ ªÑ¥»: 3.832»õ ¥Dn·~°È: ¨xŦ¯e¯fªvÀø¤Î¯kµhªvÀø¬ÛÃöÃĪ«¬ã¨s¤Î¶}µo ¸³ºÊ«ùªÑ¤ñ¨Ò: 21.7%(¼W¥[¤¤) ¥~¸ê«ùªÑ¤ñ¨Ò: 0.22%(¼W¥[¤¤) Ä~Äò©¹¤U¬Ý...! ============================================================================= ²£«~01¡GSNP-610 (ªvÀø¯×ªÕ¨x¯e¯f·sÃÄ) ¾AÀ³¯g: «D°sºë©Ê¯×ªÕ¨xª¢ ²£«~Àu¶Õ: 1.¥Ø«e©|µL¼Ð·ÇªvÀøÃĪ« 2.¥«³õº¨£·sÃÄ(First-in-class) 3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x 4.µL¦w¥þ©Ê°ÝÃD ¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C Ävª§¤O: 1.¦h«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢ 2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A°§C¨x¯× 3.¥i´£¥X¨uÃĥӽСAÀ³¥Î©óªvÀø§³®W«æ©Ê¯×ªÕ¨x ¬ãµo¶¥¬q: 1.¤w³q¹LUSFDA¤ÎTFDA¼f¬d¶i¤JÁ{§É¤G´Á 2.Á{§ÉÀø®Ä¤Î·sªvÀø¾÷ÂàÅçÃÒ Àø®Ä¤ÀªR¡G 1.²Ä¤@´ÁÁ{§É¸ÕÅç¡Gµ²ªGÅã¥Ü¤HÅé¨Ï¥Î¦w¥þ¡A©Ê½è¨}¦n 2.²Ä¤G´ÁÁ{§É¸ÕÅç¨ä¤¤¤ÀªR¡G17¦ìNASH ¯f¤H (p=0.009) ============================================================================= ²£«~02¡GSNP-630 ¾AÀ³¯g:«D°sºë©Ê¯×ªÕ¨xª¢ ²£«~Àu¶Õ: 1.¬°Àu¤Æ(Optimized)¤§·s¤Æ¾Ç¹êÅé(NCE) 2.¥«³õº¨£·sÃÄ(First-in-class) 3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x 4.§@¬°²Ä¤@¥N²£«~¤W¥««áªº±µÄò¦û¦³¥«³õ¤§²£«~ ¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C Ävª§¤O: 1.¦h«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢ 2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A°§C¨x¯× 3.Àu¤ÆªºÀø®Ä±j«×¡B§@¥Î®É¶¡ 4.µL¦w¥þ©Ê°ÝÃD ¬ãµo¶¥¬q: 1.Á{§É«e 2.¹w©w¥Ó½Ð¬ü°êFDAIND¡B§Ö³t³q¹D(fasttrack)¡C 3.¥Ó½Ð¬ü°ê¬ð¯}©ÊªvÀø(breakthrough therapy)ªº»{©w¡C Àø®Ä¤ÀªR¡G 1. ¥Ø«e¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.05 ============================================================================= ²£«~03¡GSNP-810 (µL¨x¬r©Ê¤îµh·sÃÄ¡B¸Ñ¬r¾¯) ¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃÄ (¸Ñ¼öÂíµh¾¯) ²£«~Àu¶Õ: 1.¦w¥þ¤Æ¦Xª«·s²Õ¦X¡BµL¨x¬r©Ê 2.¸Ñ¨M¢¤ÁÂåÀø»Ý¨D (Important urgent unmet medical needs) 3.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¥i¼W¥[¾¯¶q ¥«³õ: ¤AñQÓi×ô¶È¦b¬ü°ê¤@¦~´N¦³40»õ¬ü¤¸ªº¥«³õ Ävª§¤O: 1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ« 2.¥i§ð¦û¼s¤j¥«³õ¡]NSAID, COX-2 §í¨î¾¯¡BOpioidsÃþ¤îµhÃÄ¥«³õ¡^ 3.¥i¬Ù°£¶D³^¶O¡B±Ð¨|°V½m¶O ¬ãµo¶¥¬q: 1.¤w§¹¦¨§C¾¯¶q¡B°ª¾¯¶qÁ{§É¸ÕÅç 2.¤w¥Ó½ÐUSFDA¼Ï纽Á{§É¸ÕÅç¡B±N¥Ó½Ð¬ð¯}©Ê¼f¬d/§Ö³t³q¹D 3.µL¨x¬r©Ê¤AñQÓi×ô¸Ñ¬r¾¯¦¨¤À¡A¤w¥Ó½Ð¬dÅçµn°O¥Î¤§Á{§É¸ÕÅç ============================================================================= ²£«~04¡GSNP-830/ SNP-840 ¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃĽƤè(ªvÀø¤¤¡B««×¯kµh) ²£«~Àu¶Õ: 1.µL¨x¬r©Ê¤AñQÓi×ôªº½Æ¤è 2.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¡A¥i¼W¥[¾¯¶q ¥«³õ: ¤AñQÓi×ô³B¤èÃĦb¬ü°ê¤@¦~´N¦³27»õ¬ü¤¸ªº¥«³õ Ävª§¤O: 1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«½Æ¤è 2.½Æ¤è¤w¥Ñ¬ü°êFDAn¨D°¾¯¶q§C©ó325²@§J¡A±N¼vÅTÀø®Ä 3.¦³¨Ï¥Î±M§Q¡A¥iקï©Î§R°£FDA¨x¬rĵ»y 4.¥i¼W¥[¤AñQÓi×ô¾¯¶q ¡]¥Ñ325mg ¦^´_¦Ü500 mg¬Æ¦Ü§ó°ª¡A·|¸û¦³®Ä¡^¥H¼W¥[Àø®Ä¡A©Î´î¤ÖOpioids¾¯¶q¡A°§C¦¨Å}°Æ§@¥Î 5.¤GªÌ¾Ü¤@±ÂÅv 6.¥i¼W¥[¥«¦û²v ¬ãµo¶¥¬q: 1.SNP-810¨ú±oÃÄÃÒ«á¡A¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê¸ÕÅç SNP-830 ¤£¬O ·s¦¨¤À ªº·sÃÄ¡A©Ò¥H¤£»Ýn¶i¦æ²Ä¤@¡A¤G¤Î¤T´ÁÁ{§É´úÅç µ¥ SNP-810 ®³¨ìÃÄÃÒ«á¡A¥H ·sÀø®Ä½Æ¤è¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê´úÅç ´N¥i¥HÀò±oÃÄÃÒ ============================================================================= ***************************************************************************** SNP-8 ¨t¦C Àø®Ä¤ÀªR¡G 1. ¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005 1. ¤w¸g§¹¦¨¤§¤HÅé¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005 ============================================================================= ***************************************************************************** ¥¼¨Ó¥Ø¼Ð±ÂÅv¥D¤O²£«~¡G 1. ¯×ªÕ¨xÃÄ¡GSNP-610 ©M SNP-630 ¦U¦³ÀuÂI¡A¥Ø¼Ð¬°¥þ²y±ÂÅv 2. ¤îµhÃÄ(OTC): SNP-810, ¥Ø¼Ð¬°¬ü°ê¤Î¥þ²y±ÂÅv 3. ¤îµhÃÄ(³B¤èÃÄ): SNP-830 ¤Î SNP-840, ¦b°Êª«¤W¬Ò¦³¥¿±ªºµ²ªG¡A¥Ø¼Ð¬°¥þ²y±ÂÅv ============================================================================= ***************************************************************************** ¥Ø«e¤½¥q»P°ê»Ú¤j«¬Ãļt¥¿¦b½Í§Þ³N±ÂÅv©M¦X§@p¹º §Ú¬Ý¹L¤½¥q©xºô©M©Ò´£¨Ñªº¸ê®Æ¡Aı±o¤½¥q«Ü¥Î¤ß¦b¸gÀç¡A¦Ó¥B¸ê®Æ¤]«Ü¸Ô²Ó ¹ï¤½¥qµo®i«Ü¦³¦Û«H¡A¥¼¨ÓªÑ»ùȱo´Á«Ý¡A¦³¾÷·|¬O ¤U¤@Ó ¦X¤@ ÄÆªÑ ----------------------------------------------------------------------------- ¥H¤W¸ê®Æ ³£°Ñ¦Ò ªÑªF·|ij¨Æ¿ý.pdf ©M ¤½¥q©xºô (¦³¿³½ìµÛÅwªï¦A²`¤J¬ã¨s»P°Q½×) |
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/8 ¤U¤È 12:12:04²Ä 920 ½g¦^À³
|
°]¤j¤£¿ù¦³°µ¥\½Ò! ´N¬OSNP-810°t¤è²Õ¦¨¤À³£¬O·~¬É¤w¥Î¼Æ¤Q¦~¦¨¤À¡A©Ò¥H§Ú¤]«ÜÃhºÃ¸ò¼~¼{·|¤£·|¬O¶BÄF! («nÁú°êÄ_¬ì¾Ç®a¶À¬ê¿ü·F²ÓM¬ã¨s³y°²...) -------------------------------------------------------------- --- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/26 ¤W¤È 08:01:06²Ä 579 ½g¦^À³ °t¤è²Õ¦¨¤À´X¥G¨SÅÜ¡AÃöÁä¤j©è¬O²V¦X¤ñ¨Ò½Õ¾ã(¥Í²£½u¤£¶·½Õ¾ãÅÜ°Ê¡A»ù®æÀ³¸Ó¤£·|¤j´T«×½Õº¦)¡A SNP-810¨ú¥N¥þ²y¤îµh¦¨¥÷ÃÄ¡u¤AñQÓi×ô¡v¡A±N¬O©ö¦p¤Ï´x! ------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/3 ¤U¤È 12:26:30²Ä 665 ½g¦^À³ °t¤è²Õ¦¨¹ê¦b¬O²³æ¨ìÅý§ÚÃhºÃ¸ò¼~¼{??? ---------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/26 ¤W¤È 08:13:06²Ä 580 ½g¦^À³ ü¤S ¹ê¦b¬O²³æ¨ìÅý§ÚÃhºÃµL¨x¬r©Ê·|¤£·|¬O¶BÄF??? |
|
|
·|û¡G°]°È¦Û¥Ñ¤H10132540 µoªí®É¶¡:2021/3/8 ¤W¤È 11:49:35²Ä 919 ½g¦^À³
|
810 µL¨x¬r©Êªº¥«³õ¡A¥un¦¨¥»¸ò¥«°â«~¬Ûªñ¡A¬O¦³¥i¯à¤jÁ|¦Y±¼¥«¦û¡C³Q±ÂÅvÃļt·Q¥²¬O¸ÔºÉ¦a¥h¨ú±o·Qn¦UºØ²Õ¦Xªº¼Æ¾Ú¡A²¦³º810 ·s»s¾¯ªº¤èªk¥i¯à²³æ¨ì¥O¤HÃhºÃ¡A©Ò¥H«áÄò¤j¼tn¨D°µªº¸ÕÅç¡A¥i¯à¦Ü¤Ön¦n¤@¬q®É¶¡¡C ÁÙ¦³¤@ÂIn¯dª`ªº¬O¡A¤½¥qªºÁ{§É¥»¨Ó¬On¸Õ°ª¾¯¶qªº¦ý FDA ¦³ºÃ¼{ ¡A©Ò¥H¤~§ï¦^¥«°â±`¨£¾¯¶q¡C¦Ó«áµL¨x¬rªºÁ{§É¡AFDA n¨D°µ GLP ªº°Êª«Á{§É¥[±j¦õÃÒ¡A¥i¨£ FDA ÁÙ¬O«Ü¤p¤ß¡C¦³Ó¯àÃÒ©úªýÂ_ NAPQI ªº MOAs ¥h»¡ªA fda ¬OÃöÁä¡A¤£µM«áÄò¥[¤j¾¯¶qªºÁ{§É¥i¯à¦]¦³¹D¼w¤Wªº·ÀI(¸ÕÅç¤H¦º¤`)¡AFDA ·|¦³ºÃ¼{¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/8 ¤W¤È 09:53:21²Ä 918 ½g¦^À³
|
³Ì¦³§Æ±æªºµ¦²¤¬O´M§ä¤@ºØ·sªº¤îµhÃÄ¡A¸Ó¤îµhÃĪº¯S©Ê»PAPAP¬Û¦P¦ýµL¬r©Ê...³oºØ·s«¬¤îµhÃĪº¦^³ø±N¬O¥¨¤jªº¡I ...ÁöµM°õ¦æ§ó¦w¥þªº·s²£«~¬O¥¨¤jªº¬D¾Ô¡A¦ý¬O¬D¾ÔAPAPªº´¶¤Î©Ê¬Oȱoªº.....APAPÁöµM¦³¦w¥þ©ÊªºÁnÅA«o¬O·í¤§[¦³]·\¡C.....±µ¨ü¤@ºØ¯u¥¿¦w¥þ¦³®Äªº¤îµhÃÄ¡C¦Ó¤£¬Oªü¤ùÃþÃĪ«ªº¡]¬rÅ}©Ê¡A«K¯µ¡A¶ÝºÎ¡^©ÎNSAIDs¡]G¸z¹D¥X¦å¡^©ÎAPAP¡]¦]«æ©Ê¨x°IºÜ¦Ó¦º¤`¡^¡C §Ú·Q¨ìªº¤@Ó¬Û¦ü¤§³B¬O¦w¯vÃĪº¤Ú¤ñ§´»ÄÆQÃþ¡A¦b1960¦~¥N©M70¦~¥N«D±`¬y¦æ¡A¦ý¬O«o¾ÉP¤FµL¼Æªº¹L¶q¦º¤`¡C f¤G´á¨ôÃþÃĪ«°Ý¥@«á¡A¤Ú¤ñ§´ÃþÃĪ«¨³³t®ø¥¢¡C-----[·N«ü:¥X²{¦w¥þµL¨x¬rSNP-810 ¨º»ò¦³¨x¬r©ÊªºAPAP±N·|®ø¥¢) ¦pªG¤j¶O©P³¹´N¥u¬°¤F1¦¨¥«¦û²v¡A¤j¹Ú¸Ó¿ô!!! ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/6 ¤W¤È 06:59:34²Ä 730 ½g¦^À³ Ĺ: ã÷®Ø William M. Lee ³o½g¤å:www.journal-of-hepatology.eu/article/S0168-8278(17)32148-7/fulltext (³oºØ·s«¬ÂíµhÃĪº¦^³ø±N¬O¥¨¤jªº!)¥H¯÷ªí´Æg¹|! ¿é: ¥h¬ü°ê©îWilliam M. Leeªº¦ª´Î ---------------------------------------------------------------------------------------- ·|û¡G´MÄ_10151381 µoªí®É¶¡:2021/3/6 ¤U¤È 10:56:15²Ä 915 ½g¦^À³ ..¦pªG¥H³ÌÃaªº±¡ªp¡]¨Ã¨S¦³»P¥ô¦óÃļt¹F¦¨±ÂÅv¡^¥´ºâ¡ASNP-810¶È¦b¬ü°ê«D³B¤èÃĤAñQÓi×ôÃÄ«~¥«³õ®³¨ì1¦¨ªº¥«¦û²v |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/8 ¤W¤È 09:00:04²Ä 917 ½g¦^À³
|
SNP-810ªº°l§L¦³½Ö»P¦³¦h¤Öªº»â¥ýÀu¶Õ¡H(¦Ü¤Ö¦³3¤ä¬ü°ê¶¤¡A¤w¶K¹L½Ð¦Û´M) [SNP-810+¤fªAªø®Ä¯Ç¯k¸Ñ]Âù°¼½¥Ãö¸`¸m´«³N«á¬OÁpÃĤîµh¹êÅç¡A2Ãħ޳N±ÂÅv¬Ò¨Ó¦ÛJ¥®®E±Ð±Â§Þ³N¹Î¶¤¡A¤¬¸É©Ê¸û°ª¦Ó«DÄvª§©Ê¡C |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/3/6 ¤U¤È 11:46:58²Ä 916 ½g¦^À³
|
³æ´N¤îµh¥ÎÃÄÉ]³õ¦Ó¨¥¡A¶¶ÃĪºªø®Ä¤îµh°w¾¯¯Ç¯k¸Ñ¡A¥Ø«e¬OSBP810¦bÂå°|³B¤èÅÒ¥ÎÃÄ»â°ì¥i·qªº¹ï¤â¡C |
|
|
·|û¡G´MÄ_10151381 µoªí®É¶¡:2021/3/6 ¤U¤È 10:56:15²Ä 915 ½g¦^À³
|
ªYÄ£¦b2021/01/26ªº«°T¤¤´£¨ì¡G¥»¤½¥qSNP-810¦]µ¦²¤¦Ò¶q¡A ¥ý¦æ¥Ó½Ð¬ü°êOTC monograph³\¥i¡A¥Ø«e¤w³q¹L¬ü°êFDA¼f¬d¨Ã¨ú±o¬ü°ê¥«³õ ¾P°â¸ê®æ¡C¹ê»Ú¤W¥«¾P°â®É¶¡µø»P¾P°â¤½¥qªº¨óij¦Ó©w¡C ³oÓ¡§µ¦²¤¦Ò¶q¡¨¤@¤è±Åý°ê»Ú¤jÃļt»{¦PSNP-810ªº¦w¥þ¦³®Ä¡A¥t¤@¤è±¨ú±o¡]¤w¥i¦b«D³B¤èÃĪ«¾P°âÅv§Q¡A®Ú¾ÚIMS Health²Îp¸ê®ÆÅã¥Ü¡A¥þ¬üAcetaminophen¤AñQÓi×ôÃÄ«~¥«³õ¾P°âÃB ¦b2018¦~¹F22»õ¬ü¤¸¡A«D³B¤è¬ù7»õ¬ü¤¸¡^§ó¦nªº½Í§PÄw½X¡C ¦pªG¥H³ÌÃaªº±¡ªp¡]¨Ã¨S¦³»P¥ô¦óÃļt¹F¦¨±ÂÅv¡^¥´ºâ¡ASNP-810¶È¦b¬ü°ê«D³B¤èÃĤAñQÓi×ôÃÄ«~¥«³õ®³¨ì1¦¨ªº¥«¦û²v¡A1¦~ªºÀ禬¬ù7000¸U¬üª÷¡]·s¥x¹ô19.6»õ¡^¡AªÑ»ù¤´¦³¬Û·í¤jªº·Q¹³ªÅ¶¡¡A¦ý´N¦p¦P«e¤@½g·Q¦VR¤j©M¦U¦ì¤j¤j½Ð±Ðªº¡A¨s³ºSNP-810ªºÀu¶Õ¯à¦³¦h¤[¡HÅ@«°ªe°÷¤£°÷°í©T¡C¡]Ó¤H¬ã¨s¤À¨É¡AÂԨѰѦҡI¡^ |
|
|
·|û¡G´MÄ_10151381 µoªí®É¶¡:2021/3/6 ¤U¤È 10:29:51²Ä 914 ½g¦^À³
|
·PÁÂR¤jªº¬ã¨s¤À¨É ¥t¥~·Q½Ð°ÝR¤j¡G¨Ì¥Ø«e¦UÃļtªºÁ{§É¶i«×¡A¯à«Â¯ÙªYÄ£810ªº°l§L¦³½Ö¡H810¦³¦h¤Öªº»â¥ýÀu¶Õ¡H ¨Ì·ÓÓ¤H¬ã¨sӪѰ]³øªº¸gÅç¡A¥«³õ¹ï©ó¤@¦¸©Ê¦¬¤J¡]¨Ò¦p¡G¥Í§ÞÂåÃĪºÅv§Qª÷¡^³q±`¤£·|µ¹¤©ªÑ»ù¤Ó°ªªºµû»ù¡A©Ò¥H¤£¾A¦X¥ÎÅv§Qª÷ªº¦¬¤J¨Óµû¦ô¥»¯q¤ñ¶i¦Ó±À¦ô¦X²zªºªÑ»ù¡C¨Ò¦p¡GªÑ¥»NT$5»õ¡AÅv§Qª÷US$5»õ¡A¹w¦ô°^ÄmEPS280¤¸¡A¦X²zªºªÑ»ù¤£·|¬OEPS280*¥»¯q¤ñ15¿=4200¡A¦]¬°Åv§Qª÷¥u¬O¤@¦¸©Ê¦¬¤J¡]¥H¼W¥[²bȪº¨¤«×¨Ó±À¦ôªÑ»ùªº¼WÈ·|¤ñ¸û«ÈÆ[¡^¡A¦Ó¤£¬O¸g±`©Ê¦¬¤J¡A©Ò¥H¥H¾P°â¤À¼í¨Ó±À¦ô¦X²zªÑ»ù·|¬O¤ñ¸û¹ê»Úªº°µªk¡C(Ó¤H¬ã¨s¡AÂԨѰѦҡI) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/6 ¤U¤È 08:14:05²Ä 913 ½g¦^À³
|
¥@¬É¾~¤ù¤j¾Ô¶}¹õ! 2021.3.3 ¼Ú¬w¯kµhÁp¦X·|¡]EFIC¡^µo¥¬·s«ü«n! europeanpainfederation.eu/european-clinical-practice-recommendations-on-opioids-for-chronic-non-cancer-pain/ --¼Ú¬w¬ì¾Ç¬Éµoªí¤FÃö©ó¨Ï¥Îªü¤ùÃþÃĪ«ªvÀøºC©Ê«DÀù©Ê¯kµhªº¦@ÃÑ©Ê«Øij --¬°¤F½w¸Ñ¹ïªü¤ùÃþÃĪ«¦M¾÷ªº¾á¼~¡A¨Ò¦p¦b¬ü°ê¡A¼Ú¬w¬ì¾Ç¬É¤w¸g¼f¬d¤F¦³Ãö¨Ï¥Îªü¤ùÃþÃĪ«ªvÀøºC©Ê«DÀù©Ê¯kµhªº ÃÒ¾Ú --¤EÓ»â¥ýªº¬ì¾Ç¾Ç·|©M¼Ú¬w»â¥ýªº¯kµh±wªÌ²Õ´¤w¸g¨î©w¨Ã»{¥i¤F·sªºÁ{§É¹ê½î«Øij --ªü¤ùÃþÃĪ«¤£©y¥Î©ó³\¦hºC©Ê¯kµh¯f¯g¡A¦ÓÀ³¦b©Ò¦³¨ä¥L±¡ªp¤U¶È§@¬°²Ä¤G½u©Î²Ä¤T½uªvÀø ¼Ú¬w¯kµhÁp¦X·|¡]EFIC¡^±Nªü¤ùÃþÃĪ«ºÙ¬°¡§¨â¤b¼C¡¨¡A¤wµo¥¬·s«ü«n¡A±j¯P«Øij¤£n¨Ï¥Îªü¤ùÃþÃĪ«ªvÀøÅÖºû¦Ùµh¡A¤UIµh¡A°¾ÀYµh¡A¸z©ö¿Eºî¦X¼x©M¨ä¥LÃþ«¬ªººC©Ê«DÀù©Ê¯kµh¡C Âå¥ÍÀ³ [º¥ý] ¨Ï¥Î [«D]ªü¤ùÃþÃĪ«©Î¤w«Ø¥ßªº«DÃĪ«Àøªk¡]¨Ò¦p¹B°Ê¡A¤ß²zÀøªk¡^¡A¨Ã¥B¶È¦b³o¨Ç¤@½uÀøªkµL®Ä¡A¤£@¨ü©Î¸T§Ò®É¤~¦Ò¼{¶}³B¤èªü¤ùÃþÃĪ«¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/6 ¤U¤È 03:21:57²Ä 912 ½g¦^À³
|
2021.3.5 ªü¤ùÃþÃĪ«»P¹L«×¨Ï¥Î¹ï½¥Ãö¸`ª¢ªº¼vÅT¬O¥¨¤jªº¸gÀÙ·l¥¢! www.usnews.com/news/health-news/articles/2021-03-05/opioid-use-and-overuse-for-knee-arthritis-takes-big-financial-toll ...¦³85.8¸U¬ü°ê¤H¨Ï¥Îªü¤ùÃþÃĪ«ªvÀø½¥Ãö¸`¯kµh¡Aªü¤ùÃþÃĪ«ªvÀø½¥Ãö¸`ª¢ªºª½±µÂåÀø¶O¥Î±µªñ75»õ¬ü¤¸....®Ú¾Ú³Ìªñ¦b¡mÃö¸`ª¢Å@²z»P¬ã¨s¡nÂø»xªº³ø§i,..¬ã¨s§@ªÌ»¡¡A¬ã¨sµ²ªGªí©ú¡A¿í´`«Øij«ü«nªº«n©Ê¡A³o¨Ç«ü«n«Øij¤£n¦b½¥Ãö¸`ª¢±wªÌ¤¤¨Ï¥Îªü¤ùÃþÂíµhÃÄ¡C --------------------------------------------------------------------------------------------- ¬Ý§¹³o½gÁÙ¬O¿N¿S¿Sªº¸ê®Æ¡A±zÁÙ¹ï[SNP-810+¤fªAªø®Ä¯Ç¯k¸Ñ]½¥Ãö¸`¤îµh¹êÅçµL·P¡A§Ú¤]¨S»³¤F! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/6 ¤U¤È 03:04:36²Ä 911 ½g¦^À³
|
´¶´ç»PMallinckrodt¦]¬°½æ¾~¤ùÃĪ«¬ÛÄ~¯}²£¡A¦^ÀY¬Ý¬Ý³o2¥ó[«D]¾~¤ùÃþ¤îµhÃıÂÅv: 1.2019.05.29 §¨Ó¥Hªñ10»õ¬ü¤¸»PCentrexion¦X§@©Ý®i 2.202.8.5 Acadia Pharmaceuticals¥H5250¸U¬ü¤¸ªº»ù®æ¦¬ÁÊCerSci (ñ¬ù0.525+ ¨½µ{ª÷8.87=9.395»õ¬ü¤¸) ¦A·Q·Q[SNP-810+¤fªAªø®Ä¯Ç¯k¸Ñ]¥Î©ó½¥Ãö¸`¸m´«¤â³N«á¤îµh¹êÅç....¯S§O¦³·P¡C(¶Â¥Õ¦§g:§O¤Hªº¥¢±Ñ´N¬O§Úªº§Ö¼Ö¡m©¯¨a¼Öº×?¡n -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/15 ¤U¤È 10:43:04²Ä 788 ½g¦^À³ ±q¬ü°êÀn¤ù¦M¾÷l¥Í2¥ó~10»õ¬ü¤¸ªº[«D]ªü¤ùÃþÃĪ«¥æ©ö! ©Ò¥H[SNP-810+¯Ç¯k¸Ñ]¤]¦³¬Û·í»ùÈ.... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/6 ¤U¤È 02:44:00²Ä 910 ½g¦^À³
|
¥þ²yAPAPì®Æ¥Í²£¶q³Ì¦hªº¬O¤j³°!(¤U±¬O«ü³æ¤@¤u¼t²£¶q¡A) Mallinckrodt¦b2020.1¤ë¦]¬°·s«a¬Ì±¡¡AAPAPì®ÆÃĨѤ£À³¨D¡AªÑ»ù±q1¶ô¥ª¥kº¦¦Ü6¶ô¦h¡A2020.10¤ë¥Ó½Ð¯}²£¨ì¬Q¤é³Ñ0.33¤òªÑ¡A2015¦~°ªÂI>80¤¸(2014ªá14»õ¬ü¤¸¦¬Áʺ¤ä¹ï¤A酰®ò°ò×ôÀR¯ßª`®g¾¯)¡A¤W¤U¾úµ{°÷®£©Æ! ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/6 ¤U¤È 02:08:14²Ä 909 ½g¦^À³ Mallinckrodt¬O¥þ²y³Ì¤jªº¼³¼ö®§µh(APAP)ì®ÆÃĥͲ£°Ó¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/6 ¤U¤È 02:08:14²Ä 909 ½g¦^À³
|
Mallinckrodt¬O¥þ²y³Ì¤jªº¼³¼ö®§µh(APAP)ì®ÆÃĥͲ£°Ó¡C ¦]¬°¾~¤ùÃĪ«¥Ó½Ð¯}²£¡A¹ï¬ü°êAPAP¥«³õ¼vÅT©Ê??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/6 ¤U¤È 01:57:41²Ä 908 ½g¦^À³
|
¤S¤@®a¤j¼t¦]¬°¾~¤ù¦M¾÷¥Ó½Ð¯}²£! 2020.10.17---¬ü°ê³Ì¤jªºªü¤ù¡]¤SºÙ¡u¾~¤ù¡v¡^Ãþ¥é»sÃĪ«¥Í²£°ÓMallinckrodt¡]¤SºÙ¡u¸UÆF¬ì¡v¡^¤w¥Ó½Ð¯}²£«OÅ@¡A¦¹«e¡AMallinckrodt²o¯A¤@µ§¬ù50»õ¬ü¤¸¶Å°Èªº«²Õp¹º½Í§P¡A¦ý¦]ªñ3000°_©x¥qÄñ¨¡AMallinckrodthµL¤OÀv¶Å¡A¤£±o¤£¥Ó½Ð¯}²£«OÅ@¡C ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/9/2 ¤W¤È 11:04:43²Ä 334 ½g¦^À³ 2014.02.11 Mallinckrodt13»õ¬ü¤¸¦¬ÁÊCadence¥HÀò±oÂíµhÃÄOfirmev(º¤ä¹ï¤A酰®ò°ò×ôÀR¯ßª`®g¾¯)(³Ì²×¦¬ÁÊ»ù¬O14»õ¬ü¤¸) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/6 ¤U¤È 01:05:39²Ä 907 ½g¦^À³
|
2021.3.3-³o4®a¤½¥q®£©È±o¥I¥X260»õ¬ü¤¸¥N»ù©M¸Ñ3¬ü°ê¾~¤ù¦M¾÷! www.bloomberg.com/news/articles/2021-03-03/at-ceo-bonus-time-billions-in-opioid-legal-costs-are-stripped-out McKesson :80»õ¬ü¤¸ ; Cardinal :65»õ¬ü¤¸ ;Amerisource: 65»õ¬ü¤¸ ; Johnson¡®Johnson: 50»õ¬ü¤¸ ------------------------------------------------------------------------------------------- 260»õ+´¶´ç110»õ=370»õ¬ü¤¸¡A¨S·Q¨ì½æ¾~¤ùÃĪ«¨ìÀY¨Ó¤Ï¦Ó±o²æ¿Ç¤l! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/6 ¤W¤È 10:14:45²Ä 906 ½g¦^À³
|
IPO¤W¥«Âd®Éµ{¤Î§@·~ ªÑÅv¤À´²:¤½¥q¤º³¡¤H¤Î¸Óµ¥¤º³¡¤H«ùªÑ¹O50%¤§ªk¤H¥H¥~¤§ªÑªF¤H¼Æ¤£¤Ö©ó 300 ¤H¡A¥B¨äÁ`«ùªÑ¥÷Á`ÃB¦Xp¥eµo¦æªÑ¥÷ Á`ÃB20%¥H¤W©Î¹O¤@¤d¸UªÑ --------------------------------------------------------------------------------------------- Q:½Ð°Ý¶Q¤½¥q¦³¥Ó½Ð¤W¥«Âdªº®Éµ{ªí¶Ü? A:§Ú̦³³W¹º2021¦~©³´£¥X¤WÂd¥Ó½Ð¡A±©¸gÀÙÁ`Å骬ªp¡B°ê»Ú¬Ì±¡¡B±ÂÅv¶i«×µ¥½Ñ¦h¦]¯À·|¼vÅT¤WÂdªº°e¥ó®É¶¡¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/6 ¤W¤È 09:59:54²Ä 905 ½g¦^À³
|
2021.3.5·s«a·sÃÄ¥_¬ü±ÂÅv¦³ÃÐ ªø¸tµn¥Í§ÞªÑ¤ý ¥Í§ÞªÑ¤ýÄ_®y´«¤H¡Iªø¸t¡]6712¡^®µµÛÂÀ±a¶¡½è·F²ÓMUMSC01°ê»Ú±ÂÅv¦³¾÷·|©é¦b¤W¥b¦~¶Ç¥X³ß°T..... ------------------------------------------------------------------------------------------- ¤j¤á«ç»ò¤£µ¥°ê»Ú±ÂÅv??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/6 ¤W¤È 09:50:01²Ä 904 ½g¦^À³
|
³ßÅw¬ÝªÑªF«ùªÑ¤À¯Å¤j¤áÄw½X·í¾Þ§@¨Ì¾Úªº¡A¥Í§Þ6712ªø¸tºâ¬O¿ÂÃƯë¤j¶H¯S¨Ò? ±qÂà¤WÂd¤é°_2021.01.08~2021.3.5¡A>1000±i¤Ö2¦ì¡A>800±i¤Ö2¦ì¡A>400±i¦h2¦ì¡A>100±i¤Ö4¦ì¡Aºâ¤F¤@¤U100±i¥H¤WªºªÑªFÁ`«ùªÑ´î¤Ö3375±i¡Aµ²ªGªÑ»ù±q160.5º¦1¿¨ì316.5!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/5 ¤U¤È 02:08:02²Ä 903 ½g¦^À³
|
1992¦~¬OTylenolªº¾P°â°ª®p¡A¬ù¦ûAPAP¥«³õ¥÷ÃB37%¡AµM«á³v¦~¤U·Æ¦Ü15%¡C Tylenoln·Q¦A¦¸°¶¤j¡A»Ýn¾ÌÂǵL¨x¬r§Q°ò¤~¯à¿WÅQ¥«³õ! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/5 ¤U¤È 12:30:36²Ä 902 ½g¦^À³
|
±À¦ô2020¦~¬ü°êAcetaminophen(¤AñQÓi×ô)ÃÄ«~¾P°âÃB¦Ü¤Ö¼Wªø>10»õ¬ü¤¸¡A¤Ñ®É¦a§Q¤H©M(¾~¤ù¦M¾÷»P·s«a¬Ì±¡)¤U«¦^¦¨ªøÁͶÕ!!! ±j¥Í¤½¥q(Johnson & Johnson, JNJ)³z¹L¤@®a¤l¤½¥q¾Ö¦³¨Ã¥Í²£®õ¿Õ(Tylenol)«~µP²£«~¡C¸Ó«~µP¦b¬ü°ê¤îµhÃÄ¥«³õ©Ò¦û¥÷ÃB¬ù¬°15%¡Chk.finance.yahoo.com/news/%E6%96%B0%E5%86%A0%E7%96%AB%E6%83%85%E6%8F%AD%E7%A4%BA%E7%BE%8E%E5%9C%8B%E5%B0%8D%E4%B8%AD%E5%9C%8B%E5%8E%9F%E6%96%99%E8%97%A5%E7%9A%84%E4%BE%9D%E8%B3%B4-044652672.html ----------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/4 ¤U¤È 10:04:05²Ä 897 ½g¦^À³ 2021.2.22 J&J©u«×·~ÁZ³ø§i....Tylenol¾P°â¦¨ªø>3.8»õ¬ü¤¸¡A¦]¬°¦³¨Ç¶µ¥Ø¨ü·s«aªÍª¢¼vÅT¦Ó§e²{t¦¨ªø |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/3/5 ¤W¤È 11:23:02²Ä 901 ½g¦^À³
|
R¤j±M·~¡A¤]®¥¹Å90¤U¥[½Xªº¤j¤j ¦ý¶h¹F«e°}¤l´N¦³®ø®§»¡·|¦³±ÂÅv¡A9¦¨9¦³¤º½u -------------------------------- 2021.3.4¶h¹F·sÃħ¹¦¨¬ü°ê±ÂÅv ³Ì°ª¥i¨ú±o2.07»õ¬ü¤¸ 6576¶h¹F(ªÑ¥»11.7»õ):Camcevi ¥þ²y¥«³õ±ÂÅvÅv§Qª÷¤w¹F¬ù 4.17 ¬ü¤¸ VS ªYÄ£(ªÑ¥»5.23»õ)......??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/5 ¤W¤È 09:40:52²Ä 900 ½g¦^À³
|
±ÂÅvÃöÁäÂà§é¶h¹F±ý±þ¥X«³ò- ª÷¿Ä®a¤ë¥Z www.financier888.com/news6_view.php?PID=23&sn=830 FP-001½wÄÀ°w¾¯§ï¨}¾¯«¬/ 505B(2) ¥þ²y¥«³õ24»õ¬ü¤¸ ..... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/5 ¤W¤È 09:14:14²Ä 899 ½g¦^À³
|
2021.3.4¶h¹F·sÃħ¹¦¨¬ü°ê±ÂÅv ³Ì°ª¥i¨ú±o2.07»õ¬ü¤¸ 6576¶h¹F(ªÑ¥»11.7»õ):Camcevi ¥þ²y¥«³õ±ÂÅvÅv§Qª÷¤w¹F¬ù 4.17 ¬ü¤¸ VS ªYÄ£(ªÑ¥»5.23»õ)......??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/5 ¤W¤È 09:06:55²Ä 898 ½g¦^À³
|
2021.2.10 ªk°êAPI»s³y°ÓSeqens·Ç³Æ¥X°â$ 24»õ¬ü¤¸(5¦~½3¿»ùÈ) www.fiercepharma.com/manufacturing/french-api-maker-seqens-primed-for-sale-to-tune-2-4b-report ..¸Ó¤½¥q¥Í²£©M¤À¾Pªü¥q¤ÇªL¡A¼³¼ö®§µh(´¶®³¯kAPAP)©M¨ä¥L¬¡©ÊÃĪ«¦¨¤À¡]API¡^¡A¨ä¥«È¥i¯à¶W¹L20»õ¼Ú¤¸¡]24»õ¬ü¤¸¡^¡A¬O¨ä®Ö¤ß¦¬¯qªº15¿¥H¤W¡C ¼ç¦bªº¶R®a¥]¬ARecipharm¡ALonza¡ACambrex©MSamsung Biologicsµ¥¤j«¬CDMO°Ñ»PªÌ¡A¾Ú¸ô³zªÀªº¤@¦ì®ø®§¤H¤hºÙ¡A...2016¦~¡AÁ`³¡¦ì©ó¤Ú¾¤ªº§ë¸ê¤½¥qEurazeo±q¨p¶ÒªÑÅv°òª÷Ardian¤â¤¤¹Ü±oSeqens 67¢HªºªÑ¥÷¡A·í®É»ùÈ6.54»õ¼Ú¤¸¡]7.92»õ¬ü¤¸¡^¡A |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/4 ¤U¤È 10:04:05²Ä 897 ½g¦^À³
|
2021.2.22 J&J©u«×·~ÁZ³ø§i johnsonandjohnson.gcs-web.com/static-files/e2a329b4-aeb6-438d-a449-f0e282cf8ee0 ²Ä21¶: J&J¦b2020¦~OTC¾P°âÃB¬°48.24»õ¬ü¤¸¡A¸û2019¦~ªº44.44»õ¬ü¤¸¼Wªø8.5¢H¡C¼Wªøªº¥Dnì¦]¬O¦]¬°·s«aªÍª¢ÅX°ÊTYLENOLªº¾P°â¦¨ªø! -------------------------------------------------------------------------------------------- 48.24-44.44 =3.8»õ¬ü¤¸µ¥©ó¼W¥[ªº¾P°âÃB¬O3.8*28=106.4»õ¥x¹ô(Tylenol¾P°â¦¨ªø>3.8»õ¬ü¤¸¡A¦]¬°¦³¨Ç¶µ¥Ø¨ü·s«aªÍª¢¼vÅT¦Ó§e²{t¦¨ªø) |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/3/4 ¤U¤È 05:37:07²Ä 896 ½g¦^À³
|
³Ì¦n¬O¤½¥q¯à¿ì³õªk»¡·|,¹ï§ë¸ê¤HÁ¿²M·¡»¡©ú¥Õ ¥h¦~¦X¤@¦ü¥G¤]¬O¦bªk»¡·|«á¤£¤[´Nñ¬ù±ÂÅv¤F~ |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/3/4 ¤U¤È 03:42:03²Ä 895 ½g¦^À³
|
¤µ¦~ªYÄ£¹wp´£¤WÂd¡A¤@©w±o¦³¦¨ÁZ¤~¦æ¡F«O¦u¦ô¤@Áû¦Ü¤Ö300¤¸¡A2Áû¦Ü¤Ö500¤¸¡AYı±o¤Ó¤Ö¦Û¤v·Q¹³¡C |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/3/3 ¤U¤È 02:39:37²Ä 894 ½g¦^À³
|
¤½¥qºô¯¸ ½Ð°Ý¶Q¤½¥q¦³¥Ó½Ð¤W¥«Âdªº®Éµ{ªí¶Ü? §Ú̦³³W¹º2021¦~©³´£¥X¤WÂd¥Ó½Ð¡A±©¸gÀÙÁ`Å骬ªp¡B°ê»Ú¬Ì±¡¡B±ÂÅv¶i«×µ¥½Ñ¦h¦]¯À·|¼vÅT¤WÂdªº°e¥ó®É¶¡¡C ¬O§_¤µ¦~´N·|¦³¨½µ{ª÷¤J±b¡Aȱo´Á«Ý¡A¥[ªo |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/3/3 ¤U¤È 12:43:05²Ä 893 ½g¦^À³
|
«ç»ò¤F °Ê°_¨Ó¤F ¬Q¤Ñ¤]¦³·Pı¦³¸êª÷¶i³õ¤F µS¿Ý¶¡n¤£n¥[½X´N¤W¥h¤F |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/3 ¤W¤È 09:02:10²Ä 892 ½g¦^À³
|
µL¨x¬r©Ê¤îµh·sÃÄ¡B¸Ñ¬r¾¯SNP-810Ävª§¤O: 1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ« 2.¥i§ð¦û¼s¤j¥«³õ¡]NSAID, COX-2 §í¨î¾¯¡BOpioidsÃþ¤îµhÃÄ¥«³õ¡^ 3.¥i¬Ù°£¶D³^¶O¡B±Ð¨|°V½m¶O Opioids(¾~¤ùÃþÃĪ«¤îµhÃÄ)---¶Â¥Õ¦§g:§O¤Hªº¥¢±Ñ´N¬O§Úªº§Ö¼Ö¡m©¯¨a¼Öº×?¡n |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/3 ¤W¤È 08:51:56²Ä 891 ½g¦^À³
|
2021.02.22 ½Ö±N¦¨¬°¤U¤@¥ôFDAt³d¤H¡H www.nytimes.com/2021/02/20/health/Covid-FDA-Biden.html ³Ì«á¤£½×½Ö¤W¥ôFDA§½ªø¡A³£¬OÅK©w¥[±jªü¤ùÃĪ«ºÞ±±¤O¹D!(¶Â¥Õ¦§g:§O¤Hªº¥¢±Ñ´N¬O§Úªº§Ö¼Ö¡m©¯¨a¼Öº×?¡n |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/3 ¤W¤È 08:40:44²Ä 890 ½g¦^À³
|
Á}Ãøªº¥¿Å-¯kµhºÞ²z¡AÃĪ«¦w¥þ©Ê©MFDA(Janet Woodcock, M.D.)---ÃĪ«nݨãÀø®Ä©Ê»P¦w¥þ©Ê¡AÃø¨o! www.nejm.org/doi/full/10.1056/NEJMp0908913 ....¹ï¤A酰®ò°ò×ô¬O³Ì±`¥ÎªºÂíµhÃĤ§¤@..... ---------------------------------------------------------------------------- 2021.2.5 pharmaphorum.com/views-and-analysis/dilemma-for-biden-as-woodcocks-audition-for-fda-chief-stumbles/ Janet Woodcock¥Ø«e¬OFDA¥N²z§½ªø¡A«ôµn´£¦W¦o·íFDA§½ªø¡A¤wÅý«ôµn³´¤J§x¹Ò! ì¦]¬OJanet Woodcock¥¼¯àªý¤îªü¤ùÃþÃĪ«ªºÀݥΡA¤º¥~³¡¤@°ï¤HÃhºÃ¦o¬O§_¾A¥ôFDA§½ªø? |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/3/3 ¤W¤È 08:19:47²Ä 889 ½g¦^À³
|
810ªº¼Ï¯Ã¹êÅç¶}©l¤F¶Ü ¬O§_ÁÙnµ¥6Ó¤ë? ¹êÅ秹¤~¦³±ÂÅv¥i¯à? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/2 ¤U¤È 09:09:02²Ä 888 ½g¦^À³
|
2020.07.27 ¬ã¨s¡G»P¦Û±þ¦³Ãöªº«D³B¤èÂíµhÃįf¨Ò¦b¤k©Ê©M¨àµ£¤¤[¤j´T¼W¥[] www.news-medical.net/news/20200727/Study-Suicide-related-OTC-analgesics-cases-have-increased-dramatically-among-females-and-children.aspx ªø´Á¥H¨Ó¡A¹ï¤A酰®ò°ò×ô¡A¥¬¬¥ªâ©M¤A酰¤ô·¨»Ä¡]ªü¥q¤ÇªL¡^µ¥«D³B¤è¡]OTC¡^ÂíµhÃĤ@ª½¬O®a®xªvÀø¯kµh ..«X¥è«X¦{¤¤³¡¬rª«¤¤¤ßªº¬ã¨s¤Hû¤ÀªR¤F±q2000¦~¨ì2018¦~¶¡°w¹ï»POTCÂíµhÃĦ³Ãöªº¦Û±þ¬ÛÃö®×¥ó..¦b¦¹´Á¶¡¤À§OÅãµÛ¼W¥[¤F57¢H©M34¢H... ----------------------------------------------------------------------------------------------- ¬Ý¨ÓFDAªº¨î±¹¬I¨S¦³¦¨®Ä¡A¾¬±æµL¨x¬rAPAPºÉ³t¤W¥«§a!!! |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/3/2 ¤U¤È 02:09:18²Ä 887 ½g¦^À³
|
¥ÏÃâ¡A§ÚÁÙ¬O»{¬°¦³¤H°½¦Y³f¡A¥§¡»ù¦b94 |
|
|
·|û¡Gop123410143906 µoªí®É¶¡:2021/3/2 ¤W¤È 08:02:18²Ä 886 ½g¦^À³
|
·PÁ¤p¤å¤lªº¸ê°T: 2021/2/4meetav¤j©Ò»¡ªº¡C ¥xÆW¥Í§Þ§j¤ûªº¤Ó¦h¡C ¦³¨Ç¤½¥q»¡2020²Ä¥|©u¦³¦n®ø®§¡C µ²ªG¨ì2021²Ä¤@©unµ²§ô¤F¡C¤°»ò³£¨S¦³¡C ¯uªºÄF«Ü¤j¡A¤S»¡ªÑªF¤H¼Æ¤S¤Ö¤F¡A¥i¨£n§ë¸ê¥xÆW¥Í§Þ¡A¯uªºn¸C¤j²´·ú¡C |
|
|
·|û¡G¤p¤å¤l10144877 µoªí®É¶¡:2021/3/2 ¤W¤È 07:37:59²Ä 885 ½g¦^À³
|
¥Í§ÞªÑªº¦n®ø®§±µ¿æ¦Ó¨Ó¡A¤w¬°ªYÄ£çE¤U¦nªº°_¤â¦¡¡A§Æ±æ±µ¤U¨Ó¯u¯à¤@»ïÅå¤H¡C¡C¡C ¥»¸ê®Æ¥Ñ¡@ (¤W¥«¤½¥q) 6541 ®õºÖ-KY¡@¤½¥q´£¨Ñ §Ç¸¹ 1 µo¨¥¤é´Á 110/03/02 µo¨¥®É¶¡ 04:54:28 µo¨¥¤H »¯¦t¤Ñ µo¨¥¤H¾ºÙ ¸³¨Æªø µo¨¥¤H¹q¸Ü 02-27010518 ¥D¦® ¥N¤l¤½¥qTanvex BioPharma USA, Inc.¤½§i»PAmgen Inc. ñq¥»¤½¥q²£«~TX01¥[®³¤j±M§Q¨óij ²Å¦X±ø´Ú ²Ä 10 ´Ú ¨Æ¹êµo¥Í¤é 110/02/27 »¡©ú 1.¨Æ¹êµo¥Í¤é:110/02/27 2.«´¬ù©Î©Ó¿Õ¬Û¹ï¤H:Amgen Inc. 3.»P¤½¥qÃö«Y:«DÃö«Y¤H 4.«´¬ù©Î©Ó¿Õ°_¨´¤é´Á¡]©Î¸Ñ°£¤é´Á¡^:¬ü°ê®É¶¡2021/02/26 5.¥Dn¤º®e¡]¸Ñ°£ªÌ¤£¾A¥Î¡^:¥»¤½¥q¤l¤½¥qTanvex BioPharma USA, Inc. »PAmgen Inc.©ó¬ü°ê®É¶¡2021/02/26ñ¸p¨óij¡AAmgen¦P·N®õºÖ¥Í§Þ¨Ï¥Î ¸Ó¤½¥q¦b¥[®³¤jªº±M§Q°õ·Ó¡C¥Dn±ø´Ú±ø¥ó¦]Âù¤è«´¬ù«O±K¬ù©w¤£¤©¥H ´¦ÅS¡C 6.¨î±ø´Ú¡]¸Ñ°£ªÌ¤£¾A¥Î¡^:µL¯S®í¨î±ø¥ó¡C 7.©Ó¿Õ¨Æ¶µ¡]¸Ñ°£ªÌ¤£¾A¥Î¡^:¨Ì¨óij¤º®e¡C 8.¨ä¥L«n¬ù©w¨Æ¶µ¡]¸Ñ°£ªÌ¤£¾A¥Î¡^:¨Ì¨óij¤º®e¡C 9.¹ï¤½¥q°]°È¡B·~°È¤§¼vÅT:¨Ì¾ÚIQVIAÉ]³õ½Õ¬d¤½¥q¤§²Îp¡AªvÀøÀù¯g¤ÆÀø ©Ò¤Þ°_¤§¶Ý¤¤©Ê¥Õ¦å²y´î¤Ö¯gTX01 (ì¼t°Ñ¦ÒÃĪ«¬°Neupogen)(Filgrastim)¡A ¬ÛÃö²£«~¦b¥[®³¤j¤§¥«³õ³W¼ÒºI¦Ü 2020¦~6¤ë¤§¹L¥h12Ӥ몺¾P°âÃB¬ù ¤@»õ¨â¤d¤T¦Ê¸U¥[¹ô¡A¥»¤½¥q°£¤F¥D§ð¥Íª«Ãij̤j¤§¬ü°ê¥«³õ¥~¡AÂǥѻP°Ó·~¹Ù ¦ñ¤§¦X§@±N¤½¥q²£«~¾P°â¨ì¨ì¥_¬ü¥«³õ¡A¦¹¶µ¨óij¥i±Æ°£®õºÖ·m§ð¥[®³¤j¥«³õªº «IÅvºÃ¼{¡A¤@¥¹¨ú±o¥[®³¤jÃÄÃÒ¡A´N¯àª½±µ¤W¥«¾P°â¡A´£¤É¤½¥q¾ãÅé§Q¯q¤Îªø´Á »ùÈ¡C 10.¨ãÅé¥Øªº:TX01¨ú±o¥[®³¤jÃÄÃÒ«á¡A¯àÅýÃÄ«~¥[³t¶i¤J¥[®³¤j¥«³õ¾P°â¡A ¼W¥[¤½¥qªø´ÁÀò§Q¤Îªø´Á»ùÈ¡A¹ï¤½¥q°]°È·~°È¦³¥¿±¼vÅT¡C 11.¨ä¥LÀ³±Ô©ú¨Æ¶µ:¥Íª«¬Û¦üÃĶ}µo®Éµ{ªø¡B§ë¤J¸g¶O°ª¥B¥¼«OÃÒ¤@©w¯à¦¨¥\¡A ¦¹µ¥¥i¯à¨Ï§ë¸ê±Á{·ÀI¡A§ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/1 ¤U¤È 12:44:54²Ä 884 ½g¦^À³
|
FDA»PÂåÀø¤Hû¾~¤ù´î¶q¤j§@¾Ô! 2021.02.23 www.sciencedirect.com/science/article/abs/pii/S0736467921000317?dgcid=rss_sd_all ... µ²ªG ±µ¨ü¥ô¦óªü¤ùÃþÃĪ«...ªº¸yµh±wªÌ¦b30¤Ñ¤º¦^³Xªº¤ñ¨ÒÅãµÛ¼W¥[¡]32¢H[OR 1.78 {95¢HCI 1.21-2.64}]¡F 33¢H[OR 1.83 {95»P±µ¨ü«DÍrÅéÃþ§Üª¢ÃÄ¡]19¢H¡^¡A¹ï¤A酰®ò°ò×ô¡]20¢H¡^©Î«DÍrÅé§Üª¢ÃĪº±wªÌ¬Û¤ñ¡A¤À§O¬°¢HCI 1.18-2.86}]©M39¢H[OR 2.38 {95¢HCI 1.35-4.12}]¡C¨âªÌªºµ²¦X¡]8¢H¡^¡C µ²½× »P±µ¨ü«DÃþ©T¾J®øª¢¤îµhÃÄ(¥¬¬¥ªâ/ªü´µ¤ÇÆF)©Î¹ï(APAP)¤A酰®ò°ò×ôªº±wªÌ¬Û¤ñ¡A±µ¨ü[ªü¤ùÃþ]ÃĪ«ªº±wªÌ¦b30¤Ñ¤º§ó®e©öªð¦^«æ¶E«Ç¡C³oªí©ú¦b«æ¶E«Ç¨Ï¥Îªü¤ùÃþÃĪ«ªvÀø¤U¸yµh¥i¯à¤£¬O¤@ºØ¦³®Äªºµ¦²¤¡A¨Ã¥B¥i¯à¦³¾÷·|¥Î [«Dªü¤ù]ÃþÃĪ«¾A·íªvÀø[§ó¦h]¦¹Ãþ±wªÌ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/1 ¤W¤È 11:18:43²Ä 883 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/4 ¤U¤È 10:36:38²Ä 692 ½g¦^À³ ¤@¤H¤§«ä¼{¦³¡A¤£¥iÁ`ª¾¼Æ¾¡A¤£°µ¨¥»y¤Wªº§ðÀ»¡A¦hªÅ¶K¤å¸Û¤ßÅwªï¡C ----------------------------------------------------------------------------------- ¡u®ü¯Ç¦Ê¤t¦³®e¤D¤j¡A¾À¥ß¤d¥QµL±ý«hè¡C¡v |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/1 ¤W¤È 11:11:55²Ä 882 ½g¦^À³
|
¬ü°ê¾~¤ù¦M¾÷---¶Â¥Õ¦§g:§O¤Hªº¥¢±Ñ´N¬O§Úªº§Ö¼Ö¡m©¯¨a¼Öº×?¡n 2018¦~¬ü°ê¤ú¬ì¨ó·|´Á¥Z«Ê± ¥¬¬¥ªâ(Advil)©M¹ï¤A酰®ò°ò×ô(APAP)ªº²Õ¦X [Àu©ó] ©Ò¬ã¨sªº¥ô¦ó§tªü¤ùÃþªº¤îµhÃĪ«¡C 2014¦~FDA¤½§i°Ç¥O°±¤î»s³yAcetaminophen§t¶q¶W¹L325 mgªº [½Æ¤è]ÃÄ«~¡A¥H´î§C¨x¬r°Æ§@¥Î¡A¨Ã¦P®É¤]¤£ãÂå®v³B¤è©M½Õ¾¯¡C ---------------------------------------------------------------------------------------------- medicalxpress.com/news/2018-04-ibuprofen-acetaminophen-effective-opioids-dental.html ....¬ã¨s¤F¤ú¬ì«æ©Ê¯kµhªº½w¸Ñ±¡ªp¡A¸Ó¬ã¨sµû¦ô¤F¼Æ¤QºØ½w¸Ñ¯kµhªº¤èªkªº¦w¥þ©Ê©M¦³®Ä©Ê¡C....¬ã¨sµo²{¡A¹ï©ó¦¨¦~¤H¨Ó»¡¡A400mgªº¥¬¬¥ªâ©M1000mgªº¹ï¤A酰®ò°ò×ôªº²Õ¦XÀu©ó©Ò¬ã¨sªº¥ô¦ó§tªü¤ùÃþÃĪ«¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/2/27 ¤U¤È 09:26:56²Ä 881 ½g¦^À³
|
¥u¬O´£¨Ñ¼Æ¾Úµ¹¤j®a°Ñ¦Ò¡A¤£³ßª«Å¥¡C¤j¼Æªk«h¡C nÁ|¨È·à±d¡A§Ú¤]¦³°Ñ»P¡C§N¼ö¦Ûª¾¡C¥ú¬O´«ªÑ´N·dªº¨ü¤£¤F¡C¦ý¥Ø«e¬O¦nªº¡C ¹³¤§«eªº¬u²±´«ªÑ¤]¬O³Â·Ð¤@°ï¡C µo°]¤£¥u¬O²´¥ú¡AÁÙn³øªº¤[¡C ¥u¬O»¡¨CÓ¤Hªº¸êª÷¤ßºA³£¤£¤@¼Ë¡C¦³ÁȤ~¬O¤ý¹D¡C °O±o¤§«eªYÄ£¯}70®É¡A¬Y¤j¤á¥X²M´X¦Ê±i«ùªÑ¡A§âªYÄ£±þ¨ì50¤¸¡Aµ²ªG¨S¦h¤[¡A¦³¤Ñ´N®tÂIº²Â_¤F¡A¨º¦ì¤j¤á¯uªº¤ÖÁȫܦh«Ü¦h«Ü¦h¡A©Ò¥H»¡¡A¿Ñ¨Æ¦b¤H¡A¦¨¨Æ¦b¤Ñ¡A¤Z¨Æ¤H¤@©wn¦³©Ò¥»¡A¤£¯à¤H¤ª¥ç¤ª¡A§Ú¤Ö¶q«ù¦³¡A¥u·Q¦³¤Ñ¯à°Ñ»P¨ìªYÄ£µo¥úµo¼ö¡C¡C¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/27 ¤W¤È 11:31:52²Ä 880 ½g¦^À³
|
2018.10.24¤t´¶µo°Ê¡u¾~¤ù¾Ôª§¡v µo¥¬¡u¥þ°êºò«æ¨Æ¥ó¡v ¶g¤T¦b¥Õ®cñ¸pªk®×¡A¸Óªk®×³z¹L´î¤Ö¾~¤ùÃþÃĪ«ªº¨ÑÀ³¤Î¨ú±o¡A·f°t¹w¨¾¤ÎªvÀø±¹¬I¡A¥HÀ³¹ï¾~¤ùÃþÃĪ«ÀݥΰÝÃD¡C ¦¹«áFDAªº«ü«n´N¬On¨DÂåÀø¤Hû³Ì¤jµ{«×ªº´î¤Öªü¤ùÃþÃĪ«¨Ï¥Î¡AºÉ©Ò¯à¥Î«D¾~¤ùÃþ¤îµhÃĨú¥N! www.eurekalert.org/pub_releases/2021-02/acos-gfr022421.php --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/25 ¤U¤È 01:59:02²Ä 863 ½g¦^À³ 2021.2.18¬ü°ê¦Õ»ó«|³ï¬ìÂø»x---[´î¤Ö]³N«á¦Õ»ó³ï¬ì±wªÌ¨Ï¥Î[ªü¤ùÃþÃĪ«] ...¤z¹w«á¶}¥Xªº¥¬¬¥ªâ©M¹ï¤A酰®ò°ò×ôªº¶q¤À§O [¼W¥[]¤F113¢H©M71¢H¡C --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/25 ¤W¤È 08:55:46²Ä 855 ½g¦^À³ [³B¤è¾Þ§@]---»¡¥Õ¸Ü´N¬O¶}¥ßAPAPªº¶q¼W¥[°Õ!!!!! §¨Óªá14»õ¬ü¤¸¡AµL«D´N¬On·mªü¤ù¦M¾÷«áªº[«D]¾~¤ùÃþ¤îµhÃĪ«¥«³õ! www.sciencedirect.com/science/article/abs/pii/S0196070921000922?dgcid=rss_sd_all ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/25 ¤W¤È 07:44:24²Ä 853 ½g¦^À³ ³oÓ¬ã¨sY¥ÎµL¨x¬rSNP-810°õ¦æ¡AAPAP§t¶q¥i¦A´£°ª¡A¤îµh®ÄªG¼Æ¾ÚªÖ©w§ó´Î! ¬ü°ê¾~(ªü)¤ù¦M¾÷¡A¨Ï±oAPAPªº¤@½uÃĪ«¦a¦ì§ó¨ü«µø!!! ¦Ò¼{¨ì¨äÀu¶VªºÀø®Ä©M@¨ü©Ê¡A¼³¼ö®§µh(APAP)¦ü¥G¬OªvÀø«æ¶E¬ì¥X°|«á»´«×¦Ü¤¤«×³Ð¶Ë«áªÏÅé¯kµhªº³Ì¦X¾Aªº¤@½uªvÀø¤èªk¡C Ų©óªü¤ùÃþÃĪ«ÀݥΦM¾÷¡A[³o¶µ¬ã¨s´£¨Ñ¤FÃÒ¾Ú¤ä«ù¦¹Ãþ±wªÌ³æ¿W¨Ï¥Î¹ï¤A酰®ò°ò×ô¡C] --------------------------------------------------------------------------------------- 2021¦~2¤ë8¤é ...¯Ã¬ù¦{¶øº¸¤Ú¥§¶øº¸¤Ú¥§Âå¾Ç¤¤¤ßªº¬ã¨s©M¾Ç³N¨Æ°È°Æ¥D®uÝ«æ¶EÂå¾Ç±Ð±Â¦w¼w¾|¡P±i¡]Andrew Chang¡^³Õ¤h¹ï¸Ó¬ã¨sµoªíµû½×¡G...¦ý¬O¼³¼ö®§µh¤ñ«DÍrÅé§Üª¢ÃÄ¥X©_ªºÀø®Ä¡]¦p¹ï¨ä¥L¤fªAÂíµhÃĪº»Ý¨D°§C¤F6.4¢H©Ò¥Ü¡^¥i¯à·|¼vÅT³B¤è¾Þ§@¡A¨Ò¦p¡A³\¦h±w¦³NSAIDSªº¸T§Ò¯g¦ý¦bED¥X°|®É»Ýn¨Ï¥Î¤îµhÃÄ¥i¯à·|¶}¥Xªü¤ùÃþÃĪ«¡CŲ©óªü¤ùÃþÃĪ«¤´¦b¬y¦æ¡A³o¶µ¬ã¨s´£¨Ñ¤FÃÒ¾Ú¤ä«ù¦¹Ãþ±wªÌ³æ¿W¨Ï¥Î¹ï¤A酰®ò°ò×ô¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/27 ¤W¤È 09:46:03²Ä 879 ½g¦^À³
|
·sÃħë¸ê¤£n¤Ó¦b·NÄw½X¨Ó¨Ó¥h¥h(µu½uªÌ«äºû)¡A¯u·Qµo¤j°]»Ýnªº¬Oºë½T¬Ý·Ç¦³µo®i¼ç¤O»PÄvª§¤OªÌ! ¥hÆ[¹î¥_·¥¬P2020.03.6~2021.02.26Äw½XÅÜ°Ê,ªÑ»ù10¤¸¦h¡A¦Ê±i¤d±i¤j¤á«ùªÑ´î¡A2021.3.3°_ªºµo®i¤w¥i·Q¦Óª¾! ¶P³ß¥_·¥¬P!(«¥¨S¶R½æ) 2021.02.26¥_·¥¬PªÍ¶¡¥ÖÀù¤T´Á´Á¤¤¤ÀªR¡A¾ãÅé¥Í¦s´Á¹F³Ì°ªµ¥¯Åªº ²ÎpÅãµÛ®ÄªG¾÷²v80%¥H¤W! ----------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/6 ¤W¤È 06:19:31²Ä 729 ½g¦^À³ ¤@°ï¤H§N¼J¼ö¿Ø¤U¥«ªº¨È·à±d¡AÁà¤pÀn²×©óÅܤÑÃZÅo!²´¥úµR§Q¦ý¤â¹B¦³®É¤]¤£¨Î¡A¤@±ÑÃĵءC ªYÄ£´Nn¤@½¨âÀü²´¶}µP©w¿éĹ! [·|û¡GROGER588910148151 µoªí®É¶¡:2019/11/11 ¤U¤È 04:33:19²Ä 1500 ½g¦^À³ ¥¢±Ñ¨Ã¤£¥i©È¡A¤ßºA¨M©w¤F§ÚÌ·|¦p¦ó¦^À³!§ë¸êµJÂI»P§ë¤J»ù¦ì¤£¦P¡A©Ò¯à©Ó¨üÀ£¤O´N¤£¤@P¡C «¥10¶ôªì§ë¤J¡A¬OÀ£µ¥«½SÃĪ«ASLAN004½µP!©ó«¥¨Ó»¡¡A©ú¦~¤~¬O¨£¯u³¹Â_¥Í¦º®É¨è¡C] |
|
|
·|û¡G¤p¤å¤l10144877 µoªí®É¶¡:2021/2/27 ¤W¤È 06:24:59²Ä 878 ½g¦^À³
|
dk¤j¡G °O±o¤§«eªYÄ£¯}70®É¡A¬Y¤j¤á¥X²M´X¦Ê±i«ùªÑ¡A§âªYÄ£±þ¨ì50¤¸¡Aµ²ªG¨S¦h¤[¡A¦³¤Ñ´N®tÂIº²Â_¤F¡A¨º¦ì¤j¤á¯uªº¤ÖÁȫܦh«Ü¦h«Ü¦h¡A©Ò¥H»¡¡A¿Ñ¨Æ¦b¤H¡A¦¨¨Æ¦b¤Ñ¡A¤Z¨Æ¤H¤@©wn¦³©Ò¥»¡A¤£¯à¤H¤ª¥ç¤ª¡A§Ú¤Ö¶q«ù¦³¡A¥u·Q¦³¤Ñ¯à°Ñ»P¨ìªYÄ£µo¥úµo¼ö¡C¡C¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/2/27 ¤W¤È 01:08:29²Ä 877 ½g¦^À³
|
¤µ¤Ñ´«´I¨¹¥X¡K¨º³o¦h±i¡I¨C¤Ñ³£¥XӦʨӱi |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/26 ¤U¤È 04:10:08²Ä 876 ½g¦^À³
|
¥È¯µ¼Æ¦r¦Û§Ú¸ÑªR¡G±þ½L±þ¨ì87¡A½T©wÀø効±ÂÅv®ø®§µo§G±j©Ô168¡A«áÄò¦h«§Q¦h³sµo¡A¤W¤W¤U¤U¬~¨êª½§ð³»®p886¡A³Õ§g¤@¯º¡C |
|
|
·|û¡GRock00910149258 µoªí®É¶¡:2021/2/26 ¤U¤È 03:37:07²Ä 875 ½g¦^À³
|
¦n°Õ!¦¬½L¤F©ñ»´ÃPÂI ÃD¥~¸Ü¡A³o¨â¤Ñ³sÄò¦¬½L88.8¡A¬Q¤Ñ§Ú¨S¬Ý¡A¤µ¤Ñ©úÅã°µ»ù88.8 ¬O¦b·t¥Ü¤°»ò¶Ü??? ¦L¶H¤¤³Ìªñ«Ü¬y¦æ¤j¤á±¾³æ·t¥Ü886/168/87... |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/2/26 ¤U¤È 02:50:28²Ä 874 ½g¦^À³
|
¦h¦h¤j§Q®` ¤p²Ä¬O±qÄ_0¶}©l¶R¥Í§Þ¡AÁȳ̦hªº¬O¬u²±´«µoªº¦X¤@¡A¥h¦~´N¾a¥L¤F~~n¤£¬O¤¤¤Ñ¤£¦Ñ¹ê¤@ª½¦X¨Ö´«ªÑ¦¨¦X¤@¡A¥H¥¦ªºªÑ¥»¡A¤£ª¾·|¼Q¨ì¨º¡C§Æ±æ¦p±z©Ò»¡¡A·sÃÄ¥i¥HÅý§ÚÌ´£¦°h¥ð --------------------------------- ¥Í§ÞªÑ¯uªº¬O¦ÒÅç¤Hªº@¤ß »»·Q·í¦~¤p§Ì¥¼¤W¥«¶R¤F¯E¹© |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/2/26 ¤U¤È 02:27:43²Ä 873 ½g¦^À³
|
¥Í§ÞªÑ¯uªº¬O¦ÒÅç¤Hªº@¤ß »»·Q·í¦~¤p§Ì¥¼¤W¥«¶R¤F¯E¹© ¶Ì©I©Iªº¤£ºÞ¥Lº¦¶^,³ºµM¦³1/4«ùªÑ¥X¦b700~750¤§¶¡ ¥i¯à¦³¦¹¶Ì«lªº¤]¤£¦h~ §Æ±æ³o¦¸ªYÄ£¯à°÷¦A¦¸¨göt,´N¦¹°h¥ð!!©Ò¥HÄ~Äò©êºò~ ¥t¥~®¥³ß¯E¹©¤º½u®×Àò§PµL¸o½T©w!! ¤]¯¬ºÖ¯Î°|ªø¼u¨ð®×¯à³QºM®×,¶¶§Q¨ú±o¿Õ¨©º¸¼ú ¥xÆW¥Í§Þ·~¥[ªo~ |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/2/26 ¤U¤È 12:41:33²Ä 872 ½g¦^À³
|
©Ò¥H§Ú¯d¤@¥b¡A³£¦í110¼Ó¤F¡A¥un¤@®Ú´N¦^¥»§a ¥i±¤¤S©ê¤W©ê¤U¡A¥»¨Ó¦³ÁÈ¿ú·d¨ì½ß¿ú ±ÂÅvª÷¥Ø«e¨S¦³¡A¥u¦³Ã±¬ùª÷§a ¤£¹Ln±ÂÅv¤]¬O¬ðµM¤½¥¬§a¡A¨S¤º®w½u¤°»ò³£¤£ª¾¨ì .................................... º¦¨S¦³¦h¤Ö ¶^¤ñ§O¤H¦h ¤j¦h¼Æ¤H§Q¦h°l¶R®M ¯àÁÈ¿úªº¬O¶Rºñ¤£¶R¬õ ¦Ü´LªÑ¤ý¸¨Ãø³Q¤ü´Û ±ÂÅv¦¨¥\·|¯º¼H¼H ªù²¼¦b¤â ÅK©w¶}¼ú ¶}¼ú®É¨Sªù²¼À³¸Ó·|¦³ÂI¹Ã ÁÙ¬O§âªù²¼´¤¦b¤â¤¤¸û¹ê¦b |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/2/26 ¤U¤È 12:13:06²Ä 871 ½g¦^À³
|
º¦¨S¦³¦h¤Ö ¶^¤ñ§O¤H¦h ¤j¦h¼Æ¤H§Q¦h°l¶R®M ¯àÁÈ¿úªº¬O¶Rºñ¤£¶R¬õ ¦Ü´LªÑ¤ý¸¨Ãø³Q¤ü´Û ±ÂÅv¦¨¥\·|¯º¼H¼H ªù²¼¦b¤â ÅK©w¶}¼ú ¶}¼ú®É¨Sªù²¼À³¸Ó·|¦³ÂI¹Ã ÁÙ¬O§âªù²¼´¤¦b¤â¤¤¸û¹ê¦b |
|
|
·|û¡G¤p¤å¤l10144877 µoªí®É¶¡:2021/2/26 ¤W¤È 10:40:31²Ä 870 ½g¦^À³
|
¤§«e¦b12¤ë©³Ã±ªº¦X§@¨óij¡A¤wªí©ú¦³Ã±¬ùª÷¡A·Ó쥻¶i«×¡A³Ì¿ðÀ³¸Ó¦b2¤ë·|¦¬¨ì¡A¦ý¤S¥d¨ì§Ú̹A¾ä¦~¹L¦~¡A¤µ¤Ñ¬O¤G¤ë³Ì«á¥æ©ö¤é¡A¤£ª¾¬O§_·|¦³Åå³ß¥X²{¡C¡C¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/2/26 ¤W¤È 08:57:07²Ä 869 ½g¦^À³
|
¬üªÑ¤j¶^¡A¬Ý¬Ý¦³¨S¦³«K©y¾ß ¥i±¤¬Q¤Ñ¨S¥X§¹ n¬O°f¶Õ©Ô°ª¦³¦³ª¿¤F |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/2/25 ¤U¤È 11:32:20²Ä 868 ½g¦^À³
|
·Q¾ß«K©yªº·íµM§Æ±æ¥¦ªºªÑ»ù¶V§C¶V¦n😎 |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/2/25 ¤U¤È 10:35:22²Ä 867 ½g¦^À³
|
¥Í§ÞªÑÁÙ¨S¶×¶°¤H®ð«e¡A¸êª÷¥u¦³¤@®M¡A·|¸IªÖ½äÄ@·N§ë¸êªº´N¨º¨Ç¤H¡A¤p§Ì¤§«e¤jÁx±À½×´N¬O¤@¨Ç¯S©w¤j¤á¶]¥h·m¦X¤@¤F¡A¬Ý¬Ý¤µ¤é¨é°Ó¶i¥X¥iª¾¡Aªñ´Á¥i¯àªº§Q¦h¥ý·Ç³Æ¤@¤U¡A¤G¤ëÀ禬¤½¥¬¡A¾Ç¦WÃĨúÃÒ¡A¤G¥N¯×ªÕ¨x¥Ó½Ð¸ÕÅç¡AªÑªF·|¬O§_´£¥XÂà¤WÂdµ¥.... |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/2/25 ¤U¤È 10:19:14²Ä 866 ½g¦^À³
|
ªG¤£¨äµM¤j¤á¸¨¶]¡A¨g½æ¡IªÑ»ù¯}½L»ù¡A©ú¤Ñ¦u¤£¦í¡I¥t¤@¥b¤]»{½ß¥X³õ¼Ú¡Iµ¥§C¦A±µ¡K¤¤¶¡¤£nµ¹§Úµo§G±ÂÅv¡A¤£µM§Ú±µ¤£¦^¨Ó |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/25 ¤U¤È 02:37:18²Ä 865 ½g¦^À³
|
±M®aÆ[ÂI¡þ«D¾~¤ùÃþ¤îµhÃÄ ¼ç¤O¤Q¨¬ www.cpmda.org.tw/news_show_n1.php?news_id=8691 ...¬ü°ê»{¬°¾~¤ùÃþ¤îµhÃÄÀݥΡA¤w¹F¨ì¡u¤½¦@½Ã¥Íºò«æª¬ºA¡vµ{«×¡A¨Ã¶É¦V§¹¥þ¸T¥Î¾~¤ùÃþ¤îµhÃÄ¡C ¨ä¹ê¦b·sÃĬãµo¤¤¡A¤£¥Fªñ¦~¨Ó¿n·¥¥¬§½©ó¤îµhÃĪ«½dÃ¥ªº·sÃĤ½¥q¡A¨ä¤¤¡AªYÄ£¥ÍÂå¤Î¶¶Ãħ¡¬°³oÓ»â°ìªºË³Ë³ªÌ¡CªYÄ£¥ÍÂå¥D¥´µL¨x¬r¤îµh¡u·s°t¤è·sÃÄ¡vSNP-810«YªýÂ_¤AñQÓi×ô©Ò²£¥Íªº¨xŦ¬r©Ê¥NÁª«ªº¥Í¦¨¡A¦Ó«D±Æ°£¬rª«¡A¤j¤j°§C¤F¹L¶q¨Ï¥Î¤AñQÓi×ô©Ò³y¦¨ªº¨x¬r©Ê·ÀI¡C¶i¦Ó¸Ñ¨M¤Fªø¤[¥H¨Ó¥O¬ü°êFDAÀYµhªº°ÝÃD¡AÄÝ©ó¡u¥i¤j´T°§C°Æ§@¥Î¤§·sÃÄ¡v¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/25 ¤U¤È 02:23:59²Ä 864 ½g¦^À³
|
2021.1.11 ¬ü°ê¥qªk³¡ªøµo¤åFDA nÀˬdFDA¦b¹ï§Üªü¤ùÃþÃĪ«ÀݥΪº³Ì·s¶i®i¡C ..... ¥qªk³¡ªø»{¬°¡AFDA¦b½T«Oªü¤ùÃþÃĪ«ªº¦w¥þ©Ê©M¦³®Ä©Ê¥H¤Î¹ªÀy¨Ï¥Î«D¦¨Å}©Ê¡A«Dªü¤ùÃþÃĪ«´À¥N«~¨ÓªvÀø¯kµh¤è±°_µÛ¦ÜÃö«nªº§@¥Î¡C www.naag.org/opioids/press-releases/attorneys-general-push-fda-to-examine-progress-in-opioid-fight/ --------------------------------------------------------------------------------------------- «Dªü¤ùÃþ¤îµhÃĪ«§Y±Nªï¨Ó§ó¤j¦¨ªø°Ê¯à! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/25 ¤U¤È 01:59:02²Ä 863 ½g¦^À³
|
2021.2.18¬ü°ê¦Õ»ó«|³ï¬ìÂø»x---[´î¤Ö]³N«á¦Õ»ó³ï¬ì±wªÌ¨Ï¥Î[ªü¤ùÃþÃĪ«] ...¤z¹w«á¶}¥Xªº¥¬¬¥ªâ©M¹ï¤A酰®ò°ò×ôªº¶q¤À§O [¼W¥[]¤F113¢H©M71¢H¡C www.sciencedirect.com/science/article/abs/pii/S0196070921000922?dgcid=rss_sd_all ------------------------------------------------------------------------------------------ ¬ü°ê¾~¤ù¦M¾÷¡A´î¤Ö¶}¥ß[ªü¤ùÃþÃĪ«]¡A¼W¥[¨Ï¥Î«D¾~¤ùÃþÃĪ«!!! APAPÃĪ«¥«³õ¥²±N¥ÑµäÁY«¦^¦¨ªø>40»õ¬ü¤¸! |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/2/25 ¤U¤È 01:44:19²Ä 862 ½g¦^À³
|
¾¤©ú«eªº¶Â·t¡AÃø¼õ§r ¥Xªº¤@¥bµ¥±µ¦^¨Ó ¦³¨S±ÂÅv®Ö·Ç³£¬O¤º³¡¤H¥ýª¾¡A¨S¤º½u´Nµ¥ |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/2/25 ¤W¤È 11:47:45²Ä 861 ½g¦^À³
|
·PÁÂR¤j´£¨Ñ¸ê®Æ ºûô¤j®aªº«H¤ß ±ÂÅv¶i«×¨}¦n ±ÂÅv¥²©w·|¹ê²{ ¬Û«H¨º¤é¤l¤£»·¤F |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/25 ¤W¤È 11:00:26²Ä 860 ½g¦^À³
|
¦Û2020.12.23¤½§i¦X§@¨óij¡A¥¦æ¹ï·Ó¦X¤@ªºFB825±ÂÅv½Í§P¹Lµ{¡A§g»{¬°SNP-810±ÂÅv½Í§P¤w¨ì¨º¸Ì? --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/9/3 ¤U¤È 10:26:03²Ä 341 ½g¦^À³ ¦Û2019.2¤ëñ¸pÄv·~¸T¤î¤§«O±K¨ó©w°_ºâ¡A¥¦æ¹ï·Ó¦X¤@ªºFB825±ÂÅv½Í§P¹Lµ{¡A§g»{¬°SNP-810±ÂÅv½Í§P¤w¨ì¨º¸Ì? 2020-04-16 01:16¸gÀÙ¤é³ø °OªÌ¶À¤å©_ ¸ô¤Õ©ú¡G¦X¤@±ÂÅv®× ¥Î¬ì¾Ç»¡ªAÃļt °Ý¡G½Ð¤À¨É½Í§P¹Lµ{¡H µª¡G¦X¤@»P§Q¶ø¦Û¥h¦~ªì¶}©l½Í§P¡A¤@¦~¦hªº½Í§P¥u»EµJ¤@¥ó¨Æ¡A´N¬O¬ì¾Ç¡C§Q¶ø¦b³o¬q´Á¶¡¤º¡A±q¥þ²y¦U¦a¬£¨Ó¦U»â°ì±M®a¡A¨Ó¬d®Ö¸Ó¦X¤@ªº¬ì¾Ç¼Æ¾Ú¡C §Q¶ø¬£¨Óªº±M®a¡A³£¬O±Mºë¦³¸gÅ窺¬ì¾Ç®a¡A¡u°ÝÃD°Ý¨ì°©ÀY¸Ì¥h¡v¡A¥þµ{³£¥u¯à¥Î¬ì¾Ç»y¨¥¦^µª¡C ¹ï¤è¤F¸ÑFB825ªº§Þ³N²z½×¡B¹êÅç³]p«á¡A¶}©l°õ¦æÃĪ«ÅçÃÒ¡AÅçÃÒ«áÂù¤è¦A®i¶}°Q½×¡A±o¥Xµ²½×«á¡A¦A¶i¦æ¹ê¦a¬d®Ö(§Q¶ø¬£¦U»â°ì±M®a¨ì¦X¤@¹êÅç«Ç¡AÀ˵ø¹êÅç°O¿ýï¡A¬O³v¶³v¦rÀ˵ø¡AY¹J°ÝÃD¡A²Ä¤@®É¶¡¥Îµø°T¡A¦V¦h°ê±M®a´£°Ý¡A¨Ã¤ÏÂХάì¾Ç»y¨¥°Q½×¡C¦X¤@¬ãµoµ²ªG¬OÅu¦b¶§¥ú¤UÀ˵ø¡AµL©Ò¹P§Î¡C) ¡A¤~¶i¤J½Í§P¡A½Í§P¶}©l«á¡A§Q¶ø¤´¹ïFB825¤ÏÂÐÅçÃÒ¡A½T©w±o¨ì¥LÌ·Qnªºµª®×«á¡A¤~¶}©l½Í±ÂÅv²Ó¸`¡C ............................................................................................ ·|û¡GROGER588910148151 µoªí®É¶¡:2020/8/19 ¤W¤È 10:20:38²Ä 293 ½g¦^À³ ±qñ¸pÄv·~¸T¤î¤§«O±K¨ó©w°_¡A2®a¤jÃļt¤@©w¬O¦b§¹¦¨SNP-810ÀË´ú»PÁ{§É¼Æ¾Ú¼f¬d«á¡A¤~»PªYÄ£¶}°Q½×·|ij¡A¦ÓªYÄ£«h®Ú¾Ú·|ijµ²ªGקïÁ{§Épµe®Ñ¤º®e¡CÓ¤H¬O¥¿¦V¬Ý«Ý! ............................................................................................. ·|û¡G«ä¦Ò¤¤10147262 µoªí®É¶¡:2020/7/23 ¤U¤È 09:36:18²Ä 195 ½g¦^À³ 2019/02 »P¸ó°ê«e¤Q¦W»sÃĤ½¥qñ¸p¦³Äv·~¸T¤î¤§«O±K¨ó©w¡A°Ó°QSNP-810¦X§@¨Æ©y¡C 2019/04 »P¸ó°ê«e¤¦W¤§»sÃĤ½¥q¡A¬ãµo¹Î¶¤¦@¤E¦ì¤£¦P³æ¦ì°ÆÁ`µô¤Î¨Mµ¦¤H¤h¡A¦b¬ü°êÁ`³¡³sÄò¤K¤p®É¡A 2019/04 »P¸ó°ê«e¤Q¦W»sÃĤ½¥q¬ãµo¹Î¶¤¡A¦b¬ü°êÁ`³¡¡A¬¢½Íªø¹F¥|¤p®É¦³Ãö¤îµhÃÄSNP-810¦X§@¨Æ©y¡C 2019/07 »P¸ó°ê«e¤Q¦W»sÃĬü°ê¤½¥q¹Î¶¤Á|¦æ²Ä¤G¦¸¹q¸Ü·|ij¡A²`¤J°Q½×¥þ²yº¨ÒµL¨x¬r¤îµhSNP-810¤§¬ì§Þ¡B¬ãµo¶i«×¤Î¦X§@¨Æ©y¡C 2019/12 »P¸ó°ê«e¤Q¦W»sÃĤ½¥q¬ü°ê¡B¼Ú¬w¡B·ç¤h¤§°Ó·~µo®i¡B¬ãµo³¡¤Î±M§Q«ß®v¡AÄ~«e¤T¦¸§¹¦¨¬ì§Þ¤Î¬ãµo¶i«×«á¡A²Ä¥|¦¸Á|¦æ¦¸¹q¸Ü·|ij¬¢½ÍSNP-810¦X§@¡B±ÂÅv¡B°Ó·~µo®i¨Æ©y¡C |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/2/25 ¤W¤È 10:52:31²Ä 859 ½g¦^À³
|
90¥H¤U¿ï¾ÜÄ~Äò¥[½X¡A¬Ý¦n810±ÂÅv¡C |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/2/25 ¤W¤È 10:38:07²Ä 858 ½g¦^À³
|
µu½u¸êª÷À³¸Ó©ê¤£¦í ´Á«Ý¦³ªø½u¸êª÷¶i³õ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/25 ¤W¤È 10:18:39²Ä 857 ½g¦^À³
|
¨C¤Ñn±þn¬¡ ¬Ý´I¨¹¤¸´I²n©Î¤£²n! ¨â®a¦û¨C¤é¥æ©ö¶q¤j¥b ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/21 ¤U¤È 04:40:49²Ä 548 ½g¦^À³ ¤µ¤Ñ354±i¡A 960T´I¨¹(³y¶Õ???) ¶R¶i114,043ªÑ / ½æ¥X108,790ªÑ ---------------------------------------------------------------------------------------- ´I¨¹ ¶R¶i140,700ªÑ / ½æ¥X134,440ªÑ (+6±i) ¤¸´I ¶R¶i91,890ªÑ / ½æ¥X87,700ªÑ (+4±i) |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/2/25 ¤W¤È 10:10:25²Ä 856 ½g¦^À³
|
¤µ¤Ñ¤S¬O¤j¤á¥X³f½L¡AÁöµM«Ü¬Ý¦n¡A¦ý·d¤£À´¥Í§Þºâ±j¡A¤j¤á¤S¨g¥X ¤p§Ì©`¦Ì¤á¥ý¥X¤@¥b¡A»{½ß §Æ±æ¤j®aÁÈ¿ú |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/25 ¤W¤È 08:55:46²Ä 855 ½g¦^À³
|
[³B¤è¾Þ§@]---»¡¥Õ¸Ü´N¬O¶}¥ßAPAPªº¶q¼W¥[°Õ!!!!! §¨Óªá14»õ¬ü¤¸¡AµL«D´N¬On·mªü¤ù¦M¾÷«áªº[«D]¾~¤ùÃþ¤îµhÃĪ«¥«³õ! ¯Ã¬ù¦{¶øº¸¤Ú¥§¶øº¸¤Ú¥§Âå¾Ç¤¤¤ßªº¬ã¨s©M¾Ç³N¨Æ°È°Æ¥D®uÝ«æ¶EÂå¾Ç±Ð±Â¦w¼w¾|¡P±i¡]Andrew Chang¡^³Õ¤h¹ï¸Ó¬ã¨sµoªíµû½×¡G...¦ý¬O(SNP-810)¼³¼ö®§µh¤ñ«DÍrÅé§Üª¢ÃÄ(ªü´µ¤ÇÆF)¥X©_ªºÀø®Ä¥i¯à·|¼vÅT[³B¤è¾Þ§@] ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/16 ¤W¤È 08:42:08²Ä 789 ½g¦^À³ 2021.01.29 §¨Ó¦Aªá4.1»õ¬ü¤¸±ÂÅv¤é¥»Asahi KaseiªºAK1780Ãþ·ÀãÃö¸`ª¢Á{§ÉÃĪ«¡AÂà§@ºC©Ê¯kµhÃĪ«¡C (§¨Ó¯kµhÃĪ«ºÞ½u¥Ø«eÁ`¦@5´ÚÃĪ«) med.sina.cn/article_detail_103_2_95654.html --------------------------------------------------------------------------------------------- 2019.05.29 §¨Ó¥Hªñ10»õ¬ü¤¸»PCentrexion¦X§@©Ý®i [«D]¾~¤ùÃþ¤îµhÃĪ«¥«³õ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/25 ¤W¤È 08:44:55²Ä 854 ½g¦^À³
|
¦]¬°¬ü°êFDA¤w¹ï(¤j§Å)¾~¤ùÃþ¤îµhÃĪ«¶}îÔ¡A(¤p§Å)APAPÃĪ«¥«³õ¥²±N¥ÑµäÁY«¦^¦¨ªø>40»õ¬ü¤¸! ¤j§Å: ®Ú¾Ú¬ü°ê¯eºÞ¸p 2016 ¦~ªº¸ê®Æ¡A¬ü°ê¨C¦~¦]ÃĪ«¹L¶q¦º¤`ªº¤H¼Æ¡]6 ¸U 4 ¤d¤H¡^¡A¥H¤Î¨ä¤¤¬O¦]¬°¾~¤ùÃĪ«¹L¶q¦Ó¦ºªÌ¡]4 ¸U 2 ¤d¤H¡^¡A³£¶W¹L¤F¦]¨®º×¡]4 ¸U¤H¡^©ÎºjÀ»¡]3 ¸U 8 ¤d¤H¡^¦Ó¦ºªº¤H¼Æ¡C ¤p§Å: ¬ü°ê¨C¦~¦]Acetaminophen¡]AAP¡^¹L¶q°eÂ媺±wªÌ¡A¤´°ª¹F56,000¤H¡A¦í°|¤H¼Æ¬ù26,000¦W¡A¦º¤`¤H¼Æ¶W¹L450¤H¡C --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/5 ¤W¤È 10:26:06²Ä 700 ½g¦^À³ ¦]¬°¾Ö¦³§O¤H¸ó¤£¹Lªº325mg½Æ¤è»ÙêªùÂe¡AAPAP§t¶q´£°ª>325mg/500mg¬Æ¦Ü§ó°ª(®ÄªG§ó¦n)!!! ´N¯à¦A·m¦^³QNSAIDªü´µ¤ÇÆF /Opioidsªü¤ùÃĪ««I»kªº¥«³õ ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/5 ¤W¤È 09:52:09²Ä 696 ½g¦^À³ ³æ´N¬ü°ê¥«³õ§Y¦³¾÷·|¾aµL¨x¬rSNP-810»P¥[°ªAPAP¾¯¶q«¦^40»õ¬ü¤¸!!! ¬ü°ê¥«³õ¬O¦]¬°FDAªº¨î±¹¬I(2014¦~¤½§i°Ç¥O°±¤î»s³yAcetaminophen§t¶q¶W¹L325 mgªº½Æ¤èÃÄ«~¡A¥H´î§C¨x¬r°Æ§@¥Î¡A¨Ã¦P®É¤]¤£ãÂå®v³B¤è©M½Õ¾¯¡C),±q>40»õ¬ü¤¸´î¤Ö¦¨20»õ! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/25 ¤W¤È 07:44:24²Ä 853 ½g¦^À³
|
³oÓ¬ã¨sY¥ÎµL¨x¬rSNP-810°õ¦æ¡AAPAP§t¶q¥i¦A´£°ª¡A¤îµh®ÄªG¼Æ¾ÚªÖ©w§ó´Î! ¬ü°ê¾~(ªü)¤ù¦M¾÷¡A¨Ï±oAPAPªº¤@½uÃĪ«¦a¦ì§ó¨ü«µø!!! ¦Ò¼{¨ì¨äÀu¶VªºÀø®Ä©M@¨ü©Ê¡A¼³¼ö®§µh(APAP)¦ü¥G¬OªvÀø«æ¶E¬ì¥X°|«á»´«×¦Ü¤¤«×³Ð¶Ë«áªÏÅé¯kµhªº³Ì¦X¾Aªº¤@½uªvÀø¤èªk¡C Ų©óªü¤ùÃþÃĪ«ÀݥΦM¾÷¡A[³o¶µ¬ã¨s´£¨Ñ¤FÃÒ¾Ú¤ä«ù¦¹Ãþ±wªÌ³æ¿W¨Ï¥Î¹ï¤A酰®ò°ò×ô¡C] --------------------------------------------------------------------------------------- 2021¦~2¤ë8¤é «æ©Ê³Ð¶Ë«á¯kµh¤¤¤îµhÃĪº¬ã¨sµ²ªG-¾Ç³N«æ¶EÂå¾Ç¾Ç·| ¥ì§Q¿Õ¥ì¦{DES PLAINES-»P³æ¿W¨Ï¥Î¹ï¤A酰®ò°ò×ô¬Û¤ñ¡A¤j¾¯¶qNSAID»P¼³¼ö®§µhªº²Õ¦X¤£·|¼W¥[Âíµh§@¥Î¡C¬ã¨s¤HûÁÙµo²{¡A¹ï©ó³Ð¶Ë«áªÏÅé¯kµh¡A³æ¿W¨Ï¥Î¼³¼ö®§µhÀu©ó³æ¿W¨Ï¥Î¤j¾¯¶qNSAID¡C³o¨Ç¬O¤@¶µ¦W¬°¹ï¤A酰®ò°ò×ô©Î«DÍrÅéÃþ§Üª¢ÃĩΨâºØÂíµhÃÄÁp¦XªvÀø«æ©Ê³Ð¶Ë«á¯kµhªº¬ã¨sµ²ªG¡G¤@¶µÀH¾÷¹ï·Ó¸ÕÅç¡A±N©ó2021¦~2¤ë¦b¾Ç³N«æ¶EÂå¾Ç¡]AEM¡^¤Wµoªí¡A¾Ç³N«æ¶EÂå¾Ç¾Ç·|¡]SAEM¡^ªº´Á¥Z¡C ®Ú¾Ú¸Ó¬ã¨s¡A¦Ò¼{¨ì¨äÀu¶VªºÀø®Ä©M@¨ü©Ê¡A¼³¼ö®§µh¦ü¥G¬OªvÀø«æ¶E¬ì¥X°|«á»´«×¦Ü¤¤«×³Ð¶Ë«áªÏÅé¯kµhªº³Ì¦X¾Aªº¤@½uªvÀø¤èªk¡C ¸Ó¬ã¨sªº¥Dn§@ªÌ¬O¨Ó¦Û¬ð¥§´µ²ö¯Ç´µ´£º¸ªºªk¹Ïº¿¡P¥¬º¸¦N¤Ú¤j¾ÇÂå°|«æ¶E¬ìªº¿p¨uÀq¼w¡Pªü¦Ì¥§¡P©i¯Á§QÂå¾Ç³Õ¤h¡C ¯Ã¬ù¦{¶øº¸¤Ú¥§¶øº¸¤Ú¥§Âå¾Ç¤¤¤ßªº¬ã¨s©M¾Ç³N¨Æ°È°Æ¥D®uÝ«æ¶EÂå¾Ç±Ð±Â¦w¼w¾|¡P±i¡]Andrew Chang¡^³Õ¤h¹ï¸Ó¬ã¨sµoªíµû½×¡G ¡§³o¶µ°w¹ï1500¦W¬ð¥§´µ¦¨¦~¤Hªº¬ã¨sªí©ú¡A¹ï¤A酰®ò°ò×ô¡]¹ï¤A酰®ò°ò×ô¡^¥i³æ¿W©Î»PNSAIDÁp¦X¥Î§@¤@½uÂíµhÃÄ¡A¥Î©óªvÀø³N«áªº«æ©ÊªÏÅé·l¶Ë«æ¶E¬ì¡]ED¡^¥X°|ÁöµM³o¤£¬O¥L̪º¥Dn°²³]¡A¦ý¬O¼³¼ö®§µh¤ñ«DÍrÅé§Üª¢ÃÄ¥X©_ªºÀø®Ä¡]¦p¹ï¨ä¥L¤fªAÂíµhÃĪº»Ý¨D°§C¤F6.4¢H©Ò¥Ü¡^¥i¯à·|¼vÅT³B¤è¾Þ§@¡A¨Ò¦p¡A³\¦h±w¦³NSAIDSªº¸T§Ò¯g¦ý¦bED¥X°|®É»Ýn¨Ï¥Î¤îµhÃÄ¥i¯à·|¶}¥Xªü¤ùÃþÃĪ«¡CŲ©óªü¤ùÃþÃĪ«¤´¦b¬y¦æ¡A³o¶µ¬ã¨s´£¨Ñ¤FÃÒ¾Ú¤ä«ù¦¹Ãþ±wªÌ³æ¿W¨Ï¥Î¹ï¤A酰®ò°ò×ô¡C ### Ãö©ó¾Ç³N«æ¶EÂå¾Ç ¡m¾Ç³N«æ¶EÂå¾Ç¡n¬O¡m¾Ç³N«æ¶EÂå¾Ç¾Ç·|¡n¤ë¥Z¡A¨ä¯S¦â¬O¦b¦P¦æµû¼f¤¤¡A»P«æ¶E¹ê½î©M½Õ¬d¦³Ãöªº³Ì¥ý¶iªºì³Ð©Ê¬ã¨s¤è±ªí²{³Ì¦n¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/2/25 ¤W¤È 06:59:20²Ä 852 ½g¦^À³
|
©M¤@´N¬O¤ºÀ`¡A¦³¤H¦¤w¸gª¾¹D¡A©M·sÄ£¤W¦¸¤@¼Ë¡I¦pªG¦³¦³¦n®ø®§¡A¤j¤á¤£·|½æ |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/2/24 ¤U¤È 10:20:26²Ä 851 ½g¦^À³
|
¦b¿³Âd¥æ©öÀ³¸Ó¤£¬O¯uªk¤H¥~¸ê§a¡A³o´X¤Ñ¦³¸û¤j¤á¥X¥i¯à¥þ¶]¥h½Ä¦X¤@¤F¡A¦ý¦Ü¤Ö¥Í§Þ±Ú¸s¦n®ø®§¸sµo¡A¸êª÷·|À½¤@¨Ç¨ì¥Í§Þ¡AªYÄ£ªÑªF¤£¦h¡A©Ò¥H©xºô¸ê°T¤]¨S¦X¤@¸ÔºÉ¡A¥u¦nÄ~Äòµ¥¤U¥h |
|
|
·|û¡Gjerry7691110151211 µoªí®É¶¡:2021/2/24 ¤U¤È 09:49:31²Ä 850 ½g¦^À³
|
«D±`¬Ý¦n¡I ¥u¬Oªñ´ÁÄw½X¬Ý°_¨ÓÀ³¸Ó¬O¦³¦¬¨ì¸ê°T·|©µ«á©Î¬Onµ¥¤@°}¤l¤~¥i¯à¦³µ²ªG¡I ¤£µM¥~¸ê¬Q¤Ñ«e¤Ñ¦U¤p¶R20±i¤µ¤Ñ«ç¬ðµM³£»{½ß¥X²M¡H |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/2/24 ¤U¤È 09:39:48²Ä 849 ½g¦^À³
|
±À´ú¥i¯à¥h¦~¤E¤ë¥Ó½Ð¾Ç¦WÃÄÃÒ¡A¤@¯ë¤»¦Ü¤CӤ릳µ²ªG¡A¦p¨S¸É¥ó³Ì§Ö¤UӤ릳¾÷·| |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/2/24 ¤U¤È 07:40:37²Ä 848 ½g¦^À³
|
½Ð°Ý¦³¤Hª¾¹DªYÄ£¬O¦ó®É¥Ó½Ð¥xÆWÃÄÃÒªº¶Ü¡H ¦X¤@¬O¥h¦~8¤ë¡A¤µ¤Ñ¹LÃö¤F... ªYÄ£©xºô¥u¼g¥Ó½Ð¤¤¡A¤S¨S¼g¥Ó½Ð¤é´Á¡A¦³°÷Äꪺ |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/2/24 ¤U¤È 07:13:35²Ä 847 ½g¦^À³
|
è¬Ý¨ä¥¦®a¤½¥q¡Añ¬ùª÷¶i±b¡A¦ý¬O¹j¤ëªº°]³ø³£¨S¦³¶i±bªºª÷ÃB¡A§Ú¬ÝÁÙ¬O¹ïñ¬ùª÷¦º¤ß¦n¤F |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/2/24 ¤U¤È 05:35:41²Ä 846 ½g¦^À³
|
¤½¥qºô¯¸¸ÕÅç¶i«×§ó·s¬O§_·|µ¥¨ì¦X§@¦³·sªº¶i®i¤~·|§ó·s? ªñ´Á¥i¯àªº·s¶i®i±À¦ô´N¬O¨ú±o¥xÆW¾Ç¦WÃÄÃÒ! ©MSNP-630ªñ´Á¥Ó½Ð¤@´Á¸ÕÅç! ¥u¬O«e¦¸«°Tªº {¥Ø«e¥»¤½¥qSNP-810·sÃĤw»P°ê»Ú¥Dn¤îµhÃĤj¼tñq ¦X¬ù¡A°£¦³Ã±¬ùª÷¥t¦³¨½µ{¸Oª÷¡C²{¥¿¿n·¥¶i¦æ½T»{¸ÕÅç¡]confirmation study)¤¤ ¡A¦³³Ì·s¶i®i¡A±NÀH®É¤½§i} ³oºØ½T»{¸ÕÅçÓ¤H»{¬°³£À³¸Ó¦³¤@¨âÓ©u«×§a,¥u¦nÄ~Äòµ¥¤U¥h~ |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/2/24 ¤U¤È 05:04:09²Ä 845 ½g¦^À³
|
¬Ý½L¤¤¶R¶iªº¦¨¥æ»ù.... §ÚÓ¤H»{¬°¬O¦b°½¦YC... ¶È¨Ñ°Ñ¦Ò... |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/2/24 ¤U¤È 03:31:20²Ä 844 ½g¦^À³
|
½Ð°Ý¸¹§b¤j¤j¡A¬°¤°»ò»{¬°¬O¦b°½¦Y?? ¤è«K½ç±Ð¶Ü §Ú¬Ý¨S¦³¯S©wªº¤j¤á±µ§r?? ................................ ·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/2/24 ¤U¤È 12:41:07²Ä 843 ½g¦^À³ ¬°¦ó§Úı±o¬O¦b°½¦YÀò¡A¦n´X¤Ñ¤F |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/2/24 ¤U¤È 12:41:07²Ä 843 ½g¦^À³
|
¬°¦ó§Úı±o¬O¦b°½¦YÀò¡A¦n´X¤Ñ¤F |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/2/24 ¤U¤È 12:33:35²Ä 842 ½g¦^À³
|
¬°¬Ý¥ý²q¡A¤µ¤Ñ¤S¬O¤§«e¤j¤á¥X²æ ªÅÀY³Ó¥X |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/2/24 ¤W¤È 11:55:06²Ä 841 ½g¦^À³
|
©R¹B¥æÅT¦±~~~~µ¥µ¥µ¥µ¥~~~~µ¥µ¥µ¥µ¥~~~~~ |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/2/24 ¤W¤È 09:47:22²Ä 840 ½g¦^À³
|
´N¨Æ½×¨Æ ³o¤G¶g³£¬O¤j¤á¦b¥X?!why?¦³¤º½u??¤£·Qµ¥?? ¦pªG¬O«ÒÙÃÄ¡An¤£nªø´Á«ù¦³¡A¦Û¦æ¨M©w 96¼Óµ¥¸Ñ®M ¦ýªÑ»ù¥Ø«e´N¼µ¦b³o¨½¡A½æÀ£¤j¶R¤è¤Ö¡AÁÙºâ¥i¥H¡A¦ý½Ö¦¬¤F |
|
|
·|û¡G¬K¤Ñô10143192 µoªí®É¶¡:2021/2/24 ¤W¤È 12:02:02²Ä 839 ½g¦^À³
|
SNP-810±ÂÅvª÷¥i¯à³W¼Ò? ¤AñQÓi×ô¬O¥@¬É¤W·¥«nªº¤îµhÃĤ§¤@¡A¦ý¬O¦³¨x¬r©ÊP¦ºªº¯ÊÂI¡C§Ú̬O¥H·¥¥©§®ªº¤è¦¡¨Ó¸Ñ¨M60¦~¤jÃļt¤@ª½µLªk¸Ñ¨Mªº°ÝÃD¡C¥HÀ°§U¯f¤H´£¨Ñ§ó¦w¥þªºÃÄ«~¡A±ÂÅvª÷±N¬O¦b¤Ï¬M¦¹°^Ämªº»ùÈ¡A¤]±o¨ì°ê»Ú¤j¼tªº»{¥i¡C ¥H¤W¬O¤p§Ì¦b©xºô¬Ý¨ìªº¡A⋯⋯±ÂÅvª÷±N¬O¦b¤Ï¬M¦¹°^Ämªº»ùÈ¡A¤]±o¨ì°ê»Ú¤j¼tªº»{¥i¡C |
|
|
·|û¡G¬K¤Ñô10143192 µoªí®É¶¡:2021/2/23 ¤U¤È 10:36:11²Ä 838 ½g¦^À³
|
ÁÂÁÂR¤jªº§iª¾ ¥i¯à¤½¥q¦³¤°»ò¶i®i¤~·|¤½§G¦b©xºô⋯⋯³o¤]¬O½u¯Á¤§¤@⋯ §Æ±æ¯à·F¨Ç¤j¨Æ⋯⋯ ³Ìªñ¦³·sx¤ý¶i¥X⋯⋯À³¸Ó¤£¬Oªü¤¯¤j⋯¤£¥i¯à¶R³o麽¤Ö⋯⋯ ¤£¹L¦pªG¬O¦B¤s¤@¨¤¡A¨º´N⋯⋯ ¤§«eºa¬´¤]¬O¦³·sX¤ý¶i¥X¤§«á¤@¤f®ð¤jº¦¦n´X¦¨⋯⋯ ¬O¤£¬O§ðÀ»µo°_缐¡A¥u¬O¤p§ÌªºÁr´ú⋯⋯ ¤£¹LÁÙ¬Oµo«°T¤ñ¸û¹ê¦b⋯⋯²{¦b¥u¦³¡¨µ¥¡¨ |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/2/23 ¤U¤È 09:25:55²Ä 837 ½g¦^À³
|
ÁÂÁÂR¤j»P¤½¥qÁpô |
|
|
·|û¡GRock00910149258 µoªí®É¶¡:2021/2/23 ¤U¤È 06:44:48²Ä 836 ½g¦^À³
|
¤µ¤é¦³»P¤½¥q¤HûP¹qÁpô ªñ´Á·|§ó·s©xºô¤Wªº¬ãµoùµ{»P¶i«×®Éµ{ ¦U¦ì¤£³X¦³ªÅ¥i¥H¥h¦h«ö´X¦¸«·s¾ã²z¬Ý¬Ý¦³µL§ó·s!! |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/2/23 ¤U¤È 02:06:15²Ä 835 ½g¦^À³
|
§Ú¬Ý¦nªº¬O8¨t¦C¦Ó¤£¬O6¨t¦C |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2021/2/23 ¤U¤È 01:39:37²Ä 834 ½g¦^À³
|
·sÃĶ}µo®Éµ{ªø¡B§ë¤J¸g¶O°ª¥B¨Ã¥¼«OÃÒ¤@©w¯à¦¨¥\¡A¦¹µ¥¥i¯à¨Ï§ë¸ê±Á{·ÀI¡A §ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/2/23 ¤U¤È 01:36:09²Ä 833 ½g¦^À³
|
±q¦U¤j¤j´£¥X¸ê°T¡A³Ì¨ü¬Ý¦nªº¨ä¹ê¬O630³oÁû¡A¤]¬O2023¦~¤j©è§¹¦¨¡CY¥þ²y350»õ¬ü¤¸¡A¥«¦û¤@¥b175»õ¬ü¤¸¡A¤À¼íª÷¤@¦¨17»õ¬ü¤¸¡A500»õ¥x¹ô¡A¨CªÑÁÈ100ӸꥻÃB¢w1000¤¸/ªÑ¡A¬O¥Ø«e¤j¥ß¥ú5¿¡A¤£°g¤H¶Ü¡H¤£¹Ú¤Û¡H·íµM¡A¥«¦ûn®É¶¡¡A³o´N¬Or¤j»¡ªº¢w¡m§Únªø´Á«ù¦³¡I¡n¡A§ÚÀ´±zªº©ú¥Õ¡AÅý§Ú¸ò§a¡I |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/2/23 ¤U¤È 12:58:03²Ä 832 ½g¦^À³
|
¥»¤½¥q©Ò¶}µoªºµL¨x¬r©Ê¤îµh·sÃÄSNP-810«Y»P°ê»ÚÃļtñq·sÃÄ¡u¬ãµo¦X§@¡v ¨óij¡A¶i¦æÀø®Ä½T»{µ¥¬ÛÃö¹êÅç¡A¸Ó¦X§@¨óij«DÄݱÂÅv¦X¬ù¡AÁö¦³Ã±¬ùª÷¤Î¨½µ{ ª÷¡A¦ý«DÄݱÂÅvª÷¡C¸Ó³ø¾É¯ÂÄÝ´CÅéÁr´ú¡B±À¦ô¡C ¼È®É¨S±ÂÅvª÷¡A§O·Q¤Ó¦h |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/2/23 ¤W¤È 11:59:47²Ä 831 ½g¦^À³
|
¤j®a³£¦bµ¥±ÂÅvª÷´¦¾å¡A3¤ë10¤éÀ禬¤½¥¬±Àºâ¤]¬O¤@Ó¾÷·|¡C¨ä¹ê¡A¹³³o»ò¬Ý¦nªº¤½¥q¡AªÑ»ùº¦°ª¬O°ª¿³¤]¬O±Ë¤£±o½æ¡A©È¶R¤£¦^¨Ó¡C©ñÓ3¦~«á¡AªÑ»ù¼Æ¦r¥²µM®t«Ü¦h¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/23 ¤W¤È 07:53:57²Ä 830 ½g¦^À³
|
¤°»ò¥s¹Ú´K¥H¨Dªºµª®×??? ¦]¬°SNP-610´Á¤¤¤ÀªR 1.F4(ÄY«ÅÖºû¤Æ)ªvÀø«e«á [¦³ÅãµÛ]®t²§¡C 2.ªì¨B¼Æ¾ÚÀu©ó:Ocaliva , MGL3196¡]Resmetirom¡^, Selonsertib [ÅÖºû¤Æ]¬ONASH¯f¤H [³Ì¦MÀI] ªº¯f²z¯S¼x¡A»P¨xµw¤Æ¡B¨xÀù©M¥þ¦]¦º¤`¬ÛÃö©Ê³Ì±j¡C FDA«ü«n¤]©ú½T¦a±NÅÖºû¤Æ§@¬°Á{§É¸ÕÅ窺¤@Ó¤J²Õ¼Ð·Ç¡CµM¦Ó¡A§í¨îÅÖºû¤ÆªºNASHÃĪ«¬ãµo«o¹ð¹ð¨ü®À¡C GileadÁ{§É³]p¤ñ¸û¿E¶i(¤G´ÁÁ{§É¬OF2~F3)¡A¤T´ÁÁ{§É¹êÅç«h¬O[ÅÖºû¤Æ3]»P[ÅÖºû¤Æ4]¦U¶}¤@Ó! ¦N§Q¼wNASHÁ{§É¸ÕÅç¦A¦¸¥¢±Ñ(F4¥ý±ÑF3¦A±Ñ)Selonsertib«e´º¤£©úwww.gbimonthly.com/2019/04/44502/ -------------------------------------------------- ------------------------------------------ ·|û¡GROGER588910148151µoªí®É¶¡¡G2020/7/3¤W¤È08:05:38²Ä35½g¦^Î` - The decreases in several clinical parameters from baseline to the end of treatment were greater in SNP-610-12-week treatment than Ocaliva, Cenicriviroc, Elafibranor, MGL3196 or Selonsertib treatment in literature, especially in ALT. --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/7 ¤W¤È 09:27:45²Ä 748 ½g¦^À³ ¤°»ò¥s¹Ú´K¥H¨Dªºµª®×??? ¦]¬° SNP-610´Á¤¤¤ÀªR:F4(ÄY«ÅÖºû¤Æ)ªvÀø«e«á¦³ÅãµÛ®t²§¡C VS InterceptªºOcaliva¹ïF2(¤¤«×ÅÖºû¤Æ)©ÎF3(««×ÅÖºû¤Æ)±wªÌ幷¥¼¥X²{ÅãµÛ§ïµ½¡C ¹ïF1(»´«×ÅÖºû¤Æ)±wªÌªºªvÀø®ÄªG§ó爲©úÅã¡C -------------------------------------------------- ---------------------------------------- µû¦ô¨xÅÖºû¤ÆÄY«µ{«× ¡´ F0¡G¥¿±`¨x²Õ´¡]µLÅÖºû¤Æ¡^ ¡´ F1¡G»´«×ÅÖºû¤Æ¡]ÅÖºû¤Æ«]¦b¨xªù¯ß°Ï¤¤¡AµL¶¡¹j¡C¡^ ¡´ F2¡G¤¤«×ÅÖºû¤Æ¡]¤Ö³\ÅÖºû§ô¦Û¨xªù°Ï¦ù¥X¦Ü¤p¸¤¤¡A¦³¤Ö¼Æ¶¡¹j¡C¡^ ¡´ F3¡G««×ÅÖºû¤Æ¡]³\¦hÅÖºû§ô¦Û¨xªù°Ï¦ù¥X¦Ü¤p¸¤¤¡A¦³¦h¼Æ¶¡¹j¡C¡^ ¡´ F4¡GÄY«ÅÖºû¤Æ¡]«p«pªºÅÖºû²Õ´§â¨x²ÓM³ò¦¨¤@¹Î¤@¹Îªº¡C¡^ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/23 ¤W¤È 06:59:49²Ä 829 ½g¦^À³
|
Intercept¯u¬O½ß¤F¤Ò¤H¤S§é§L¡A«Îº|¤S³{³s©]«B! ¦]¬°[¨x¬r©Ê]°Æ§@¥Î¡A¥Ó½ÐNASHÃÄÃÒ³Q§_¨M«á¡AFDA¤S¦^ÀY½Õ¬dOcaliva¼ç¦bªº¨x¯f·ÀI! endpts.com/in-another-blow-to-intercept-the-fda-investigates-ocaliva-for-potential-risk-of-liver-disorder/ ³o¤U¤l2016¦~Àò㪺ìµo©ÊÁxºÞª¢¡]PBC¡^ÃÄÃÒ¦³¥i¯à¤S¦]¬°[¨x¬r©Ê]°Æ§@¥Î¦Ó³QºM¾P!? --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/21 ¤U¤È 12:54:38²Ä 807 ½g¦^À³ ¦b³Ì¦³¾÷·|¹Ü±o²Ä1¤äNASH¤W¥«ÃÄÃÒªºOcaliva¡]Intercept¡^¦]¬°[¨x¬r©Ê]°Æ§@¥Î³Q§_¨M«á¡A |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/2/22 ¤U¤È 08:30:04²Ä 828 ½g¦^À³
|
¥Ø«eªYÄ£SNP-810·sÃĤw»P°ê»Ú¥Dn¤îµhÃĤj¼tñq¦X¬ù¡A°£¦³Ã±¬ùª÷¥t¦³¨½µ{¸Oª÷¡C²{¥¿¿n·¥¶i¦æ½T»{¸ÕÅç¡]confirmation study)¤¤¡A¦³³Ì·s¶i®i¡A±NÀH®É¤½§i¡C ½Ð°Ý¡A¤å¤¤²{¥¿¶i¦æ¿n·¥½T»{¸ÕÅç¡A¬O¦b½T»{¸ÕÅ礰°Ú¡H¬O°Êª«¬r²z¸ÕÅç¶Ü¡H |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/2/22 ¤U¤È 07:18:27²Ä 827 ½g¦^À³
|
«O±K±ø´Ú¦n¹³¶Â½c§@·~³á¡I ¨ì®É§O»¡±ÂÅvª÷¦h¤Ö¤]n«O±K@@ |
|
|
·|û¡Gop123410143906 µoªí®É¶¡:2021/2/22 ¤U¤È 07:07:59²Ä 826 ½g¦^À³
|
µ¥¤½¥qªk§G«¤j°T®§¡A¼È°±¥æ©ö¡C§Æ±æ¦³¦n®ø®§¡C¯¬¤j®a²ü¥]º¡º¡¡C |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/2/22 ¤U¤È 07:06:56²Ä 825 ½g¦^À³
|
¥ý¬Ýqª÷¦h¤Ö§a¡I±ÂÅvª÷¨S¨º»ò§Ö¨ì¤â§a¡H Y¬O¥H45¤Ñ¥æ¥Iqª÷¡A³oÓ¤ë¤J±b¡Aµ¥¤UÓ¤ë¦A¬Ý¬Ý°]³ø |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/22 ¤U¤È 06:52:34²Ä 824 ½g¦^À³
|
ºÃ????????? «¥¨º½g¶K¤å±À´ú»¡2/25??????? ¿³Âd¤½¥qªÑ¥»¤p¬y³q©Ê¤£¦n¡A³q±`¥~¸ê§ë«H©Î¦ÛÀç°ÓÁÙ¤£·|¯A¤J¤~¬O¡C ------------------------------------------------------------------------------ ·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/22 ¤U¤È 05:48:57²Ä 820 ½g¦^À³ ...³Ì«á«ÂI¡GR¤j±À´úªº´Á¤é2012/2/25´N¦b¤j«á¤Ñ¡A«Ü´Á«Ý¯àºë½T©R¤¤¤½¥qµo§G«¤j°T®§ªº®É¶¡¡A±ÂÅv¤º®e¾Ù°Ê¥xÆW¥Í§Þ¥«³õ¡A¦a°Ê¤s·n¡C --------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/26 ¤U¤È 08:13:26²Ä 596 ½g¦^À³ ·|û¡GROGER588910148151 µoªí®É¶¡:2020/12/23 ¤W¤È 09:09:55²Ä 413 ½g¦^À³ ±ÂÅvª÷«¥¤ß¸Ì¤]¨S©³!±ÂÅvª÷«¥¤ß¸Ì¤]¨S©³!±ÂÅvª÷«¥¤ß¸Ì¤]¨S©³! ------------------------------------------------------------------------------------------ °ª¤£¥ÎÁ§ڡA§C¤]§O«è§Ú¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/22 ¤U¤È 06:42:21²Ä 823 ½g¦^À³
|
·|û¡G¬K¤Ñô10143192 µoªí®É¶¡:2021/2/22 ¤U¤È 06:19:56²Ä 822 ½g¦^À³ ³o¨â¤Ñ¥~¸ê¦U¶R¶W20±i¡A¦@40±i¡I ----------------------------------------------------------------------- ¥~¸ê¶R¿³ÂdªYÄ£??? |
|
|
·|û¡G¬K¤Ñô10143192 µoªí®É¶¡:2021/2/22 ¤U¤È 06:19:56²Ä 822 ½g¦^À³
|
³o¨â¤Ñ¥~¸ê¦U¶R¶W20±i¡A¦@40±i¡I ¤£ª¾¬O¯u¥~¸êÁÙ¬O°²¥~¸ê¡H ÁÙ¤£¯à¼g¬K¦¿¤ô·xÀn¥ýª¾⋯⋯⋯«¢«¢¡I |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/22 ¤U¤È 05:58:49²Ä 821 ½g¦^À³
|
§ó¥¿¡G¦X¤@¨Mij¿ì²z²{¼W¤é´Á2020/8/28¡A±ÂÅvª÷¦¬¤J¤é´Á2021/1/14¡C |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/22 ¤U¤È 05:48:57²Ä 820 ½g¦^À³
|
¦X¤@©ó2012/08/28¿ì²z²{ª÷¼W¸êµo¦æ´¶³qªÑ°Ñ»Pµo¦æ®ü¥~¦s°U¾ÌÃÒ¡Cµo¦æªÑ¦b 18,000¥aªÑ¦Ü30,000¥aªÑ´¶³qªÑªº½d³ò¤º¿ì²z²{ª÷¼W¸ê¡C¦Z©ó2012/1/14¦¬¨ì±ÂÅvª÷11.2»õ¤¸¡A²{ª÷¦¬¤J¨ÑÀ³µu¡B¤¤´ÁÃĪ«¬ãµo¡B¹êÅç¸êª÷¡CªYÄ£¤é«á±ÂÅvª÷Y¦³¤J±b¡A½T¥i¼È§KÂǥѸꥻ¥«³õÄw±¹¸êª÷¡A¤£¹L±ÂÅvª÷¦¬¤J³¡¤À¥²¶·À±¸É¤jªÑªF¤¤¤Ñ¶°¹Î¦´ÁѺª`ªº硏µo¡B¹êÅç¶O¥Î¡A³¡¤À¯d¨Ñ¤½¥q«áÄòÃĪ«¬ãµo¡B¹êÅç©Ò»Ý¡A¦]¦¹¡A±ÂÅvª÷¹ïEPSªº°^Äm«×¬O§_n¥´§é¦©¡H³Ì«á«ÂI¡GR¤j±À´úªº´Á¤é2012/2/25´N¦b¤j«á¤Ñ¡A«Ü´Á«Ý¯àºë½T©R¤¤¤½¥qµo§G«¤j°T®§ªº®É¶¡¡A±ÂÅv¤º®e¾Ù°Ê¥xÆW¥Í§Þ¥«³õ¡A¦a°Ê¤s·n¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/2/22 ¤U¤È 04:14:12²Ä 819 ½g¦^À³
|
¦Ñ¸Ü¤@¥y¡An¶Rn½æ¬O¦Û¤wªº¿ú ¨S±ÂÅvª÷¥X¨Ó¡A´N¬Oµ¥ ³Ìªñ³£¬O¤j¤á¥X¡Aµ¥§a ¦pªG¬O³o¼Ë¡A¦´Nº¦¨ì½¥h¤F¡AÁÙ¬Onµû¦ô¦Û¤wªº¯à¤O§a ~~~~~~~~~~~~~~~~~~~~~~~~ ªYÄ£810¤@ÁûÃÄY§C¦ô5»õ¬ü¤¸±ÂÅv¡B¥BªYÄ£´£¤W¥«¡A»P¦X¤@¤ñ»ù¡A¦X²zªÑ»ù¬O1500¤¸¡C²{¦b¶RªÑ²¼³£¬O«K©yªº¤£¥Î©È¡A¥u©È¨S¦³¿ú¦Ó¤w¡C ¸ò¨ä¥L¤W¥«Âdªº¤ñ¡Aºâ«Ü®z¤F!!¦X¤@¡AÄ_0³£10%¡C¤Og¹q20% ~~~~~~~~~~~~~~~~~~~~~~ ¦³¨S¦³¾÷·|¥ý¦¨¬°¿³ÂdªÑ¤ý? ¤µ¤Ñ«ç»ò¬Û¹ï®z®zªº? |
|
|
·|û¡GRock00910149258 µoªí®É¶¡:2021/2/22 ¤U¤È 03:14:15²Ä 818 ½g¦^À³
|
2020.12.23 ¸ò°ê»Ú¤j¼tñ¤U¦X§@¨óij 2021.01.26 ¬ü°êOTCÃÄÃÒ¨ú±o ±ÂÅv¨Æ©y¤K¤E¤£Â÷¤Q¡A¥u®t¤½§i«á¬O¦h¤Öª÷ÃB¦Ó¤w ¤W¥«¡B¤WÂd¿ð¦ªº¨Æ¡A¦ý±ÂÅv¹L«á...ªYÄ£À³¸Ó¤£¯Ê¿ú¤F ^^ |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/2/22 ¤U¤È 01:33:45²Ä 817 ½g¦^À³
|
ªYÄ£810¤@ÁûÃÄY§C¦ô5»õ¬ü¤¸±ÂÅv¡B¥BªYÄ£´£¤W¥«¡A»P¦X¤@¤ñ»ù¡A¦X²zªÑ»ù¬O1500¤¸¡C²{¦b¶RªÑ²¼³£¬O«K©yªº¤£¥Î©È¡A¥u©È¨S¦³¿ú¦Ó¤w¡C |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/22 ¤U¤È 01:09:14²Ä 816 ½g¦^À³
|
ªYÄ£¤d¸U§O©M¿³Âd¨ä¥LªÑ²¼¸ò·¶]¥½¤É¬q¡A«ô°U¥D¤OÀ£½L¡A§Ú̦n§ä¶¢¿ú¶i¨Ç³f¡AªYÄ£·|¨«¦X¤@¸ô½u¡A¿³Âd¤£©öÄw¸ê¥R¹ê¬ãµo¡B¹êÅç¸êª÷¡A転¤W¥«¡BÂd§ó¦³¬ÝÀY¡I |
|
|
·|û¡G¬K¤Ñô10143192 µoªí®É¶¡:2021/2/22 ¤U¤È 12:57:08²Ä 815 ½g¦^À³
|
¿³ÂdªÑ¤ý¡H ¥H¥Ø«e¨Ó¬ÝÀ³¸Ó¬O©Ô°ª¥X³f§a¡I ºG⋯⋯⋯⋯⋯ |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/22 ¤W¤È 11:47:22²Ä 814 ½g¦^À³
|
ªÑ»ù©Ô°ª¸I¨ì«e°ª»ù¡B«e°ª¥æ©ö¶q¡A®M¨cªÌ¸Ñ®M½æÀ£¤j¡A¦³«Ý¸É¶q®ø¤Æ½æÀ£Äw½X¡C |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/2/22 ¤W¤È 11:05:15²Ä 813 ½g¦^À³
|
¦³¨S¦³¾÷·|¥ý¦¨¬°¿³ÂdªÑ¤ý? ¤µ¤Ñ«ç»ò¬Û¹ï®z®zªº? |
|
|
·|û¡G¤p¤å¤l10144877 µoªí®É¶¡:2021/2/21 ¤U¤È 04:30:02²Ä 812 ½g¦^À³
|
¥xÆW²£¬ã¬É§ë¤J·sÃĶ}µoº¥¦¨·®ð¡A¦Ó¤@Áû·sÃĦU¶¥¬qªk³W¼f®Ö§Y²o°Ê¸ê¥»¥«³õ¨g¼ö¨Ã±a°ÊªÑ»ùötº¦¡C¤jP¦Ó¨¥¡A·sÃıq¬ãµo¨ì¤W¥«¡A¥§¡¯Ó¶O¤Q»õ¬ü¤¸»Pªñ¤Q¤¦~®É¶¡¡A¦]¦¹¡A¬°½T«OÀò§Q»P¥«¥e¡A·sÃĶ}µo¤½¥q°£»Ýºë¤ßµ¦¹º¥«³õ¦æ¾P¡B«È¤á³q¸ô»P¦h¤¸°Ó·~¼Ò¦¡¥~¡AÁٻݵ½¥Î¦U°êÂåÃĪk³W¥[³t·sÃļf¬d¡A¥H·m¤U¥«³õ¿W¥e´Á¡C ¾Ú²Îp¤ÀªRÅã¥Ü¡A·sÃÄ¥«³õ¿W¥e´Á¤@¥¹µ²§ô¡AYìÃļtµL¥ô¦ó¦]À³±¹¬I¡A¦Ü¤Ö¤K¦¨¥«¥e±N¨³³t³Q¸Á¾Ö¦Ó¤Wªº¾Ç¦WÃļtÅú¹¥Ê¤À¡C¦]¦¹¡AìÃļt¦hºÜºÉ¸£¥Ä¹B¥Î¦U°êªk³W³]ªkÅý·sÃÄ´£«e¤W¥«¡A¨Ã©µªø·sÃÄ¥«³õ¿W¥e´Á¡C ¥H¤p¤À¤l·sÃĬ°¨Ò¡A¬ü°êªk³WÁYµuÁ{§É¼f¬d¹Lµ{¡A¥iÅýìÃļt´£«e¨ä¥LÄvª§ªÌ¶i¤J¥«³õ¡A¥Ø«e¬ü°ê¹«~ÃĪ«ºÞ²z§½¡]FDA¡^´£¨Ñ¤p¤À¤l·sÃÄ¥|ºØ¥[³t¼f¬d¾÷¨î¡]Expedited Programs¡^¡A¥]¬A¡u§Ö³t³q¹D¡v¡B¡u¬ð¯}©ÊÀøªk¡v¡B¡u¥[³t®Öã¡v¤Î¡uÀu¥ý¼f¬d¡v¡C ¥H 2012¦~7¤ë³q¹L¨Ã¬I¦æ¡u¬ð¯}©ÊÀøªk¡v¥[³t¼f¬d¾÷¨î¬°¨Ò¡A¨ä³W½d·½¦ÛFederal Food, Drug, and Cosmetic Act 506¡]a¡^³¹¸`¡A±ý²Å¦X¦¹¸ê®æ·sÃÄ¡A¥²¶·¬O°w¹ï«¯g¯e¯fªvÀø¡A¥B»Ý°w¹ï¦Ü¤Ö¤@ÓÁ{§É¸ÕÅç²×ÂI¡]Clinically Significant Endpoint¡^´£¨Ñªì¨BÁ{§É¼Æ¾Ú¡A¥HÃÒ©ú¨ä»P²{¦³Àøªk¬Û¤ñ¡A¯à¦bªvÀø¤W±a¨ÓÅãµÛ§ïµ½¡A¸Ó¾÷¨îªº¥Ó½Ð¤é¡A³Ì¦¥i¦P®É»PÁ{§É¸ÕÅç¼f¬d¥Ó½Ð¡]Investigational New Drug¡^¤@¨Ö»¼¥æFDA¡A¦Ü¿ð¤£±o±ß©óFDA³]©wÁ{§É¤G´Áµ²§ô·|ij¡]End-of-Phase 2 Meeting¡^¡A¥B©ó·sÃĤ½¥q¥Ó½Ð°e¥ó60¤Ñ¤º¡AFDA¹ï²Å¦X¸ê®æ·sÃħY·|µo¥X³qª¾«H¨ç¡A¨Ã¦b·sÃĶ}µo¬yµ{´£¨Ñ©Ò»Ý¨ó§U¡C «ez¥[³t¼f¬d¡A¥i´À·sÃĤ½¥q±a¨Ó½Ñ¦h§Q¯q»PÀu¶Õ¡A¦pìÃļt¯àÂǦ¹©MFDAÀWÁc¤¬°Ê¡A°Q½×Á{§É¸ÕÅç³]p¡B©Ò»Ý¦w¥þ©Ê¸ê®Æ¡B¾¯¶q¤ÏÀ³¬ÛÃö°ÝÃD¡B¥Íª«¼Ð°O¨Ï¥Îµ¥¡AìÃļt±NÀò±o FDA§ó§¹¾ã»P§Y®Éªº¤ÏõX¡A¶i¦Ó¯à°÷¼u©Ê¥BÆF¬¡½Õ¾ãÁ{§É¸ÕÅç¥H²Å¦X¨ú±o·sÃij\¥i¤§n¨D¡C¦AªÌ¡A¡u¬ð¯}©ÊÀøªk¡v¼f¬d¹Lµ{¤¤¡A¦h¥ÑFDA¸ê²`¤Hû°Ñ»P°Q½×¡A¸Óµ¥¸ê²`¤Hû¦h¥i´£¨Ñ½Ñ¦h«Ø³]©Ê·N¨£¡A¦³®Ä¨ó§UìÃļt¥[³t¨ú±oÃÄ«~¬dÅçµn°O¡]New Drug Application¡ANDA¡^¡C ¬ü°ê¬I¦æ¡u¬ð¯}©ÊÀøªk¡v¥[³t¼f¬d¾÷¨î1¦~¤º¡A§Y¦³¨â¶µ·sÃÄÀò±o¡u¬ð¯}©ÊÀøªk¡v¸ê®æ§Ö³t¨ú±oÃÄÃÒ¡A¸ûª¾¦W®×¨Ò§Y¬O¼b¥Í»PPharmacyclics¦@¦P¶}µo¥Î©óªvÀø³Q®M²ÓM²O¤Ú½F¤p¤À¤l·sÃÄ¡uImbruvica¡v¡A¸Ó·sÃÄ©ó2013¦~6¤ë¶¡¦VFDA´£¥XNDA¥Ó½Ð¡A¦P¦~11¤ë§Y¨ú±oÃÄÃÒ¡A¤j´TÁY¨ú±oÃÄÃҮɵ{¨Ã¸`¬ÙÃe¤j¤ä¥X¡C ·sÃļt°Ó°£³z¹L«ez¥[³t¼f¬d¾÷¨î¡A´£«e¶i¤J¥«³õ·m§ð¥«¥e¡A¥ç¥iÂùy¨Ö¶i¡Aª§¨úªk³Wµ¹¤©ªº¥«³õ¿W¥e´Á¡C¦P¼Ë¥H¬ü°ê¤p¤À¤l·sÃĬ°¨Ò¡A°w¹ï¤£¦PÃÄ«~»P¾AÀ³¯g¡Aªk³Wµ¹¤©¥|ºØ¤£¦P¥«³õ¿W¥e´Á¡G¤¦~ªº¤p¤À¤l·sÃÄ¿W¥e´Á¡B¤T¦~ªº·sÁ{§É¸ÕÅç¿W¥e´Á¡B¤C¦~ªº©t¨àÃÄ¿W¥e´Á¥H¤Î¥b¦~ªº¤p¨à¥ÎÃÄ¿W¥e´Á¡C¨ä¤¤¡A¤¦~ªº¤p¤À¤l·sÃÄ¿W¥e´Á¡A´X¥G¥iªý¾×©Ò¦³§t¦³¬Û¦P¤p¤À¤l505¡]b)¡]2)Ãþ·sÃÄ»P¾Ç¦WÃĪº°e¥ó¡F¤T¦~·sÁ{§É¸ÕÅç¿W¥e´Á»P¥b¦~ªº¤p¨à¥ÎÃÄ¿W¥e´Á¡A¥i¨¾°ô©Ò¦³§t¦³¬Û¦P¤p¤À¤lªº505¡]b)¡]2)Ãþ·sÃÄ»P¾Ç¦WÃĪº®Öã¡F¤C¦~©t¨àÃÄ¿W¥e´Á¡A«h¬Oªýê©Ò¦³¬Û¦P·sÃÄ·f°t¬Û¦P¾AÀ³¯gªº505¡]b)¡]1)·sÃÄ¡B 505¡]b)¡]2)Ãþ·sÃÄ»P¾Ç¦WÃĪº®Öã¡C ¦Ó¥B¡A¥R¤À´x´¤ªk³WÁÙ±a¨Ó½Ñ¦hªþÀH§Q¯q¡A¨Ò¦p¨u¨£¯e¯fªº©t¨àÃij\¥i¡A°£¤F¤C¦~ªº¥«³õ¿W®a¾P°â±MÄÝÅv¡A©|¥i¨Ì¾Úªk³W¨ú±o¬F©²¬ãµo¸É§U¡B¨É¨ü¬ãµo©è´î¯²µ|Àu´f¥H¤Î¤W¥«³W¶OÁŧKµ¥¡C ¥»¤åÁö¥H¬ü°ê¤p¤À¤l·sÃÄ¥«³õ¬°¨Ò¡A¦ýµL½×¦b¥ô¦ó°ê®a¡A·sÃĶ}µo¦h¬°Ãe¤j¸ê·½»Pª÷¿ú®ø¯Ó¾Ô¡A¦UºØµLªk½T©w»P±±¨î¦]¯À§ó¼h¥X¤£½a¡A³z¹L¹ïªk³W±M·~¥B¹ý©³ªº´x´¤¤Î¨ä°t®Mµ¦²¤¡A¶i¦ÓÆF¬¡·f°t¡B¼_¼ôÀ³¥Î¡A¥²¯à´À·sÃĶ}µo»P¤W¥«¥´³y¥X³Ì¨ÎÀò§Q¼Ò¦¡¡A¦³®ÄÁYµu¼f¬d¹Lµ{¡A´£«e·m¤U¥«¥e¨Ã¨É¨ü¥«³õ¿W¥e´Á¡AÅý¥ø·~Àò§Q¨«±o§ó»·§óªø¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/21 ¤U¤È 04:22:05²Ä 811 ½g¦^À³
|
SNP-810:¥@¬Éº¤äµL¨x¬rAPAP·sÃÄ¡A2020.12.23¸ò°ê»Ú¤j¼tñ¦X§@¨óij! SNP-6:P2¼Æ¾ÚÀu©ó¹w´Á·|¦b2020®Öã¤W¥«ªº Ocaliva¡]µ²§½¬O³QFDA§_¨M)! ¥çÀu©ó±µ¤U¨Ó·~¬É»{¬°2023¦~²Ä1¤ä¤W¥«ªºNASHÃĪ«: MGL3196¡]Resmetirom¡^? 2020.12¤ëÀ禬46¸U¤¸¬O»P ¦X¥þÃÄ·~»´ä¦³¤½¥q 109/12~ÃÄ«~¦X¦¨¥X³f ©e°UÃÄ«~¦X¦¨¬ÛÃö¨Æ©y 2021.1¤ëÀ禬264¸U¡A³Ò°È¦¬¤J ¦Ñ½Õ«¼u¡A°£¤Fµ¥ÁÙ¬Oµ¥¡A§OµL¥Lªk¡A¦]¬°±µ¤U¨Ó¤½¥¬ªº·¥¦³¥i¯à´N¬OSNP-810©ÎSNP-610ªº±ÂÅv? ---------------------------------------------------------------------------------------------- ·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/2/8 ¤U¤È 02:59:09²Ä 761 ½g¦^À³ ¤W¤ëÀ禬264¸U¡A³Ò°È¦¬¤J ------------------------------------------------------------------------------------------- ·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2021/1/19 ¤U¤È 10:44:38²Ä 524 ½g¦^À³ ¦~³ø¦³§ó·s¤WӤ리¤J¬O»P ¦X¥þÃÄ·~»´ä¦³¤½¥q 109/12~ÃÄ«~¦X¦¨¥X³f ©e°UÃÄ«~¦X¦¨¬ÛÃö¨Æ©y |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/21 ¤U¤È 03:52:58²Ä 810 ½g¦^À³
|
SNP-6(P2)Àu©ó·~¬É»{¬°±N¬O²Ä1¤äNASH¤W¥«ÃĪ«ªºMGL3196¡]Resmetirom¡^¡A ¥H¶g¤Madrigal¥«È18.85»õ¬ü¤¸¥«È¡A¸Õ°ÝªYÄ£ªº¹Ú¦³¦h¤j?(¥Ø«eªYÄ£¥«È¤£¤ÎMadrigalªº10%) Madrigal¤½¥q°£¤F2¤äNASHÃĪ«MGL-3196(P3) /MGL-3745(Á{§É«e)¥~¡A[§OµL¥Lª«]! VS ªYÄ£ SNP-610(P2) /SNP-630(P1)¡A¥~¥[º¤äµL¨x¬rSNP-810¡C -------------------------------------------------------------------------------------------- 2021.2.16 Madrigal: Leading Biotech In Race For NASH Approval That Nobody Has Been Able To Win ... ¸Ó¼Æ¾Ú¨ÏResmetirom¦¨¬°¶W¹L50ºØÄvª§©ÊNAFLD / NASHªvÀøÃĪ«¤¤ªºË³Ë³ªÌ seekingalpha.com/article/4406410-madrigal-leading-biotech-in-race-for-nash-approval-nobody-able-to-win ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/9/12 ¤U¤È 02:42:06²Ä 344 ½g¦^À³ SNP-6Àø®Ä¦w¥þ©ÊÀu©ó«eªuªºMadrigal MGL-3196?! ¦ý¬OªYÄ£¥«È«o¤£¤ÎMadrigalªº10%!!! ¶g¤ªYÄ£¥«È37.2»õ¥x¹ô(¬ù1.3»õ¬ü¤¸) ¶g¤Madrigal¦¬½L¥«È15.8»õ¬ü¤¸(°ªÂI¬O2018¦~ªº43»õ¬ü¤¸) Madrigal±q43×¥¿¨ì15.8¡A¦]¦¹n»¡°ê¥~°ª¦ôMadrigal¦æ¤£³q¡A¦]¬°°ê¥~¤ÀªR®v¤W½ÕMadrigalªºªÑ²¼¥Ø¼Ð»ù) Madrigal´N2¤äÃĪ«MGL-3196(P3) /MGL-3745(Á{§É«e)¡A¤G¤ä³£¬ONASHÃĪ«¡C(ªYÄ£5¤ä...) www.madrigalpharma.com/ourapproach/pipeline/ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/21 ¤U¤È 01:31:18²Ä 809 ½g¦^À³
|
SNP-6¤SÀu©óMadrigal¤½¥qªºMGL3196¡]Resmetirom¡^¡A°ê»Ú¤jÃļt¯u¤ß¤£°Ê??? -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/6 ¤U¤È 07:58:04²Ä 740 ½g¦^À³ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/6 ¤U¤È 07:49:18²Ä 739 ½g¦^À³ ±À½×SNP-6¨t¦CÀò±oNASHÃÄÃÒ¾÷²v¬Û·í°ª!!!! ¦]¬°SNP-630Àu©óSNP-610 ; SNP-610 Àu©ó Ocaliva (³Ì¦³§Æ±æ²Ä1¤ä¨úÃÒªºNASHÃĪ«)! ------------------------------------------------------------------------------------------- ¥Ñ¤W±oª¾-·s»D³ø¾É¤w¦³5®a°ê»Ú¤jÃļt¡A¿n·¥°Ó½Í¦X§@±ÂÅv¤¤-¤]µ´«D§ù¼¶! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/21 ¤U¤È 01:16:24²Ä 808 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/6 ¤U¤È 07:49:18²Ä 739 ½g¦^À³ ±À½×SNP-6¨t¦CÀò±oNASHÃÄÃÒ¾÷²v¬Û·í°ª!!!! ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/6 ¤U¤È 08:21:13²Ä 743 ½g¦^À³ .......SNP-610ªº¬ãµoµ¦²¤¡B¥Ø«e¶i®i¤Î¹w©w¦ó®É±ÂÅv¡H §Ú̥ѹê»Ú±ÂÅv¬¢°Óªº¹Lµ{¤Î¸gÅç¡A¯S§O±N·sÀø®Ä¤Î·s¦¨¥÷SNP-610¤Î630¦U¦³¨äµ¦²¤³W¹º ...Ó¤H±À´ú610¨«Áp¦XªvÀøÁ{§É?¦Ó630¨«³æÃĪvÀøÁ{§É? ---------------------------------------------------------------------------------------- ¬JµMSNP-6¨t¦CÀò±oNASHÃÄÃÒ¾÷²v¬Û·í°ª¡A¬°¦ó¤@¤ä¨«Áp¦X¥ÎÃĤ@¤ä¨«³æÃĪvÀø? ¬Ý¤U±¨Ò¤l¦Û¤v·Q! THR-beta§í¨î¾¯:Madrigal¤½¥qMGL3196¡]Resmetirom¡^---Á{§É¤T´Á³æÃĪvÀø ¥ÌµÜ¤½¥qªºASC41--Á{§É¤T´ÁÁp¦X¥ÎÃÄ 2020.09.09 ¥ÌµÜ»sÃÄ»PGalmed©Ý®iNASHºÞ½u ¶}®iAramchol»PASC41Áp¦X¥ÎÃĬã¨s hk.prnasia.com/story/290909-2.shtml |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/21 ¤U¤È 12:54:38²Ä 807 ½g¦^À³
|
¦b³Ì¦³¾÷·|¹Ü±o²Ä1¤äNASH¤W¥«ÃÄÃÒªºOcaliva¡]Intercept¡^¦]¬°[¨x¬r©Ê]°Æ§@¥Î³Q§_¨M«á¡A ±µ¤U¨Ó·~¬É»{¬°²Ä1¤äNASH¤W¥«ÃĪ«·|¬OMadrigal¤½¥qªºMGL3196¡]Resmetirom¡^¡H ¦³«GÂIªº¬OªYÄ£ªºªk»¡·|¸ê®Æ¡]²Ä19〜22¶¡^¡GSNP-610ªºP2ªì¨B¼Æ¾ÚÀu©óMGL3196¡]Resmetirom¡^¡A·íµM¦¨©Î±Ñ±o¬ÝP3³Ì²×µ²ªG¡C -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151µoªí®É¶¡¡G2020/7/3¤W¤È08:05:38²Ä35½g¦^Î` 108/07/24 Bio-Asia¨È¬w¥Í§Þ¤j®iÁ|¿ì¤§¤½¥q®i±æ»¡©ú·| mops.twse.com.tw/nas/STR/663420190724M001.pdf Phase II study: - The decreases in several clinical parameters from baseline to the end of treatment were greater in SNP-610-12-week treatment than Ocaliva, Cenicriviroc, Elafibranor, MGL3196 or Selonsertib treatment in literature, especially in ALT. --------------------------------------------------------------------------------------- 2021.2.3 FDA开讲®y«ü点NASH·s药¬ã发 mp.weixin.qq.com/s?__biz=MzI5NzY0NDQyNQ==&mid=2247597425&idx=5&sn=5603a91a3d5e1887bf2a13fdd349484d&chksm=ecb2c597dbc54c813151617dccf12977839e42fd2f0716ebdc70ba293bbf63b233b21e5a922f&scene=21#wechat_redirect ..2022¦~¦ô计会¬ONASH领°ì°_飞ªº¤@¦~¡A¦pªG [Madrigal]ªºPh3¤£n¥X¤j问题¡A§Ú们会¦b2023¦~¬Ý¨ì²Ä¤@个获§åªºNASH药ª«¡A¨ì时Ô¾ã个资¥»¥«场会¥Î«D±`¤£¦Pªº²´¥ú来¬Ý¾ã个领°ì¡C当§ó¦h资¥»¯F进来ªº时Ô¡A¨Æ±¡会变±o«D±`¦³·N«ä¡C |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/2/19 ¤U¤È 07:07:28²Ä 806 ½g¦^À³
|
³ÌªñÁ`¬O¦³´X®a¯S©w¨é°Ó¥Î¤O¥X¡A¤£Ä@·Nµ¥¶}¼ú?! |
|
|
·|û¡GRock00910149258 µoªí®É¶¡:2021/2/19 ¤W¤È 11:49:45²Ä 805 ½g¦^À³
|
¤µ¤Ñ¦³ºØ¸êª÷Âà¤J¥Í§Þªº®ðª^!! ´Á«Ý¥Í§Þ¦hÂI¶}ªá...Åý®ðª^¬¡µ¸°_¨Ó!! |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/2/19 ¤W¤È 11:35:49²Ä 804 ½g¦^À³
|
ÁÂÁ¤j¤jªº¸Ñ»¡ |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/19 ¤W¤È 11:35:06²Ä 803 ½g¦^À³
|
ºK¿ý-¶ð¤ì¼w-¤@®Ñªºª÷¿úÆ[©À½g¡G ¦pªG¥Ļâª÷¿ú¬Ý±o«Ü«¡A´N¤£´±¦A¨º¼Ë¤ß¤£¸õ¡B®ð¤£³Ý¦aÁÈ¿ú¤F¡A¤]¤£´±¨º¼Ë«÷©R¦aÁȨú°]´I¤F¡C¡]¡ö©Ò¥H§ë¸ê²z°]¯à°÷¾Õ©óºÞ²z¡A¹B¥Î«D¥²nªºª÷¿ú¨Ó§ë¸ê¡A¤£É¿ú§ë¸ê¡A§A¦b§ë¸ê²z°]ªº«ä¦Ò¤W¤]¤ñ¸û«ÈÆ[¡A¤Ï¦Ó§AÁȧó¦hªº¿ú) n·QÁÈ¿ú¡A´Nµ´¹ï¤£¯àµ¹¦Û¤v¼W¥[¤ß²zªºt¾á¡A¦Ó¬OÀ³¸Ó¤Q¤À±q®e¦a¡B§NÀR¦a¹ï«Ý¡A¹ïª÷¿ú¤£·P¿³½ì¦ÛµMÁȤ£¨ì¿ú¡AµM¦ÓÕY§âª÷¿ú¬Ý±o¤Ó«¤]´Nµ¹¦Û¤vIt¤F¨I«ªº¥]µö¡A³oÓ®ÉÔ¡A§A©Ò»Ýnªº´N¬O¹ý©³¦a§Ñ±¼¿ú³o¦^¨Æ¡A¤d¸U¤£n¦A§â¥¦·í°µ¬O¤@ºØ¨I«ªºt¾á¤~¦n¡C µS¤Ó¤H¥u§âª÷¿ú·í§@¬O¤@ºØ«Ü¦nª±ªºª««~¡A¥¦¦b¨ë¿EµÛ¨C¤@Ó¤Hªº¯«¸g¥h°ª«×¦a§ë¤J¥¦¡A¤Ḩë¤J¸êª÷®É¡A´N¬O§ë¤J¤F¤@¦¸¦¸¦MÀI¥B¦³½ìªº¹CÀ¸¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/19 ¤W¤È 10:09:53²Ä 802 ½g¦^À³
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/18 ¤U¤È 01:16:11²Ä 794 ½g¦^À³ §ë¸ê¤Hn@±o¦íªÑ»ù¤W¤U¬~¨êªº¸Õ·Ò¤~¯à¦³©Ò¦¬Ã¬¡C ----------------------------------------------------------------------------------------- ¿å20~30%¡A¤@°ï¤H´Nª§¥ý®£«á¦Ó¥X!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/19 ¤W¤È 09:54:31²Ä 801 ½g¦^À³
|
´º³Í¬O·m¨ì±ÂÅvÀY»¥i±¤¤£º}«G! ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/7/8 ¤W¤È 08:37:04²Ä 66 ½g¦^À³ ©Ó»X«C·ý¡A¸Ün¬OÁ¿³z¤ä¡A«P½¥ªø½Í ¤Tº\¤T¤é¹ÀÁ¿°L§¹¡C ³o¤G®aªºÃĪ«¦b¨S¦³±ÂÅvñ¬ù©Î¨ú±oÃÄÃÒ«e¡A¤£¦nµû½×½ÖÀu½Ö®t¡A¶È¬ù²¤¤T¨â¨Æ: 1.2020.6.16´º³Í¤½§i»PMerck Healthcare KGaA¼w°êÀq§J¶°¹Îñqª«½è²¾Âà¦X¬ù («´¬ù©Î©Ó¿Õ°_¨´¤é´Á(©Î¸Ñ°£¤é´Á):109/06/16~109/12/04)--¤£½T©wÀq§J·P¿³½ìªº¬OJKB-122©ÎTJC-0133©ÎTWJ-265? 2020.6.24´º³Í¤½§i¿ì²z²{ª÷¼W¸êµo¦æ·sªÑ®× ¥Ø«e¶È¦³©}«ü¥i¼Æªº±i¼Æ(¥´±a¶])¡A¦]¬°´º³Íªº¦~³ø»Pªk»¡·|¸ê®Æ¡A¨S¬Ý¨ì°Êª«©Î¤HÅé¹êÅç¼Æ¾Ú¡C ©Ò¥HÂÇ¥ÑÀq§JÀË´úÃĪ«»P¼fµø¼Æ¾Ú«áªº¤U¨B°Ê§@¡A¦A¨M©w¶i°h!ªYÄ£ªº¦~³ø»Pªk»¡·|¸ê®ÆÁö¦³¼Æ¾Ú¦ý¤]¤£¬O¥þ³¡(¬D¦n¦a)¡C 2.ªYÄ£¬Û¹ï¦w¥þ¬OÁÙ¦³SNP8¨t¦C¡A¶i¥i§ð°h¥i¦u! ¤½¥q¸ê®ÆSNP810¬O¤AñQÓi×ô+¯S©w¤½»{¦w¥þ¤§¦¨¤À---¦~³ø¤W¦³»PPanadol®¹ï·Ó²Õ¬Û¤ñ¼Æ¾Ú¸ê®Æ¡A«¥»{©wÁ{§É¦¨¥\¾÷²v ¬Û·í°ª! ¥t¥~SNP810¤w¥Ó½ÐFDA¼Ï纽Á{§É¸ÕÅç¡B±N¥Ó½Ð¬ð¯}©Ê¼f¬d/§Ö³t³q¹D---¦pªG¶¶§Q®³¨ì¬ð¯}©ÊªvÀø»P§Ö³t³q¹D¸ê®æ¡A¹ï©ó ±ÂÅvª÷µLºÃ¬O¤j¤j¥[¤À! ¤Ï¤§´º³Í°£¤FJKB-122¥~¡A¨ä¥L¶µ¥Ø¶iµ{ÁÙ¦³º©º©ªø¸ôn¨«... ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/7/3 ¤W¤È 09:09:27²Ä 44 ½g¦^À³ OK°Õ©M®ð¥Í°]!!! ´º³Í¤]³Q±a¤W¨Ó¤F(³o®a«¥¥u«ù¦³Ó¦ì¼Æ¡A¥´±a¶]) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/19 ¤W¤È 09:38:22²Ä 800 ½g¦^À³
|
»PMerckÁpÃĵ²ªG¥¿¦V¡Aµ²ªG¬OùÚÁlªá5,150¸U¬ü¤¸®³¨ì¥þ²y(©Ò¦³°ê®a¦a°Ï)??? ----------------------------------------------------------------------------------------- (6549)´º³Í-¤½§i¥»¤½¥q±ÂÅvùÚÁl¥Íª«ÂåÃĬì§Þ·sÃÄTJC-265 ...¥»¤½¥q»PùÚÁl¥Íª«ÂåÃĬì§Þ(¤W®ü)¦³¤½¥q(¥H¤U²ºÙùÚÁl¥Íª«)ñq·sÃÄAutotaxin Inhibitor TJC-265¿W®a±ÂÅv¸g¾P¦X¬ù¡A±NÀò±o¥»²£«~©ó [¥þ²y] ªº¿W®a¶}µo¾P°âÅv§Q¡A©ó±ÂÅv¦a°Ï¶i¦æ²£«~¬ãµo¡B»s³y¡B¾P°â¤Î±À¼s¬¡°Ê¡C ----------------------------------------------------------------------------------------------- 2020¦~6¤ë19¤é ¡X ´º³Í¡]6549¡^19¤é«Å¥¬¡A¸Ó¤½¥q»PMerck Healthcare KGaA¼w°êÀq§J¶°¹Îñqª«½è²¾Âà¦X¬ù¡A¦@¦P¦X§@¶i¦æ¤Æ¦Xª«¦b«D°sºë©Ê¯×ªÕ¨xª¢(NASH --------------------------------------------------------------------------------------------- 2020.10.14 ´º³Í¡]6549¡^14¤é¤]«Å¥¬¡AºX¤UTJC-265 ¡]autotaxin §í¨î¾¯¡^¤p¤À¤l·sÃÄ»P¼w°êÀq§J¶°¹Î¤p¤À¤l·sÃÄFASN§í¨î¾¯¦b«D°sºë©Ê¯×ªÕ¨xª¢¡]NASH¡^°Êª«¸ÕÅç¡Aµ²ªG¥¿¦V¡A¥Ø«e¤w³W¹º¦b2021¦~¦V¬ü°êFDA´£¥X¤@´ÁÁ{§É¥Ó½Ð¡A¨Ã±Ò°Ê°ê»Ú±ÂÅv¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/2/19 ¤W¤È 09:27:13²Ä 799 ½g¦^À³
|
©Ò¥H¤§«e§Ú»{¬°¬Omerckªº¾÷²v¤p¡AJJ GSK¾÷·|¤jÂI ¦ý¦pªG´º³Í¬O±Âµ¹¤j³°50KK¡A·sÄ£Y¬Oµ¹°ê»Ú¤j¼t¡A»ù¿ú´N¤£¤@¼Ë¤F ¥P¨Ö¥P¡A½Ö³£¤£·Ç¡C ----------------------------------------------------------------------- ´º³Í¡GTJC-265¤p¤À¤l·sÃÄ»PªYÄ£SNP-610®t¦bþÃä¡H ´º³Í¤w¸g±ÂÅv¡A±ÂÅvª÷¤~5000¦h¬üª÷¡A¹ïªYÄ£ªºSNP-610·|¦³¼vÅT¶Ü¡H |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/2/19 ¤W¤È 01:29:00²Ä 798 ½g¦^À³
|
5000¦h¸U¬üª÷¤~¹ï¡A¼g¿ù |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/2/18 ¤U¤È 09:24:46²Ä 797 ½g¦^À³
|
½Ð°Ý ´º³Í¡GTJC-265¤p¤À¤l·sÃÄ»PªYÄ£SNP-610®t¦bþÃä¡H ´º³Í¤w¸g±ÂÅv¡A±ÂÅvª÷¤~5000¦h¬üª÷¡A¹ïªYÄ£ªºSNP-610·|¦³¼vÅT¶Ü¡H |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/18 ¤U¤È 04:49:25²Ä 796 ½g¦^À³
|
¤µ¤Ñ§À½L¥æ©ö¸Þ²§¡A±±½LªÌ¥H¤Ö¶q©Ô§À½L¡A¬O±±¨î§Þ³N½u«¬¡H©Î¬O»¤¦h¡H¤£±o¦Óª¾¡C |
|
|
·|û¡GRock00910149258 µoªí®É¶¡:2021/2/18 ¤U¤È 04:18:19²Ä 795 ½g¦^À³
|
¤½¥¬±ÂÅv¦X¬ù¤@¨Æ¬O§_¦³©Ò¿×ªºº¡¨¬±ø¥ó ¨Ò¦p»Ý¨ú±o¬ü°êOTCÃÄÃÒ«á¦h¤Ö®É¶¡«á§Y¥i¥Í®Ä ªYÄ£©ó2021/01/26¨ú±oOTCÃÄÃÒ ³Ì²z·Q±ø¥ó¬°¨ú±o«á¤@Ó¤ë¤]´N¬O2021/2/26¤U©P¤½L«á¤½§i ¦Ü©ó¬O¤£¬O´N¤£ª¾¹D¤F¥u¦³»P·´°ª¼hª¾¹D µo¤F°ÝÃDµ¹¤½¥q¤@Ó¦h¤ë¤]©|¥¼±o¨ì¦^ÂÐ ²{¶¥¬q¥u¦³µ¥«Ý... |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/18 ¤U¤È 01:16:11²Ä 794 ½g¦^À³
|
§ë¸ê¤Hn@±o¦íªÑ»ù¤W¤U¬~¨êªº¸Õ·Ò¤~¯à¦³©Ò¦¬Ã¬¡C |
|
|
·|û¡G³®¦10149782 µoªí®É¶¡:2021/2/18 ¤W¤È 11:50:06²Ä 793 ½g¦^À³
|
¶X¤µ¤Ñ©Ô¦^¶R¨â±iµ¥¶}µP |
|
|
·|û¡G³®¦10149782 µoªí®É¶¡:2021/2/18 ¤W¤È 11:42:28²Ä 792 ½g¦^À³
|
¦X¤@ªÑ»ùº¦¶^ªi´Á¡G 109/2/28 ©³¦¬¨ì§Q¶ø»sÃĪºÄ³¬ùª÷400¸U¬ü¤¸31.3¡ù20.3¡û31.55¡ô 109/04/15ñ¸p¦X¬ù§ÜÅé·sÃÄFB825¤§·sÃÄ¿W®a¬ãµo¦X§@¤Î±ÂÅv¡C31.55¡ù75¡ô 109/05/13 MSCI¥þ²y¤p«¬«ü¼Æªº¥xªÑ¦¨¤ÀªÑ·s¼W¦X¤@72¡ù270¡ô 109/07/02ñ¸pFB825¥þ²y¿W®a±ÂÅv¨óij¡Añ¬ùª÷»P¨½µ{¸Oª÷5.3»õ¬ü¤¸ (·s¥x¹ô 159 »õ¤¸) 270¡ù450¡ô 109/07/10¾DÂd¶R¤¤¤ß³B¸m§ï¥H¤H¤u¼¼¦X§@·~450¡û153.5¡õ 109/07/30 ²{ª÷¼W¸ê85»õµo¦æ´¶³qªÑ°Ñ»P®ü¥~¦s°U¾ÌÃÒ153.5¡ù367¡ô 109/09/19 §Q¦h¥XºÉ367¡û198¡õ 110/02/02 ¬ãµo¤¤·sÃÄON101¨Å»I³q¹L¬ü°ê¡u«P¶i¶Ë¤f¡¦X¥~¥Î»s¾¯°t¤è¡vµo©ú±M§Q¡A¥¼¨Ó·sÃĤW¥««á±M§Q¦³17¦~±M§Q«OÅ@´Á¡C198¡ù220¡ô ·Ó¦X¤@ªº¶i«×¨âÓ¥b¤ë´Nñ¥þ²y¿W®a±ÂÅv5.3»õ¬üª÷ ªYÄ£20201223ñ¦X§@¨óij¨ì²{¦b¤]¹L¤Fªñ¨âÓ¤ë ¬O§_¦n¨Æªñ¤F©O |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/16 ¤U¤È 07:05:29²Ä 791 ½g¦^À³
|
¬ü°êKalyra·s³Ð¤½¥q«D±`¶§¬Kªººô¶¡A°£¤F¤@½g»¡©ú´N¤@µL©Ò¦³! kalyrapharma.com/ Our mission is to develop novel, potent, non-opioid, non-NSAID pain therapeutics that can be safely used alone and in combination with other analgesic classes to treat moderate to severe pain without the potential for addiction or abuse. §Ú̪º¥ô°È¬O¶}µo·s¿o¡A¦³®Ä¡A«Dªü¤ùÃþÃĪ«¡A«DNSAIDªº¯kµhÀøªk¡A³o¨ÇÀøªk¥i¥H¦w¥þ¦a³æ¿W¨Ï¥Î(=SNP-810³æÃÄ)¡A¨Ã»P¨ä¥LÂíµhÃÄÁp¦X¨Ï¥Î(=SNP-810+ªø®Ä¤fªA¯Ç¯k¸Ñ½Æ¤èÃĪ«)¡A¥HªvÀø¤¤«×¦Ü««×¯kµh¡A¦Ó¤£·|¤WÅ}©ÎÀݥΡC «Dªü¤ùÃþÃĪ«--³o¬OÁͶÕ! §â«DÃþ©T¾J®øª¢¤îµhÃÄNSAID(ªü´µ¤ÇÆF)¤]±Ë±ó¡AÃø¹D³o®a¥u±M§ðµL¬rAPAP??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/16 ¤U¤È 04:13:56²Ä 790 ½g¦^À³
|
SNP-810Ävª§¹ï¤â¦A+1¡A¬ü°ê¶¤¤w¦³3®a(¦³2®a®³¨ì¬ü°ê°ê¥ß½Ã¥Í¬ã¨s°|¡]NIH¡^ÃÙ§U)!!! 3®a¬ü°ê¶¤¥þ¬OAPAPµ²ºcÃþ¦üª«¡A»PªYÄ£SNP-810(¨Ï¥Îì¨Ó¦³®Ä¦¨¤À¡A¤S¤£¦A¦³¥ô¦ó¨x¬r©Ê)§@¥Î¾÷¨îºIµM¤£¦P¡C [»P¹ï¤A酰®ò°ò×ô¬Û¤ñ¡A¦w¥þ©Ê¬Û¦P©Î§ïµ½ªº¦w¥þµL¨x¬r©ÊÃĪ«±N¦¨¬°ªvÀø¯kµhªº¬ð¯}©Ê·s²£«~¡C] [»P¹ï¤A酰®ò°ò×ô¬Û¤ñ¡A¦w¥þ©Ê¬Û¦P©Î§ïµ½ªº¦w¥þµL¨x¬r©ÊÃĪ«±N¦¨¬°ªvÀø¯kµhªº¬ð¯}©Ê·s²£«~¡C] ¹ï¤A酰®ò°ò×ô¬OªvÀø¯kµhªº«nÃĪ«¡C¦ý¬O¡A¹L¶q¡]³o«Ü±`¨£¡^·|¾ÉP¨x·l®`¡AÀH«áªº¨x°IºÜ¬Æ¦Ü¦º¤`¡C»P¹ï¤A酰®ò°ò×ô¬Û¤ñ¡A¦w¥þ©Ê¬Û¦P©Î§ïµ½ªº¦w¥þµL¨x¬r©ÊÃĪ«±N¦¨¬°ªvÀø¯kµhªº¬ð¯}©Ê·s²£«~¡C Kalyra Pharmaceuticals...¦X¦¨¤F³\¦h»P [µ²ºc] ¬ÛÃöªº¹ï¤A酰®ò°ò×ô [Ãþ¦üª«]¡A¨Ãµo²{¤F¤£·|§Î¦¨¦³¬r¥NÁ²£ª«ªº·s«¬°ª®Ä¤îµh¤Æ¦Xª«¡C¦³¤F·§©ÀÅçÃÒ¡A³q¹L¥H¤U·§zªº¨ãÅé¥Ø¼Ð¡A±N³o¨ÇÃþ¦üª«ªº¶i¤@¨B¶}µo§@¬°ª½±µ¥Î©ó²Ä¤G¶¥¬qªº´£®×ªº¥DÃD¡G²Ä¤G¶¥¬q¡G°w¹ï¯kµh¥Ø¼Ðªº·sÀøªkªº«DÁ{§É¶}µo1.¥\®Äªº¶i¤@¨Bªí¼x©MÅ餺ÃIJz¾Ç¥Øªº2. ADMET¡A¨ä¥LÃIJz¾Ç©Mªì¨B¬r²z¾Ç¥Øªº3.ÃÄ¥N°Ê¤O¾Ç¬ã¨s¡A¥H½T»{¥Î©ó¦w¥þ¥Øªºªº²Ä¤GºØ¿ï¾Ü¡C4.¤ä«ùIND³Æ®×ªº«DÁ{§É¬r²z¾Ç¬ã¨s¦b¸Ó´£®×¤¤¡A§Ú̹wp±N¦VFDA´£¥æIND¥Ó½Ð¡A¥H¶}©l¤HÃþÁ{§É¸ÕÅç¡A¥H¶}µo¤@ºØ·s¿o¡A¦w¥þ¡A¦³®Ä¥B«D¦¨Å}ªº¯kµhªvÀø·sÀøªk¡C www.jpain.org/article/S1526-5900(19)30663-7/pdf --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/8/27 ¤W¤È 10:21:21²Ä 323 ½g¦^À³ µL¨x¬r©ÊSNP-810ªºÄvª§ªÌ¤§(¤G)¡C 2006¦~8¤ë21¤éµL¨x¬r©Ê[¹ï¤A酰®ò°ò×ô]Ãþ¦üª«ªº¦X¦¨(pubmed.ncbi.nlm.nih.gov/16919959/ ) ³o¤ä¬ü°ê¶¤¸g¹Lº©ªø14¦~²×©ó¬ð¯}²~ÀV¡A³Ìªñ·s»D¦h¡A¶i«×¤]»â¥ý©³¤UÄvª§ªÌ¤§(¤@)¦n¨Ç¦~¡A¦ý¤´µM»·»·¸¨«áªYÄ£¡A³o¤G¤ä¬ü°ê¶¤³£¬O¶}µoµL¨x¬r©Ê[¹ï¤A酰®ò°ò×ô]Ãþ¦üª«¡A»PªYÄ£SNP-810§@¥Î¾÷¨îºIµM¤£¦P¡C Ó¤H³W¹º¬Oªø´Á«ù¦³ªYÄ£(±ÂÅv«á¤£¶È¤£·|½æ¥X¤ÏË·|¥[½X¡A°£«D¦X¬ùª÷ÃB»P«¥¦ô»ù®t¶Z«Ü¤j)¡A¦³Ävª§ªÌ«_¥XÀY¡A ©Ò¿×ª¾©¼ª¾¤v¡A¦Ê¾Ô¤£¬p¡A¦C¤Jªø´Á°lÂܦӤw¡A¤ð±e¼~¼{! ............................................................................................... ·|û¡GROGER588910148151 µoªí®É¶¡:2020/8/24 ¤W¤È 09:08:58²Ä 315 ½g¦^À³ ³o¬O¤w«_¥XÀYȱoÆ[¹îª`·NªºÄvª§ªÌ¤§(¤@)¡A¥Ø«e®t¶ZÁÙ«Ü»»»·¡C Researchers have developed a safer building block for the development of new medicines. www.futurity.org/1-aminonorbornane-aniline-side-effects- -------------------------------------------------------------------------------------------- |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/16 ¤W¤È 08:42:08²Ä 789 ½g¦^À³
|
2021.01.29 §¨Ó¦Aªá4.1»õ¬ü¤¸±ÂÅv¤é¥»Asahi KaseiªºAK1780Ãþ·ÀãÃö¸`ª¢Á{§ÉÃĪ«¡AÂà§@ºC©Ê¯kµhÃĪ«¡C (§¨Ó¯kµhÃĪ«ºÞ½u¥Ø«eÁ`¦@5´ÚÃĪ«) med.sina.cn/article_detail_103_2_95654.html --------------------------------------------------------------------------------------------- 2019.05.29 §¨Ó¥Hªñ10»õ¬ü¤¸»PCentrexion¦X§@©Ý®i [«D]¾~¤ùÃþ¤îµhÃĪ«¥«³õ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/15 ¤U¤È 10:43:04²Ä 788 ½g¦^À³
|
±q¬ü°êÀn¤ù¦M¾÷l¥Í2¥ó~10»õ¬ü¤¸ªº[«D]ªü¤ùÃþÃĪ«¥æ©ö! ©Ò¥H[2.SNP-810+¯Ç¯k¸Ñ]¤]¦³¬Û·í»ùÈ! 2020.08.25 Acadia Pharmaceuticals¥H5250¸U¬ü¤¸ªº»ù®æ¦¬ÁÊCerSci (0.525+8.87=9.395»õ¬ü¤¸) news.futunn.com/hk/stock/14136314?level=1&data_ticket=1609504391351702 ----------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/9 ¤U¤È 11:33:43²Ä 770 ½g¦^À³ ¬Y¨Ç¬ã¨s¶°¤¤©ó [«·s§Q¥Î] NSAID¡A¨Ò¦p¹ï¤A酰®ò°ò×ô(APAP)- 2019.05.29 §¨Ó¥Hªñ10»õ¬ü¤¸»PCentrexion¦X§@©Ý®i [«D]¾~¤ùÃþ¤îµhÃĪ«¥«³õ news.gbimonthly.com/tw/article/show.php?num=28151&page=258&kind=22 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/15 ¤U¤È 09:21:45²Ä 787 ½g¦^À³
|
®£©Æ£x¾~¤ù¦M¾÷! ´¶´ç¯}²£¡A2020.12.09ªe°¨¦{¶}¤j¤f¦VJ&Jn93»õ¬ü¤¸(¯Ã¬ù¦{¶}¤f20»õ¬ü¤¸)---³Ì«áJ&J±oªá$$$Â\¥? www.thestar.com/news/world/us/2020/12/09/oklahoma-asks-court-make-jj-pay-93b-to-end-opioid-crisis.html |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/14 ¤U¤È 04:33:26²Ä 786 ½g¦^À³
|
...Âù¤è°ò©ó¦X§@¨óij¡A¦A¨ó°Ó«áÄò [ÂX¤j¦X§@]µ¥¬ÛÃö¨Æ©y¡A©¡®É±N¥t¦æ¤½§i¡C[ÂX¤j¦X§@]? °ê»ÚÃļt¬ãµo¦X§@¨óijµæ³æ¬OÂI¤F 1³½1¦Y? 1³½2¦Y? 1³½3¦Y? 1.SNP-810 2.SNP-810 + ¯Ç¯k¸Ñ (¶¶ÃĪø®Ä«¬¯Ç¯k¸Ñ¦P¼Ë§ÞÂà¦ÛJ¥®®E±Ð±Â) 3.[¨xŦ¥NÁÂ酶][°ò¦]½Õ±±§Þ³N]ÃĪ«¶}µo¥¥x ----------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/28 ¤W¤È 08:26:34²Ä 612 ½g¦^À³ ¤jÃļt¤â¤W¤@°ï¦]ÃĪ«©Ê¨x·l¶Ë¢Ò¢×¢Ú¢×¡^¦Ó¤¤Â_©Î²×¤îªºÃĪ«¡C ¬JµM[ªYÄ£ªº§Þ³N¥¥x]¯à¸Ñ¨M§x´o60¦h¦~ªºÃøÃD¡A¤jÃļt¥i¯à¤£·|·Qn[ªYÄ£¥¥x]¸Ñ¨M¨ä¥LÃĪ«ªº¨x¬r©Ê? ªYÄ£¥H[¨xŦ¥NÁÂ酶]»P[°ò¦]½Õ±±§Þ³N]¶}µoÃĪ«¡A¦¹ºØ§Þ³N¥iÀ³¥Î©ó¥i¯à¾ÉP¨x¬r©Ê¤§ÃĪ«¥H¤Î¨xŦ¯e¯f(NASH)¤§ªvÀø¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/2/13 ¤U¤È 11:14:36²Ä 785 ½g¦^À³
|
¤p¨È¤j¡A¿W¨¤Ã~¬O«ü¥«È10»õ¬ü¤¸¢w300»õ¥x¹ô¡FªYÄ£¨CªÑ600¤¸¥H¤W¡A´N¹F¼Ð¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/13 ¤U¤È 09:35:49²Ä 784 ½g¦^À³
|
²Ä 3 ²ÕAAP 1000 mg+¯Ç¯k¸Ñ 20 mg??? [«·s§Q¥Î]SNP-810 1000mg+¯Ç¯k¸Ñ20mgªº(½Æ¤è)¤îµhÃÄ¡An¥´¯}2014¦~FDA¤½§i°Ç¥O°±¤î»s³yAcetaminophen§t¶q¶W¹L325 mgªº [½Æ¤è] ¤îµhÃĸT¥O??? -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/25 ¤U¤È 10:28:31²Ä 574 ½g¦^À³ »O¥_ºa¥ÁÁ`Âå°|¤HÅé¸ÕÅç©eû·|(¤@)²Ä 131 ¦¸·|ij¬ö¿ý ¤½§iª© ¶}·|®É¶¡¡G109 ¦~ 11 ¤ë 2 ¤é¤U¤È 2 ®É¥¿ pµe¥D«ù¤H¡G³¯¥¿Â× pµe¦WºÙ¡G·s±j®Ä¤£¦¨Å}¤îµh²Õ¦XÃÄ Sebacoyl Dinalbuphine Ester ¤Î [µL¨x¬r¤AñQÓi×ô]¥Î©óÂù °¼½¥Ãö¸`¸m´«³N«á¤§¤¤«×¦ÜÄY«¯kµhªvÀø |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/13 ¤U¤È 09:11:28²Ä 783 ½g¦^À³
|
§Ú̪YÄ£SNP-810´N [¤ñ¤H¥d²Óº~]¡H ¥¥Ãl¬O¤îµhÃÄ(2¤ä´N¬OAPAPÃĪ«¡A1¤ä«Dªü¤ùÃĪ«(¤£§tªü¤ùªº¤îµhÃijq³qºÙ¬°«Dªü¤ùÃĪ«:APAP/ ªü´µ¤ÇÆF...) 2014¦~Ofirmev VS 2014¦~CL-108 VS 2019.05.29 §¨Ó¥Hªñ10»õ¬ü¤¸»PCentrexion¦X§@ ¨º¤@¤ä±ÂÅvª÷<5»õ¬ü¤¸??? -------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/9 ¤U¤È 11:33:43²Ä 770 ½g¦^À³ ¬Y¨Ç¬ã¨s¶°¤¤©ó [«·s§Q¥Î] NSAID¡A¨Ò¦p¹ï¤A酰®ò°ò×ô(APAP)- 2019.05.29 §¨Ó¥Hªñ10»õ¬ü¤¸»PCentrexion¦X§@©Ý®i [«D]¾~¤ùÃþ¤îµhÃĪ«¥«³õ news.gbimonthly.com/tw/article/show.php?num=28151&page=258&kind=22 ------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/9 ¤W¤È 11:34:51²Ä 474 ½g¦^À³ SNP-840¡GSNP-810(Acetaminophen+¯S©w¤½»{¦w¥þ¦¨¤À)+ hydrocodone (²B¥ià¬) CL-108: Acetaminophen + promethazine +hydrocodone (²B¥ià¬) 2014¦~CL-108±ÂÅvª÷ 6.8»õ¬ü¤¸ www.fiercebiotech.com/biotech/daiichi-axes-650m-pain-pact-7-months-after-fda-setback .................................................. ......................................... ·|û¡GROGER588910148151 µoªí®É¶¡:2020/9/2 ¤W¤È 11:04:43²Ä 334 ½g¦^À³ 2014.02.11 Mallinckrodt13»õ¬ü¤¸¦¬ÁÊCadence¥HÀò±oÂíµhÃÄOfirmev(º¤ä¹ï¤A酰®ò°ò×ôÀR¯ßª`®g¾¯)(³Ì²×¦¬ÁÊ»ù¬O14»õ¬ü¤¸) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/13 ¤U¤È 08:56:32²Ä 782 ½g¦^À³
|
±z°¨À°À°¦£¡A [¿W¨¤Ã~]¬O«ü? ³oª©¦³2R³æ¦r©ö²V²c! |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/13 ¤U¤È 07:50:18²Ä 781 ½g¦^À³
|
10e¬üª÷x28.025¶×²v/5.23·s¥x¹ôªÑ¥»=EPS535x20¿¥»¯q¤ñ=ªÑ»ù10700(1070¸U/1±i)¡AR¤j¡A¤Ö¨Ó¤F¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/13 ¤U¤È 07:32:13²Ä 780 ½g¦^À³
|
Âù°¼½¥Ãö¸`¸m´«³N«á¤§¤¤«×¦ÜÄY«¯kµhªvÀø---§ï¥ÎJ&J Tylenol? ¯Ç¯k¸Ñ¤fªA¾¯+SNP-810 ·|¬OJ&J´£¥Xªº[«·s§Q¥Î]APAP??????????? ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/9 ¤U¤È 11:33:43²Ä 770 ½g¦^À³ 2020.01.07 (¤é´Á«Üªñ¨þ) MPM¤ä«ù´M§ä«Dªü¤ùÃþÂíµhÃĪº·s¥Íª«§Þ³N endpts.com/mpm-backs-new-biotech-in-the-hunt-for-non-opioid-painkiller/ ¬Y¨Ç¬ã¨s¶°¤¤©ó [«·s§Q¥Î] NSAID¡A¨Ò¦p¹ï¤A酰®ò°ò×ô(APAP)--(³o¬qªí¥ÜSNP-810»ùȦA´£¤É!!) ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/25 ¤U¤È 10:40:47²Ä 575 ½g¦^À³ --[µL¨x¬r¤AñQÓi×ô]¥Î©óÂù°¼½¥Ãö¸`¸m´«³N«á¤§¤¤«×¦ÜÄY«¯kµhªvÀø---§ï¥ÎJ&J Tylenol? --------------------------------------------------------------------------------------------- ²ö«D¥h¦~¤½§iñ¦X§@¨óijªº¬OJ&J??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/13 ¤U¤È 07:16:54²Ä 779 ½g¦^À³
|
2¦~«e¦¶¸³¦³»¡n¦¨¬°¿W¨¤Ã~! (¾Ì¯×ªÕ¨xª¢ÃÄ»PµL¨x¬r¤îµhÃĦ¨¬°¿W¨¤Ã~?) ¿W¨¤Ã~¬O«ü¦¨¥ß¤£¨ì10¦~¦ý¦ôÈ10»õ¬ü¤¸¡]$1 billion¡^¥H¤W¡A¤S¥¼¦bªÑ²¼¥«³õ¤W¥«ªº¬ì§Þ³Ð·~¤½¥q¡C --------------------------------------------------------------------------------------------- 2018-11-28 记ªÌ¡GªL«É¨°www.microbio.com.tw/cn/news_detail.php?nwno=336 兴Ï@药ÉDªYÄ£¥Í医 (6634-TW) ¤µ (28) ¤é参¥[亚¤Ó¥Í§Þ§ë资论坛¡AªYÄ£¥Í医¸³¨Æ长¦¶凯©ú¦b¡u«½S·s药¥ø业¡v发ªí时ªí¥Ü¡A§Y¨Ï¤£¬O¤j¥ø业¡A¨ÌµM¥i¥H¦³·s药ªº¬ã发ÉO¤W¥«¡A对¦¹¬Û当¦³«H¤ß¡A§Æ±æ¥i¥H¾aþӯתըxª¢药ÉOÆÓ¨x¬r¤îµh药¡A¦b¥¼来¦¨为[独¨¤兽]¤§¤@¡C |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/13 ¤U¤È 01:56:44²Ä 778 ½g¦^À³
|
·Q¤£¨ì¤j®a°µªº¬ü¹Ú¤ñ°_§Úªº§ó¤j¡A説¬O§j¤û®£¤S°¾»á¡A¦]¬°Rock¤jªº¥ß½×¥¿½T¡A¨ä¤¤¥H²{ª÷¬y±ÀºâªÑ»ùªº«ÈÆ[¤½¦¡§Ú´¿¸g¬yÆl¹L¡AÃþ¦üEPSÆ[©À¡C¥HÁ`¥«È´«ºâªÑ»ù«h³Ì¶KªñªÑ¥«ªº¦X²z¤è¦¡¡A¤£·Q¦A°µ¬ü¹Ú¤F¡A·Q¿ìªkÄw²{ª÷¶RªÑ³Ì¹ê¦b¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/2/13 ¤U¤È 12:35:25²Ä 777 ½g¦^À³
|
r¤jÁÂÁ¸ѻ¡¡A·PÁ¡IªYÄ£¯u¬O¿ú³~µL¡C ¥t¤@¥ó¨ÆÁÙ¬O¤£¸Ñ¡A810¡B610¯à±ÂÅv¨SºÃ°Ý¡C630¡B830¡B840¤@¼Ë¬O¿W¥ßÓÅé¡A¥i¥H±ÂÅv¥X¥h¶Ü¡H½Ð±Ðr¤j¡AÁÂÁ¡C ¦pªG«á±¨º¤TÁû¡A¯u¯à¿W¥ß±ÂÅv¡A¨º¤j¥ß¥úªÑ¤ý¡AÅK©w´«¤H·í¤F¡C |
|
|
·|û¡GRock00910149258 µoªí®É¶¡:2021/2/13 ¤W¤È 10:45:54²Ä 776 ½g¦^À³
|
¥Í§Þ·sÃĪѻùµû¦ô¦³¤U¦C¤èªk¡G ¤@¡G ²{ª÷¬y¶q§é²{ªk¡G ±qñ¬ùª÷丶¨½µ{ª÷丶¤À¼íª÷¡Aªø¹F¦h¦~ªº¹w´Á²{ª÷¬y¤J¶q¡A¥Î°]°È¾Çªº§é²{¤èªk¡A´«ºâ¬°²{¦bªº¦X²z»ùÈ¡C ±i¥ß¸s¤j®v§Y±Ä¥Î¦¹¤èªk¡C ¤G¡G±ÂÅvª÷¤èªk¡G §Y±ÂÅvª÷ªº¤¿¦Ü¤Q¿µ¥©óÁ`¥«È¡A¦A´«ºâ¬°ÓªÑªºªÑ»ù¡C ⋯ ¦X¤@²{¦bªºªÑ»ù¡Aè¦n¤ÏÀ³±ÂÅvª÷ªº¤¿¡C ¤§«e¤ÏÀ³¨ì4¦Ê¤¸¥H¤W¡A¬O¦b¤ÏÀ³²Ä¤GÁû¿}¨¬ªºÃÄ»I¡C ⋯ ²{¦b¨ÓpºâªYÄ£ªº¦X²zªÑ»ùȦh¤Ö¡H °²³]¡G ¤@¡G ¤¿´N¦n¡A±Ä³Ì§C¼Ð·Ç¡C ¤G¡G±ÂÅvª÷¦p¶Ç»Dªº¤»õ¬ü¤¸¥H¤W¡C§ÚÌ´N±Ä¤»õ¬üª÷´N¦n¡C ⋯ pºâ¦p¤U¡G 5»õ¬ü¤¸¬ùµ¥©ó150»õ¥x¹ô¡C 150»õªº5¿µ¥©ó750»õ¡]Á`¥«È¡^¡C 750»õ°£¥H5»õ¡]ªÑ¥»¡^µ¥©ó150¡]¿¡^¡C 10¤¸¡]±ÃB¡^¼¥H150¿µ¥©ó¡G1500¤¸¡]§Y¥Ø¼ÐªÑ»ù¡C ⋯ ³o¥u¬Opºâ¤îµhÃĪº³¡¤À¡C Y¯×ªÕ¨xªº²Ä¤GÁûÃıÂÅv¥X¥h¡A¥Ø¼Ð»ù¶W¹L¤j¥ß¥ú¡A«ü¤é¥i«Ý¡I ⋯ µ²½×¡G ªYÄ£ªºªÑ»ù·|¶]¦h»· ³Ì«nªº°Ñ¼Æ´N¬O¡G ±ÂÅvª÷¦³¦h¤Ö¡H |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/12 ¤U¤È 07:54:42²Ä 775 ½g¦^À³
|
¯¬¦U¦ì¤j¤j·s¦~§Ö¼Ö¡A¬Ý¨Ó¦³¥²n¤@¦¸·dÀ´±ÂÅvª÷¤º®e¡A§K±o§Ú¤û¦~¤Ñ¤Ñ°µ¬ü¹Ú¡G ·sÃĤ½¥q±ÂÅv®É·|¥ý¦³£¸µ§Ã±¬ù±ÂÅvª÷(¤SºÙ§@«eª÷¡Fupfront payment)ªº¦¬¤J¡AÃþ¦üqª÷ªº·§©À¡C¤§«áÀHµÛ§¹¦¨¶}µo¶i«×¦A¨Ì¾ÚÁ{§É¸ÕÅ窺¶i®i¡A¥i¯àÁÙ·|¦³2~3¦¸ªº¶¥¬q©Ê±ÂÅvª÷ªº¦¬¤J(§Y¨½µ{ª÷) (milestone payment)¡C¥H¤W¬O±ÂÅvñ¬ù¤º®e¡]À³¸Ó¬OªYÄ£©Òñqªº¬ãµo¦X§@¨óij§a¡^¡A¦]¬°¬ù©wª÷ÃB·|¨Ì¾Ú¼i¬ù¶i«×¡]Àø®Ä½T©w¡^¤ä¥I¡A³Ì«á«O¯d¤@µ§§À´Ú¤ä¥I¡A¦]¦¹±ÂÅvª÷«E¥i¯à¦b¤£¦P·|p¦~«×¤º¤À§å¤J±b¡A¤]³s±a¼vÅTEPSpºâ¡C Y²£«~¦¨¥\¤W¥«¡A¨C¦~ÁÙ¥i¥H®Ú¾ÚÀ禬ª÷ÃB¡A©â¨ú¤W¥«¾P°âÅv§Qª÷ (royalty)¡A³oºØÅv§Qª÷´N¬O§ÚÌ©ÒºÙªº¤À¼íª÷¡C §Ú̦b°Q½×°Ï¤½¶}°Q½×¡A¤º®e¤jªÑªF©M¥D¤O³£¤À¨É±o¨ì¡AªÑ¥«©{¦p¤ß²z±þ¼®¾Ô³õ¡A¦hªÅ¬Ýªk¬Ò¦³©Ò¾Ú¡A°ß¤@¤£Åܪº¨Æ¹ê¬O¤jªÑªF©M¥D¤O¤£·|µL¬GÀ°¤p´²¤á©ïÃ⪺¡AµL½×ªYÄ£±Ò°Ê¯u¥¿¤jªi¬qº¦¶Õªº®É¶¡ÂI¦b¤°»ò®ÉÔ¡Aµo°Ê«eºD±`·|¦³°²áè±þ¯u§C±µªºÀ¸½X¦ÒÅç´²¤á̪ºÅ²½à¤O¡I |
|
|
·|û¡GRock00910149258 µoªí®É¶¡:2021/2/12 ¤U¤È 05:26:19²Ä 774 ½g¦^À³
|
¨Ì·Ó°ê¥~µû¦ô¥Í§Þ·sÃıÂÅvª÷ªººâªk 15E±ÂÅvª÷§é¦XªÑ»ù¬O4500 35E±ÂÅvª÷§é¦XªÑ»ù¬O10500 ¥H¤W¬O²©öªºµû¦ôªk ¦ý¨CÓ¥«³õ¹ï·sÃĪºµû¦ô¦³©Ò¤£¦P¶È¨Ñ°Ñ¦Ò¡I ¦p¦X¤@5.3E±ÂÅvª÷¦X²zªÑ»ùpºâ¥X¨Ó¬ù227¡A¦pªG¦³²Ä¤GÁû±ÂÅv´N©¹¤W¥[¤§¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/2/12 ¤U¤È 02:13:02²Ä 773 ½g¦^À³
|
¦U¦ì¤j¤j·s¦~§Ö¼Ö¡I ·Q¸ÕºâªYÄ£¥¼¨Ó¡AY¦³¤£·í½Ð¦U¤j«ü±Ð¡C ±ÂÅvª÷810¡B610¦X15»õ¬ü¤¸¡A630¡B830¡B840ºâ20»õ¬ü¤¸¡A¦Xp35»õ¬ü¤¸¢w10000»õ¥x¹ô¡A¨CªÑÁÈ2000¤¸¡A¤À30¦~¬°70¤¸/¦~¡BªÑ¡F¤À¼íª÷810¢w150¤¸¡F610¡B630¡B830¡B840¢w300¤¸¡Ap450¤¸¡AÁ`p520¤¸¡A¥»¯q¤ñ20¡AªÑ»ù10000¤¸/ªÑ¡A¥´5§é5000¤¸¡AÁÙ¯u¬O¦Ü´LªÑ¤ý¡C |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/10 ¤W¤È 09:18:11²Ä 772 ½g¦^À³
|
³o«h°T®§¶Z¤µ¤w¸g¨â¦~¤Ó¤ë¤F¡A¤j·|¬¡°Ê·í®É¤¤°ê«e¤T¤jÃļt¥D°Ê¦VªYÄ£ªí¥Ü·NÄ@¡A¬Ý¨ÓSNP-6«Â¤O±j¤j¡A¤@ÂI¤]¤£¿éµ¹SNP-810¡A👍¡G¡C ³°ÂåÃijЧë¤j·| ¥x¼tµo¥ú ¡@¡@¾Ö¦³¤¤°êJPMorgan¤§ºÙªº²Ä¤T©¡¤¤°êÂåÃijзs»P§ë¸ê¤j·|¡]CBIIC¡A²ºÙ¡u³Ð§ë¤j·|¡v¡^¡A¬Q¡]18¡^¤é¦bĬ¦{µn³õ¡A°£¶}·|«e¤iĬ¦{¤u·~°Ï¡B¬ü°ê§N¬u´äñ¸p·sªº¤Q¦~¦X§@¨óij¥~¡A¨ã»â¥ý§Þ³Nªº®õ¦X¡BªYÄ£¡B¥¨¥Í¤ÎÑÔ¼wÂà§ë¸êªºªFÂ`µ¥¥x¸ê¼t¤]¦¨¬°«GÂI¡A¦³¾÷·|±È°_¨â©¤¦X§@°Ó¾÷¡C ¡@¡@Ĭ¦{¥«°Æ¥«ªø·¨ª¾µûªí¥Ü¡A³Qµø¬°¤j³°¥ÍÂå³Ð·s¶é°Ï«~µPªºÄ¬¦{¤u·~¶é°Ï¡A2017¦~¥Íª«ÂåÃĪº²£È¤]¤w¹F615»õ¤¸¤H¥Á¹ô¡A9/17¤é¤]¦A¦¸©M¬ü°ê§N¬u´ä¹êÅç«Çñq·sªº¤Q¦~¦X§@¨óij¡A«ùÄò¦b즳ªº§N¬u´ä¨È¬w½×¾Â¡B§N¬u´ä¾Ç²ß¤¤¤ß°ò¦¤W¡A«Ø³]§N¬u´ä¬°¨È¬w¾Ç³N¤¤¤ß¡C ¡@¡@¤µ¦~ªº³Ð§ë¤j·|¡AÁ`p¨Ó¦Û»´ä¡B»OÆW¡B¬ü°ê¡B¼w°ê¡Bªk°ê¡B¿D¬w¡B¥[®³¤j¡B²üÄõ¡B¤é¥»¡B«Xù´µµ¥¤Q¾l°ê¥Nªí¹Î¡A¤µ¦~°Ñ»P¥ø·~¤Î§ë¸ê¾÷ºc¹O300®a¡A1,500¤H¥X®u¡C°Q½×¥DÃD¥]¬Aº«×µoªíÁ{§É¼Æ¾Úªº¥ø·~¡B²ÓMªvÀø¡BA.I.¡]¤H¤u´¼¼z¡^¦bÂåÀø¤¤ªºÀ³¥Îµ¥¡C ¡@¡@¥Ñ©ó¹w´ÁÂåÃÄ»P³Ð§ë¤j·|¡A¥i±æ±a°Ê¥xÆW¡B¤j³°¡B»´ä©M¿Dªùªº§ë¸ê¼ö¼é¡A«P¦¨¥|¤èªº¦X§@¡AÀ£§í¤w¤[ªº¤¤¡B´ä¥Íª«ÂåÃĪѬQ¥þ±¤Ï¼u¡A©Ô¥X¦nªöÀY¡C ¡@¡@¥xÆW¤µ¦~¥Ñ¥Íµ¦·|°õ¦æªø¿ú©v¨}¬ù¹Î¬ù40¦ì¨Ó¦Û©ó²£¡B¾Ç¬ã¬É±M®a¥X®u¡C®õ¦X¡BªYÄ£¡BÃh¯S¡B±d讥ÍÂå±N¦æ¸ôºt²³ø¡A¥¨¥Í¡B¥þºÖ¡B§ö°ê¡B¤¤¤Ñµ¥³Ð·s¬ãµo¥ç³Æ¨üÃöª`¡C ¡@¡@¨ä¤¤¡AªYÄ£¥ÍÂå«h±q¤¤°ê²³¦h³Ð·sÃħë¸ê¶µ¥Ø¤¤²æ¿o¦Ó¥X¡AÀò¿ïÁ{§Éºµo¤fÀY²Ä¤@¦W³ø§i¨ä¤w¦b¤G´ÁÁ{§É¡uªvÀø«D°sºë©Ê¯×ªÕ¨xª¢¡]NASH¡^¡v·sÃÄSNP-6Á{§É¼Æ¾Ú¡CªYÄ£¸³¨Æªø¦¶³Í¥Áªí¥Ü¡ASNP-6¬°¥«³õº¨£·s¦¨¤À·sÃĤηs¥Î³~NASH·sÃÄ¡A¨ä¨ã¦³¦h«§@¥Î¾÷Âà¡G¥i°§C¨xŦ¤T»Ä¥Ìªo¯×°ï¿n¡B§í¨î¨xŦomega®ñ¤Æ¬ÛÃö¡]¨»¨C¡^°§Cµoª¢®ñ¤Æª«½è¡A¥H¤Î°§C¨xµoª¢ÅÖºû¤ÆªºÁͤƦ]¤lCCL2¡C ¡@¡@°ê»Ú¬ã½Õ¾÷ºc¹w´ú¡A2025¦~¥þ²yNASHªºÃĪ«¥«³õ³W¼Ò±N¶W¹L350»õ¬ü¤¸¡AÃe¤jªº¥«³õ§l¤Þ°ê»Ú¤jÃļt§ë¤J¶}µo¡C<2018/9/19ºK¿ý¤u°Ó> |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/10 ¤W¤È 07:21:59²Ä 771 ½g¦^À³
|
1955¦~¡A ±j¥Í¤½¥q¡]Johnson & Johnson¡^¤§¤AñQÓi×ôÃĤù¦b¬ü°ê¹Ò¤º¤W¥«¾P°â¡A°Ó«~¦W®õ¿Õ¡]Tylenol¡^¡C 2014¦~FDA¤½§i°Ç¥O°±¤î»s³yAcetaminophen§t¶q¶W¹L325 mgªº [½Æ¤è] ¤îµhÃÄ¡C SNP-810¥i¼W¥[¤AñQÓi×ô¾¯¶q¡]¥Ñ325 mg ¦^´_¦Ü500 mg¬Æ¦Ü§ó°ª¡A·|¸û ¦³®Ä¡^¥H¼W¥[Àø®Ä ¨º»ò¥H«e³QFDA¤U¬[ªºAPAP [½Æ¤è] ÃĪ«¦³¾÷·|«·s¤W¥«§Ö³t¨ú±o¥«³õ¡AAPAP³oºØ¨Ï¥Î¶W¹L66¦~ªºÃĪ«¡A§@¥Î¾÷¨î¤w¼sªx¬ã¨s¡A¦w¥þ©Êµ´¹ï»·»·³Ó¹L¨º¨Çè¦b¶}µoªº·s¯«¸g³q¸ô¤îµhÃĪ«! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/9 ¤U¤È 11:33:43²Ä 770 ½g¦^À³
|
2020.01.07 (¤é´Á«Üªñ¨þ) MPM¤ä«ù´M§ä«Dªü¤ùÃþÂíµhÃĪº·s¥Íª«§Þ³N endpts.com/mpm-backs-new-biotech-in-the-hunt-for-non-opioid-painkiller/ ¬Y¨Ç¬ã¨s¶°¤¤©ó [«·s§Q¥Î] NSAID¡A¨Ò¦p¹ï¤A酰®ò°ò×ô(APAP)--(³o¬qªí¥ÜSNP-810»ùȦA´£¤É!!) ¤£¹L¡A§ó±`¨£ªº¬O¡A¬ã¨s¤Hû¥¿¦b´M§ä·sªº¯«¸g³q¸ô--(¨S§JªAAPAP¨x¬r¡A±z¤£Â¶¹D¦æ¶Ü?) §¨Ó»PCentrexion¦X§@... ----------------------------------------------------------------------------------- 2019.05.29 §¨Ó¥Hªñ10»õ¬ü¤¸»PCentrexion¦X§@©Ý®i [«D]¾~¤ùÃþ¤îµhÃĪ«¥«³õ news.gbimonthly.com/tw/article/show.php?num=28151&page=258&kind=22 |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/9 ¤U¤È 02:43:08²Ä 769 ½g¦^À³
|
¦X¤@³æ¾Ì¾a¤@°¦Âù®Ä§ÜÅé·sÃÄFB825¤§¿W®a¬ãµo¦X§@¤Î±ÂÅv®×¡A´N¯à¦b¥xªÑ¤Wºt¤@ÄÕº¦´T¹d¤jªº¦nÀ¸¡A§Ú̵o²{¥¦ªº±ÂÅv¶i«×ªºªº½T½Tºò±±µÛ¦X¤@ªºªÑ»ùªí²{¡A«¥ÌªºªYÄ£ªÑ¥»«D±`»´¬Õ¡A·sÃĤº®e«p¹ê¡ASNP-810»P°ê»Ú¤jÃļtªº¬ã¨s¦X§@¨óij®×¶i«×¡AÀH®É·|¤½§G¡CSNP-6¤G´ÁÁ{§É¸ÕÅç´Á¤¤¤ÀªRµ²ªG«G²´¡A¥Ø«e¤w¸g¦³¤®a°ê»Ú¤jÃļt¡A¿n·¥°Ó½Í¦X§@±ÂÅv¤¤¡A¥¼¨Ó«e´º¥O¤H´Á«Ý¡C¥BÅý§Ú̲ӲӦ^ÅU¦X¤@¥h¦~ºë±mªºÀ¸¸ô¡G 109/2/28©³¦¬¨ì§Q¶ø»sÃĪºÄ³¬ùª÷400¸U¬ü¤¸ 109/4/15¦@¦P»P°ê»Ú¤jÃļtLEO PHARMA A/Sñ¸p¦X¬ù§ÜÅé·sÃÄFB825¤§·sÃÄ¿W®a¬ãµo¦X§@¤Î±ÂÅv¡C®Ú¾Ú¨óij¡A§Q¶ø»sÃıN¨Ì¬ù¤ä¥Iñ¬ùª÷»P¨½µ{ª÷¾P°âÅv§Q±Nµø¾P°âÃB¥Ñ°ªÓ¦ì¼Æ¨ìÂù¦ì¼Æ¡C¥ý«e¦X¤@¤w§âFB825ªº¤¤°êÅv§Q±ÂÅvµ¹¤¤¤Ñ(¤W®ü)¡A¥¼¨Ó±N¨Ì·Ó¤¤°êGDP¤À¼í14%¡C 109/5/14¦¬¨ì²Ä¤@¶¥¬qñ¬ùª÷ 1448 ¸U¬üª÷ (µ|«á 1303.2 ¸U¬ü¤¸)¡A¦X¤@¤w¦¬¨ìñ¬ùª÷¦@ 1848 ¸U¬ü¤¸ (µ|«á 1663.2 ¸U¬ü¤¸)¡C 109/6/15 FB825¤T´Á²Ä¤G¦¸µ²ªG¸Ñª¼¦¨¥\¡C 2-109/7/2¦X¤@»P¤¦³Á¥Ö½§Âå¾ÇÃļt LEO Pharma ñ¸p²§¦ì©Ê¥Ö½§ª¢¡B¹L±Ó©Ê®ð³Ý·sÃÄ FB825 ªº¥þ²y¿W®a±ÂÅv¨óij¡Añ¬ùª÷»P¨½µ{¸Oª÷¹F 5.3 »õ¬ü¤¸ (¬ù·s¥x¹ô 159 »õ¤¸)¡A¥]¬A±ÂÅv®×ñ¬ùª÷ 4000 ¸U¬ü¤¸¤Î¨½µ{¸Oª÷ 4.9 »õ¬ü¤¸¡C 110/01/14¤é¦X¤@¦¬¨ì²Ä¤G¶¥¬qFB825·sÃıÂÅvñ¬ùª÷1,512¸U¬üª÷¡A¦Xp¤w¦¬¨ì3,360¸U¬üª÷¥þÃBñ¬ùª÷ 110/2/3¬ãµo¤¤·sÃÄON101¨Å»I¥¿¦¡³q¹L¬ü°ê¡u«P¶i¶Ë¤f¡¦X¥~¥Î»s¾¯°t¤è¡vµo©ú±M§Q¡A¥¼¨Ó·sÃĤW¥««á±M§Q¦³17¦~±M§Q«OÅ@´Á¡A¹ï±ÂÅv½Í§P¬O«¤j§Q°ò¡C ¦X¤@ªÑ»ùº¦¶^ªi´Á¡G 109/2/28 ©³¦¬¨ì§Q¶ø»sÃĪºÄ³¬ùª÷400¸U¬ü¤¸31.3¡ù20.3¡û31.55¡ô 109/04/15ñ¸p¦X¬ù§ÜÅé·sÃÄFB825¤§·sÃÄ¿W®a¬ãµo¦X§@¤Î±ÂÅv¡C31.55¡ù75¡ô 109/05/13 MSCI¥þ²y¤p«¬«ü¼Æªº¥xªÑ¦¨¤ÀªÑ·s¼W¦X¤@72¡ù270¡ô 109/07/02ñ¸pFB825¥þ²y¿W®a±ÂÅv¨óij¡Añ¬ùª÷»P¨½µ{¸Oª÷5.3»õ¬ü¤¸ (·s¥x¹ô 159 »õ¤¸) 270¡ù450¡ô 109/07/10¾DÂd¶R¤¤¤ß³B¸m§ï¥H¤H¤u¼¼¦X§@·~450¡û153.5¡õ 109/07/30 ²{ª÷¼W¸ê85»õµo¦æ´¶³qªÑ°Ñ»P®ü¥~¦s°U¾ÌÃÒ153.5¡ù367¡ô 109/09/19 §Q¦h¥XºÉ367¡û198¡õ 110/02/02 ¬ãµo¤¤·sÃÄON101¨Å»I³q¹L¬ü°ê¡u«P¶i¶Ë¤f¡¦X¥~¥Î»s¾¯°t¤è¡vµo©ú±M§Q¡A¥¼¨Ó·sÃĤW¥««á±M§Q¦³17¦~±M§Q«OÅ@´Á¡C198¡ù220¡ô |
|
|
·|û¡G¬K¤Ñô10143192 µoªí®É¶¡:2021/2/8 ¤U¤È 09:41:04²Ä 768 ½g¦^À³
|
²{¦b¦n¹³ªA°ÈªºµL§Î©Ê⋯⋯ ªA°È(±ÂÅvª÷)¨S¦³¯u¥¿¤U¨Ó¡A¬O¤£ª¾¹DªA°È¦nÃa⋯⋯ ²{¦b¥u¦³n¦³ªº½u¯Á(¤½¥q¶}©l¦³À禬46=¡n264)⋯ ¤§«eªº¼Æ¾Ú⋯⋯ ¥h±À²z⋯⋯ §âµL§ÎÂà´«¦¨¦³§Î⋯⋯ ¤£¹L¯u¥¿ªºµ²ªG¬O¤£¬O¤j®a¤ß¤¤·Q¹³ªº¦³§Î¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/8 ¤U¤È 09:06:10²Ä 767 ½g¦^À³
|
¦]¬°¥¦ªºÂaÄg¡Aµ¹¤F¤H¤@ºØ«Ü¯S§Oªº¬ü¡C¦]¬°¥¦ªºÂaÄg¡Aµ¹¤F¤H¤@ºØ¹I·QªºªÅ¶¡¡A¦ý³oºØªÅ¶¡§Y¤£·|Åý§A·Qªº¤Ñ°¨¦æªÅ¤]¤£·|Åý§A·QªºµL³B¥i·Q¡C¥¿¬O¦]¬°¥¦ªºªÅ¶¡¾A¤¤¡A©Ò¥Hµ¹¤F¤H̤@ºØµLºÉªº¬ü¡C¦Ó¤H¤S¦ó¹Á¤£¬O©O? |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/8 ¤U¤È 08:48:29²Ä 766 ½g¦^À³
|
§ó¥¿¡GÂù¤è¦X¬ùÄÝ©ó¬ãµo¦X§@¨óij(§t¦³Ã±¬ùª÷©M¨½µ{¸Oª÷)¡A«D±ÂÅv¨óij(§t±ÂÅvª÷©Î¬O¦A¥[p¦~¾P°â¤À¼íª÷) |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/8 ¤U¤È 08:38:00²Ä 765 ½g¦^À³
|
´±°ÝR¤j¡G¨Ì¾ÚÅÞ¿è¦X²z±À´ú¡A¬O§_±ÂÅv¤è¤w¸g¨Ì¾Ú¦X¬ù¤º®e¡A¶}©l±Ò°Ê·~¤wº¡¨¬Ó§O«´¬ù约©w¨Æ¶µ¾Ú¦V±Â¨ü¤è¦¬¨ú¬ù©w¤ä¥Iª÷ÃB¤§¶iµ{¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/8 ¤U¤È 08:23:00²Ä 764 ½g¦^À³
|
¤]¦³¥i¯à¬O³oµ§! 12¤ë³¯ó¥ý¦æ¡A 1¤ë¬£û¨ì¼t§Þ³N«ü¾É¡C ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/31 ¤W¤È 07:48:32²Ä 644 ½g¦^À³ ....Ãļtn¦Û¦æ¦X¦¨À³¸Ó¤]¦³¤@©wÃø«×¡C ------------------------------------------------------------------------------------------ ·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/1/30 ¤U¤È 05:38:27²Ä 640 ½g¦^À³ ¥h¦~12¤ë46¸UÀ禬¬O¤w¸g¶}©l¤p¶q¥Í²£«D³B¤èÃÄ? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/8 ¤U¤È 08:14:09²Ä 763 ½g¦^À³
|
«ö2020.12.23¤½¥¬ªº¦X§@¨óij ¬}¹î¸ÑªR 107¦~·s¬D¾Ô¡Ð«È¤á¦X¬ù¦¬¤J (IFRS 15) ¤W¸ô¡A±z·Ç³Æ¦n¤F¶Ü¡Hwww2.deloitte.com/tw/tc/pages/audit/articles/ready-for-ifrs15.html ¶Ô·~²³«H¡þ¦¿¬üÆA·|p®v¡B±iªé²Þ¨ó²z ......IFRS 15±N¥H³æ¤@ì«h³W½d©Ò¦³«È¤á¦X¬ù¤§¦¬¤J»{¦C¡C°w¹ï²Å¦X«È¤á¦X¬ù±ø¥ó¤§¦X¬ù¡A¥ø·~¨Ì¦X¬ù¬ù©wÀ˵ø©Ò©Ó¿Õ¤§©Ò¦³°Ó«~©Î³Ò°È¡A¾Ú¥H¿ë»{¦X¬ù¤§¼i¬ù¸q°È¡A±µµÛ±N¦X¬ù¬ù©w©Î¦ôp¤§¥æ©ö»ù®æ¡A¨Ì·Ó¬Û¹ï³æ¿W°â»ù¤ÀÅu¦Ü¦U¶µ¼i¬ù¸q°È¡A©ó¦U¶µ¼i¬ù¸q°È³Qº¡¨¬®É¤À§O»{¦C¦¬¤J¡C |
|
|
·|û¡GRock00910149258 µoªí®É¶¡:2021/2/8 ¤U¤È 05:13:22²Ä 762 ½g¦^À³
|
³Ò°È¦¬¤Jªº»{©w ¤Z´£¨Ñ¥[¤u¡BÀç«Ø¡B׳y¡B¿éÀx¦¬¤Jµ¥Äݤ§¡C |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/2/8 ¤U¤È 02:59:09²Ä 761 ½g¦^À³
|
¤W¤ëÀ禬264¸U¡A³Ò°È¦¬¤J |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/7 ¤U¤È 10:28:02²Ä 760 ½g¦^À³
|
LIN¤j¥Îµüºë²¡A¦r¥y¬Òª½Ä²®Ö¤ß¡A¬O·~¤º¥»¬ìµLºÃ¡A´Á¬ßLIN¤j¦h¦h«üÂI°g¬z¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/7 ¤U¤È 10:17:16²Ä 759 ½g¦^À³
|
¤p¨È¡A§Ú¬OWŪ¥b±í¤ô¡AL¤jÀ³¸Ó¬O¥»¬ì¡C APAP¨x¬r©ÊªºÄpµ²¦b[ªvÀø¾¯¶q]»P[¦w¥þ¾¯¶q4g/¤Ñ]ªº¾¯¶q½d³ò¤Óªñ(¯¶)¡C¸T¹/ ³Ü°s /¯S®í¯e¯f/¬Y´XÃþÃĪ«·|Åý¦w¥þ¾¯¶q4g¦A©¹¤U½Õ°¡A¥[¤W¼tµPºØÃþ¦h¦WºÙ¨S¤@P¡A®ø¶OªÌ´N®e©ö²V¥Î¹L¶q¡C ©Ò¥H§Y¨ÏSNP-810¥u¼W1¿¡A¤w±N¾¯¶q½d³ò©Ô¤j¡A¨¬³ô±N©³¤U¼Æ¾Ú´î¥h¤j³¡¤À¡C ¬ü°ê¨C¦~¦]¨Ï¥Î¤AñQÓi×ô¹L¶q¤¤¬r«æ¶E®×¨Ò¶W¹L¤¸U¤»¤d¤H(µL·NªÌ¦û¤j³¡¤À)¡A¦í°|¤G¸U¤»¤d¤H(µL·NªÌ¦û¤j³¡¤À)¡A¦º¤`¤H¼Æ¹F¥|¤¡³¤H¥H¤W(¸ê®Æ¼g50%¬OµL·N¡A 50%¬O¦Û±þ)¡C -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/22 ¤U¤È 12:13:53²Ä 559 ½g¦^À³ ³s¦bÂå°|¥ÑÂå®v¬IÃĪºª¬ªp¤U¡AÁÙ·|µo¥ÍÄY«ªºP©R©Ê«æ©Ê¨x°IºÜ! °ÝÃDÄpµ²´N¦bAPAPªºªvÀø¾¯¶q»P¦w¥þ¾¯¶qªº¾¯¶q½d³ò¤Ó¯¶¡C |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/7 ¤U¤È 09:30:01²Ä 758 ½g¦^À³
|
LIN¤j¡BROGER¤j¡G¨â¦ì¦n±M·~¡ASNP-810»P°ê»Ú¤jÃļtñq±ÂÅv¦X¬ù¡A¹Lµ{ªá¤F¤@¦~¾l¡A¤j¼t·|¤ä¥Iñ¬ùª÷©M¨½µ{¸Oª÷¡A¦P®Éñ¦³«O±K¨óij¡A²{¦b¨«ªº¬yµ{¬O½T»{Àø®Ä¡Aµ²ªGÀH®É·|¤½§i⋯µ²ªGÀH®É·|¤½§i⋯µ²ªGÀH®É·|¤½§i¡C¥²¶·ª`·N¡GÂù¤èñ¬ù¤º®e¬O·sÃĬãµo¦X§@¡AÂù¤è1+1¤j©ó2¦X§@¡A¤pÃļtªYÄ£SNP-810¯¸¥ß¦b°ê»Ú¤j¼tªÓ»H¤W¦@¦P·m¥«¦û¡AÁ׶}Ävª§¡A³oºØ¦X§@¼Ò¦¡©MÅ@°ê¯«¿n¹p¦P¡AÆg👍¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/7 ¤U¤È 07:00:41²Ä 757 ½g¦^À³
|
[µ¥©óPanadol®¾¯¶q¥u¥i¼W¥[¤@¿´N¹F¨ìì¨Óªº¨x¬r©Ê]---·N«ä¬O±N¬r©Ê¥NÁª«AAP-Cys 47-55% *2¿=¨x¤¤¬r³o¼Ë¶Ü??? ¬JµM°Êª«ÃÄ°Ê»P°·±d¤HÅéÃİʸÕÅç¬Û¦Pµ²ªG¡A³o¬q[¦bSD¤j¹«¤¤¡Aµ¹¤©¹ï¤AñQ®ò°ò×ô¬Û·í©ó¨C¤Ñ¤HÃþ¨Ï¥Î¾¯¶q¬°77gªºSNP-810¡Aµ¹ÃÄ«á¡A¤j¹«¨x¥\¯à¤´µM«O«ù¥¿±`¡C]À³·í¬O«ç»ò¸ÑÄÀ¤~«ê·í? HUYPS07 ©ó°·±d¨ü¸ÕªÌ»P°Êª«ÃÄ°Ê(P.12~P.14): www.tpqri.org.tw:8080/FileUpload/News/News449/88%E5%B1%86%E8%AA%B2%E7%A8%8B%E8%AC%9B%E7%BE%A9.pdf ÃİʸÕÅçµ²ªG¥çÅã¥Ü¡AHUYPS07 ½T¹ê¯àÅãµÛ°§C AAP¬r©Ê¥NÁ²£ª«¡A¥]¬A AAP-Cys ¤Î¨ä¤U´å¥NÁª« AAP-NAC ¤§¦å¤¤¿@«×(p < 0.005)¡CAAP-Cys ÃÄ°Ê°Ñ¼Æ Cmax (³Ì°ª¦å¤¤ÃĪ«¿@«×)¡BAUCt ¤Î AUCinf §¡ÅãµÛ¤U°¦Ü¥¿±`¹ï·Ó²Õªº 30-40% (p < 0.005)¡C -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/7/27 ¤U¤È 10:51:23²Ä 217 ½g¦^À³ www.sinewpharma.com/upload/userfiles/file/About%20us/About+Us.pdf SNP-810¡]µL¨x¬r©Ê¹ï¤AñQ®ò°ò×ô¡^ªºÁ{§É«e©MÁ{§É¬ã¨sµ²ªG ¦bSD¤j¹«¤¤¡Aµ¹¤©¹ï¤AñQ®ò°ò×ô¬Û·í©ó¨C¤Ñ¤HÃþ¨Ï¥Î¾¯¶q¬°77gªºSNP-810¡Aµ¹ÃÄ«á¡A¤j¹«¨x¥\¯à¤´µM«O«ù¥¿±`¡C ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/7/17 ¤U¤È 10:56:33²Ä 168 ½g¦^À³ AAPM 2018¦~·|ºK (SNP-810) ...Acetaminophen (AAP) is the leading worldwide cause of drug-induced acute liver failure (ALF) ... could maintain normal hepatic function even with AAP doses of 2000 mg/kg, demonstrating a protective index (LD50) of more than 4X. These CYP450 inhibitors (referred to as antidote, research code: SNP-810) reduced AAP-induced hepatotoxicity by lowering the levels of aspartate aminotransferase, alanine aminotransferase, histology activity index (HAI-score) and inhibition of NAPQI formation (as shown by AAP-Cys, a biomarker representing NAPQI) (p < 0.005). The survival was 100% (24/24) in a majority of antidote-treated groups, whereas the survival rate was 17% (2/12) in AAP-only group and 50% (6/12) in the NAC-treated group. ............................................................................................ ¦s¬¡²v: SNP-810(100%) VS AAP(APAP)17% VS NAC(AAP¸Ñ¬r¾¯)50% |
|
|
·|û¡GLIN10137582 µoªí®É¶¡:2021/2/7 ¤U¤È 05:13:42²Ä 756 ½g¦^À³
|
»PPanadol®¹ï·Ó²Õ¬Û¤ñ¡A¨Ö¥ÎHUYPS07·|¨ÏAAP ¬r©Ê¥NÁ²£ª«AAP-Cys¡B AAP-NAC ¤§¦å¤¤¿@«×¤U°¡A¨ä Cmax¡BAUCinf ÅãµÛ¤U°¦Ü¥¿±`¹ï·Ó²Õªº 47-55%(p < 0.005)¡C AAP ¬r©Ê¥NÁ²£ª«AAP-Cys¡BAAP-NAC °§C¤@¥b,µ¥©óPanadol®¾¯¶q¥u¥i¼W¥[¤@¿´N¹F¨ìì¨Óªº¨x¬r©Ê |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/7 ¤U¤È 02:41:45²Ä 755 ½g¦^À³
|
³o¤äÃÄ«¥¤£·|ªá®É¶¡¥h½M¦£½a¦£!!! ¤j³°À³¸Ó¤@¤j°ïÃļt¯à°µ: pg.jrj.com.cn/acc/Res/CN_RES/INDUS/2017/3/6/cccf0922-d8a9-4d3f-aab9-7c7f5e7501c2.pdf |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/7 ¤U¤È 02:33:32²Ä 754 ½g¦^À³
|
1.ªùÂe¦³¦h°ª? [°w¾¯]¯Ç¥¬°Ø§ï[¤fªA]«Ü§xÃø? ¶¶ÃĪº¯Ç¯k¸Ñªø®Ä7¤Ñ[ª`®g]¾¯(¯Ç¥¬°Ø¦¨¤À)www.ktgh.com.tw/Public/tbDrug/201905231421517055.pdf ¶¶ÃÄ[¤fªA]½¦Ån(¯Ç¥¬°Ø¦¨¤À) ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/26 ¤U¤È 01:41:11²Ä 586 ½g¦^À³ ...¬O¼t°ÓÃÙ§UªºÀH¾÷¡CSDE¡]Sebacoyl Dinalbuphine Ester¡ANaldebain¡A¯Ç¯k¸Ñ¡^¬O«DºÞ¨îÃþªºªü¤ùÃþÃĪ«¥B¤£·|¦¨Å}¡A¦ýSDE ¦b¥xÆW¤W¥«ªº¥u¦³¦Ù¦×ª`®gªº°w¾¯¡A¥»¸ÕÅ窺 SDE ¬°¤fªA½¦Ån¡C ¡y¤fªA«¬¯Ç¯k¸Ñ¡zªº©Ò¦³¦¨¤À(¥]¬A½á§Î¾¯µ¥)¬O§_»P¥»°ê¤w¤W¥«¤§¦Ù¦×ª`®g«¬¯Ç¯k¸Ñ§¹¥þ¬Û¦P¡A¦³µL¦w¥þ¤åÄm¡C¡v¦^ÂСG¤fªA¾¯«¬¯Ç¯k¸Ñ»P¤W¥«ÃÄ«~¤§¥D¦¨¤À§¹¥þ¬Û¦P¡A 2.¥«³õ¦³¦h¤j? pg.jrj.com.cn/acc/Res/CN_RES/INDUS/2017/3/6/cccf0922-d8a9-4d3f-aab9-7c7f5e7501c2.pdf ¥þ²y¥Í产盐»Ä纳¥¬°Øªº¥DnÉD°Ó为 HOSPIRA ¤½¥q¡A国¥~销°âª÷额¤j约 3000 ÉE¬ü¤¸规¼Ò... ±`¨£¤îµhÃÄ¥i°Ï¤À¬°¤TºØ¡A®ÄªG¥Ñ®z¨ì±j¤À§O¬O¡G ¤AñQÓi×ô (acetaminophen)---²Ä¤@½uÃĪ«¡A¬ü°ê®a®x¥²³Æ¨}ÃÄ¡A ¨C¶g¬ù5000¸U¤HªA¥Î¡A¦]¬°¼vÅT¼h±¤Ó¤j¤Ó¼s¡A¨S ¦³¥i¨ú¥N©ÊÃĪ«¥X²{«e¡A FDA¤£·|¶TµM¤U¬[! «DÃþ©T¾J®øª¢¤îµhÃÄ (NSAID) ¾~¤ùÃþ¤îµhÃÄ (opioid analgesics)---(¯Ç¥¬°Ø³N«e³N«á¤îµh.....) ------------------------------------------------------------------------------------------ §ÚÁÙ¨S¦³²`¤J¬ã¨sÃh¯S¡A¥H¤WÆ[ÂI©Î³\¦³»~¡AÃi¼g¦r¡AºK¿ý¸ôÁ`±M³X°µµ²§À¡C °Ý¡G§A¦p¦ó¿Å¶q·sÃÄ»ùȪº¤TÓµû¦ôÂI¡H µª: ²Ä¤@¬O¥H°ê»Ú¥«³õ¬°¤ñ¸û°ò¦¡A§Aªº¹ï¤â´N¬O°ê»Ú¤jÃļt¡C ²Ä¤G¬O²Å¦XĹ®a³q¦Yì«h¡An°µ¥þ²y¦Ñ¤j¡C¡F ²Ä¤T¬O¦b¥«³õ¤G¤À¤§¤@ªk«h¤U¡A¦Ü¤Ö¦³10»õ¬ü¤¸¥H¤W¦~¹ê½è»Ý¨D¡A¤£n½M¦£¡C ²Ä¥|¨ã¦³¥þ²y¿W¤@µL¤Gªº·sÃħ@¥Î¾÷¨î¡A¦¨¥\¤~½æ±o±¼¡C |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/7 ¤U¤È 01:22:23²Ä 753 ½g¦^À³
|
½Ð±ÐR¤j¦p¦ó¬Ý«ÝÃh¯S¤îµh·sÃÄ¥¼¨Óªº«e´º?¥Ø«e§Ú°ê¦@®Öµo¥X9±iÃÒ¡AÃh¯S¬O°ß¤@¾Ö¦³2±iÃÄÃÒªº·sÃĤ½¥q¡A¨Ã¦³4´Ú·sÃÄ»P·s¾AÀ³¯g³q¹L¬ü°êFDA®Öã¤G´ÁÁ{§É¸ÕÅç¡C ¡uÃh¯SµhÄ_¡v¬O¥Ø«e¥þ²y°ß¤@ªº¤fªA¯Ç¥¬°Ø·s¾¯«¬·sÃÄ¡A¦b¬ü°ê¡B¥[®³¤j¡B¤é¥»¡B¤¤°ê¤Î¥xÆW¡A¤w¨ú±o¦h¥óµo©ú±M§Q¡A²{¥¿¿n·¥4®a°ê»ÚÃļt¬¢½Í±ÂÅv¡A¶ix¥þ²yªñ400»õ¬ü¤¸ªº¤îµhÃÄ«~¥«³õ¡A¦³¾÷·|»PªYÄ£¤îµhÃÄSNP-810µ¥¦h®a·sÃĤ½¥q¦@¦PÄv³v¥þ²y¤îµhÃÄ¥«³õ°Ó¾÷¡Cȱo¤@´£ªº¬O¥þ²y¥Í²£ªº¾~¤ùÃþ¤îµhÃÄ¡A°ª¹F 80%³£¬O¬ü°ê¤H¦Y¤U¨{¡A±q2000¨ì2015¦~¶¡¡A¬ü°ê¬ù¦³50¸U¤H¦º©óÃĪ«¹L¶q¡A¬ü°êFDA©ó2017/6/8n¨D¥«±¤WªºOpana ER¥þ±¤U¬[¡A³o¬OFDAº¦¸¦]¬°ÃĪ«ÀݥΪº°ÝÃD¡A¹ï¾~¤ùÃþ¤îµhÃÄ®i¶}¦æ°Ê¡AFDA¤]ªí¥Ü¡A¥ḺNÄ~Äò½Õ¬d¨ä¾l¾~¤ùÃþ¤îµhÃĪº·ÀI¤Î®Ä¯q¡A¨Ã¥B¡u°w¹ï¦¹¦¸¤½¦@½Ã¥Í¦M¾÷¡A±Nµø±¡ªp±Ä¨ú¶i¤@¨Bªº¦æ°Ê¡v¡AÃh¯SÁ`¸g²z¾G«Ø·sªí¥Ü¡A¤fªA¾¯«¬·sÃÄ¡uÃh¯SµhÄ_³n½¦Ån¡v¬°««×¯kµh¤îµhÃÄ¡A¡°¨ã----------§C¦¨Å}©Ê------¡B§C©I§l§í¨îµ¥ÀuÂI¡A³æ³æ³o¤@¶µ¤£¨ã¦w¥þ©Êªº°Æ§@¥Î«Ü©ú½T¦a´N»·»¹©óªYÄ£SNP-810ªº®Ä¯à¡C³Ì²×Ãh¯S¨s³º¯à§_¶¶§QÅD¤W»Ú»R¥x¡H¯à°÷¥Ê¤À¦h¤Ö°Ó¾÷«h¤´¦³«ÝÆ[¹î¡C Ãh¯SªÑ¥»ªñ20»õªÑ»ù24.15¡AªYÄ£5.32»õªÑ»ù93.5¡A¦X¤@37.5»õªÑ»ù220¡AªÑ»ùªí²{©úÅã¦]¬°·sÃıÂÅv¶i«×§ÖºC¥H¤Î¯à§_¹ê½îµ¥«n¦]¯À¡A¦Óª½±µ¨ü¨ì¼vÅT¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/2/7 ¤U¤È 01:16:00²Ä 752 ½g¦^À³
|
²{¦bªYÄ£»ù¦ì§ë¸ê¡A¨C¦~¤À2¸U/±i¡A´N¤£¿ù¤F¡F¨CªÑÁÈ30¤¸¡A¤À20¤¸¡C½Ð°Ý³o¼Ë·|§xÃø¶Ü¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/7 ¤W¤È 10:00:40²Ä 751 ½g¦^À³
|
´¿¬O¼öªùªºDGAT1¹vÂI¡A¦]¬°¤jÃļt»â¥ý¸s±µ³s±¾¦bÄY«ªºG¸z°Æ§@¥Î¡A¦]¦¹»{©w¦¨¤£¤FÃÄ¡A¯É¯É©ñ±óÂ੹¨ä¥L¹vÂI¡A¨S·Q¨ìÄ~SNP-810«á¡ASNP-610¦A¦¸¦¨¥\¸ó¶V¤@¹D¨ä¥L¤jÃļt¹L¤£¤Fªº[ÄY«ªºG¸z°Æ§@¥Î]»Ùê!!! ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/20 ¤W¤È 05:37:39²Ä 526 ½g¦^À³ SNP-610(CYP2E1 + DGAT1, ¥´2ÓÂI)¦b¤@´Á»P¤G´ÁÁ{§É¹êÅçÀ³¸Ó¬O¸ó¹LG¸z°Æ§@¥ÎªùÂe»Ùê¡A¦¨¥\¸ô¤W¦AÁÚªñ¤@¨B! (GSK / ¿ÕµØ/ªü´µ§Q±d/½÷·çªºDGAT1ÃĪ«¤À§O±¾¦bP1»PP2) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/7 ¤W¤È 09:43:22²Ä 750 ½g¦^À³
|
InterceptªºOcaliva±qÁ{§É¹êÅç¤@¸ôÀò±o[¥[³t³q¹D] [¬ð¯}©ÊÀøªk]¡A¥Ó½ÐÃÄÃҮɤS®³¨ìFDA[Àu¥ý¼fµû]¡A«á¨ÓFDA¼f¬d±À¿ð¤F [3¦¸]¡A³Ì«á¦]¬°¬ÛÃöªº 19 ¨Ò¦º¤`©M 11 ¨ÒÄY«¨x·l¶Ë®×¨Ò¡A[¦w¥þ©Ê]¤£°÷©ú½T³QFDA§_¨M! Intercept¿w©w¨úÃÒ©Û§L¶R°¨ÂX¤j¹Î¶¤¡Aµ²ªG¥i·Q¦Óª¾...Þ¦ºÅo!!!!!! |
|
|
·|û¡G¤p¤å¤l10144877 µoªí®É¶¡:2021/2/7 ¤W¤È 09:40:05²Ä 749 ½g¦^À³
|
§Úı±o810±ÂÅvÀ³¸Ó·|¦b2¤ë©³¥ª¥k·|¦³¬Ü¥Ø¡]¤ñ·Ó¦X¤@ñ³Æ§Ñ¿ý«á2Ó¤ë´N§¹¦¨±ÂÅv¡^¡A²{¦b¤j®a²q²q¥h¦~12¤ë©³³Æ§Ñ¿ýªºÃ±¬ùª÷¤j¬ù¦h¤Ö©O¡A¦]¬°³oª÷ÃB·|°^Äm¤@¤ë¥÷¤j³¡¥÷ªºÀ禬¡C¡C¡C§Ú²q200¸U¬üª÷¡C¡C¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/7 ¤W¤È 09:27:45²Ä 748 ½g¦^À³
|
¤°»ò¥s¹Ú´K¥H¨Dªºµª®×??? ¦]¬° SNP-610´Á¤¤¤ÀªR:F4(ÄY«ÅÖºû¤Æ)ªvÀø«e«á¦³ÅãµÛ®t²§¡C VS InterceptªºOcaliva¹ïF2(¤¤«×ÅÖºû¤Æ)©ÎF3(««×ÅÖºû¤Æ)±wªÌ幷¥¼¥X²{ÅãµÛ§ïµ½¡C ¹ïF1(»´«×ÅÖºû¤Æ)±wªÌªºªvÀø®ÄªG§ó爲©úÅã¡C ------------------------------------------------------------------------------------------ µû¦ô¨xÅÖºû¤ÆÄY«µ{«× ¡´ F0¡G¥¿±`¨x²Õ´¡]µLÅÖºû¤Æ¡^ ¡´ F1¡G»´«×ÅÖºû¤Æ¡]ÅÖºû¤Æ«]¦b¨xªù¯ß°Ï¤¤¡AµL¶¡¹j¡C¡^ ¡´ F2¡G¤¤«×ÅÖºû¤Æ¡]¤Ö³\ÅÖºû§ô¦Û¨xªù°Ï¦ù¥X¦Ü¤p¸¤¤¡A¦³¤Ö¼Æ¶¡¹j¡C¡^ ¡´ F3¡G««×ÅÖºû¤Æ¡]³\¦hÅÖºû§ô¦Û¨xªù°Ï¦ù¥X¦Ü¤p¸¤¤¡A¦³¦h¼Æ¶¡¹j¡C¡^ ¡´ F4¡GÄY«ÅÖºû¤Æ¡]«p«pªºÅÖºû²Õ´§â¨x²ÓM³ò¦¨¤@¹Î¤@¹Îªº¡C¡^ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/7 ¤W¤È 09:18:59²Ä 747 ½g¦^À³
|
2020/7/3§Ú:¥i±¤¦b¨xŦÅÖºû¤Æ¨S¤°µÛ¾¥! µ²ªG [°ò¦Ȱª(F4)ªº²Õ¡AªvÀø«e«á¦³ÅãµÛ®t²§¡C]---¥X²{§Ú¹Ú´K¥H¨Dªºµª®×! Q:½Ð°ÝSNP-610Á{§É¤G´Á¸ÕÅç¹wp¦ó®É·|¦³µ²ªG? A: SNP-610¶}©ñ¦¡Á{§É¤G´Á¬ã¨s¤wÀò±oÅãµÛ¤HÅéÀø®ÄÃÒ¾Ú¡C¾Ú109¦~7¤ë´Á¤¤¤ÀªRµ²ªG¡A SNP-610´Á¤¤¤ÀªR¦³¨xŦÅÖºû±½´y»öFibroscan data¡A°ò¦Ȱª(F4)ªº²Õ¡AªvÀø«e«á¦³ÅãµÛ®t²§¡C ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/7/3 ¤W¤È 08:05:38²Ä 35 ½g¦^À³ Comparison of the Efficacy of Oral SNP-610 & Ocaliva (Intercept)* SNP-610 shows a greater reduction of ALT ¥i±¤¦b¨xŦÅÖºû¤Æ¨S¤°µÛ¾¥! ¦]¬°°²YOcalivaªºNASH¾AÀ³¯g§åã¡A·|¬O¦b¦ñ¦³¨xŦÅÖºû¤Æªº±wªÌ³o¶ô¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/7 ¤W¤È 08:44:53²Ä 746 ½g¦^À³
|
«ç»ò§j¤û¤jÁɦ¨¤F±·¤H¤jÁÉ¡A·U±··U°ª¡C¨º¤Ñ¨Æ»PÄ@¹H¡A¤G¦ì¤£§â§ÚºL¦º? §ë¸ê§O¤£©ú¨s²z¸òÀH¨ä¥L¤H¨B¥ï! »`¶°¸ê®Æ«á¡A¸g¹L¦Û¤vÅçÃÒ«ä¦Òªº¸ê°T¤~¯u¥¿ÄÝ©ó¦Û¤v©Ò¦³¡C ¯¬ºÖ¤j®a Happy¤ûyear¡B´X¤û¨®ªº°]´I¦bµ¥µÛ§A¡B犇¶]§a2021! |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/2/6 ¤U¤È 11:20:35²Ä 745 ½g¦^À³
|
r¤j±a»â¤j®a§ó²M·¡ªYÄ£ªº±M·~»â°ì¡A¯u·PÁ¡I¤À¼íª÷¦~¦~¦³¡A¥B¬OÃe¤j±ÂÅvª÷«á¡A²£«~¥X°â¦A¥~¥[¤W¥hªº§Q¼í¶Ü¡H ¦pªG¬O³o¼Ë¡A¨º¬O¥i©Èªºª÷ÃB¡F¤S¦³5Ó«½SÃÄ¡A¨ºªÑ»ù¦³¾÷·|10000¤¸/ªÑ¡A»{¯u¤ÀªR¡A¨S¦³§j¤û·Qªk¡C ¥H¤W¡A½Ð±Ð½Ñ¦ì¤j¤j¡A¤@¨ÖÁÂÁ¡C |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/6 ¤U¤È 09:44:20²Ä 744 ½g¦^À³
|
ROGER¤jªº±M·~¬ãªR¯à¤O©M¥«³õ°Ó±¡»`ù¯à¤O¦t©z¤Ñ¤U¦Ü´LµL¼Ä¡A¤p§Ì¨ØªA¤Åé§ë¦a¡A³æ´NÄÄzªYÄ£Á{§É¹êÅçÀu²§¦¨ªG©Ò³Ð³yªº°Ó·~¹d¤j§Q¯q¡A¤w¸g§â§ë¸ê¤Háà±o¤ßÄoÄoªº¤F¡A³]·QSNP-810¡BSNP-610¡BSNP-630«½S±ÂÅv¦nÀ¸§Y±N¤@¤@©Ô¶}§Ç¹õ¡A¤û¦~ÀY§À¤@¾ã¦~±N·|¬O¦n®ø®§Åå³ß³s³s¡Aºò±µµÛªê¦~¤]±N§¤¨É°Ó«~¾P°â¤À¼íÂ׺Ӧ¨ªG¡A§Ú·|¤Ó¹L¼ÖÆ[¶Ü¡H¦U¦ì¤j¤j½Ðµû¤À¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/6 ¤U¤È 08:21:13²Ä 743 ½g¦^À³
|
SNP-610ªº¬ãµoµ¦²¤¡B¥Ø«e¶i®i¤Î¹w©w¦ó®É±ÂÅv¡H §Ú̥ѹê»Ú±ÂÅv¬¢°Óªº¹Lµ{¤Î¸gÅç¡A¯S§O±N·sÀø®Ä¤Î·s¦¨¥÷SNP-610¤Î630¦U¦³¨äµ¦²¤³W¹º¡A¥Ø«eSNP610¤w¦¨¥\§¹¦¨Á{§É¤G´Á¡ASNP-630¤]¤w§¹¦¨¬r²z¸ÕÅç¡Aªñ´Á¥¿¶i¦æ»s¾¯¤ÎÁ{§É¤@´Á¡C SNP-610³æ¿Wµo®i¤W¥«¥i»P¨ä¥L¦¨¤Àµo®i¦¨¬°½Æ¤è¡A¥H¶i¦æ½Æ¤èªvÀø¡A¦³¨ä¯S®í»ùÈ¡CNASH¤§µo®i¡A¦U¤jÃļt§¡¦]»Ý¨x¬ï¨ë¦Ó¦¬®×¸ûºC¡A±`³y¦¨©µ«á¡C --------------------------------------------------------------------------------------------- [§Ú̥ѹê»Ú±ÂÅv¬¢°Óªº¹Lµ{¤Î¸gÅç]---¬Û«H©Î¤£¬Û«H¤½¥q¦b½ÍSNP-6ªº±ÂÅv? Ó¤H¦Û¥Ñ¡C [±N·sÀø®Ä¤Î·s¦¨¥÷SNP-610¤Î630¦U¦³¨äµ¦²¤³W¹º]---Ó¤H±À´ú610¨«Áp¦XªvÀøÁ{§É?¦Ó630¨«³æÃĪvÀøÁ{§É? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/6 ¤U¤È 08:12:27²Ä 742 ½g¦^À³
|
§ó¥¿:SNP-630n¬O¯u®³¨ìFDA¬ð¯}Àøªk»P§Ö³t³q¹D¡A±ÂÅvª÷>20»õ¬ü¤¸µLÄa©À!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/6 ¤U¤È 08:05:51²Ä 741 ½g¦^À³
|
³æ¤@ÅT¬¶SNP-810¡A¸ò¥xªÑ¦Ü´LªÑ¤ýÄ_®y¬O¤@¨B¤§»»;n¬OÂùÅT¬¶¡A1ÅTSNP-610¡A¤GÅTSNP-810¡A¨¬¥i礦ܴLªÑ¤ýÄ_®y! ------------------------------------------------------------------------------------------------ SNP-630n¬O¯u®³¨ìFDA¬ð¯}Àøªk»P§Ö³t³q¹D¡A±ÂÅvª÷>10»õ¬ü¤¸µLÄa©À¡A´N§ï·f¤õ½b¨ì¤ë²yÅo!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/6 ¤U¤È 07:58:04²Ä 740 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/6 ¤U¤È 07:49:18²Ä 739 ½g¦^À³ ±À½×SNP-6¨t¦CÀò±oNASHÃÄÃÒ¾÷²v¬Û·í°ª!!!! ¦]¬°SNP-630Àu©óSNP-610 ; SNP-610 Àu©ó Ocaliva (³Ì¦³§Æ±æ²Ä1¤ä¨úÃÒªºNASHÃĪ«)! ------------------------------------------------------------------------------------------- ¥Ñ¤W±oª¾-·s»D³ø¾É¤w¦³5®a°ê»Ú¤jÃļt¡A¿n·¥°Ó½Í¦X§@±ÂÅv¤¤-¤]µ´«D§ù¼¶! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/6 ¤U¤È 07:49:18²Ä 739 ½g¦^À³
|
±À½×SNP-6¨t¦CÀò±oNASHÃÄÃÒ¾÷²v¬Û·í°ª!!!! ¦]¬° SNP-630Àu©óSNP-610 ; SNP-610 Àu©ó Ocaliva (³Ì¦³§Æ±æ²Ä1¤ä¨úÃÒªºNASHÃĪ«)! ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/7/9 ¤U¤È 09:19:40²Ä 84 ½g¦^À³ ³Ì§l·úªº§Ì¥[!!! SNP-630¥Ó½ÐFDA IND®É¤]¦P®É¥Ó½Ð§Ö³t³q¹D(first track)¤Î¬ð¯}©ÊªvÀø(breakthrough therapy)ªº»{©w¡C FDA½T¹ê¬O¤¹·ÇIND®É¤]¥Ó½Ð§Ö³t³q¹D¤Î¬ð¯}©ÊªvÀøªº»{©w¡C ÃöÁä¦bªYÄ£[¾Ì¤°»ò©ÎªÌ»¡®³¤°»ò¸ê®Æ¼Æ¾Ú]¥Ó½ÐSNP-630ªº¬ð¯}©ÊªvÀø(breakthrough therapy)??? .............................................................................................. www.sinewpharma.com/news_detail.php?nwno=30 ..SNP-610¤w§¹¦¨²Ä¤@´ÁÁ{§É¹êÅç¡A¨Ã©ó¤HÅé¤G´ÁÁ{§É¸ÕÅçÃÒ©ú¦w¥þ¦³®Ä¡A¥BÀu©ó°ê»Ú²{¦æ¥|®a¥ýµoªºNASHÃĪ«¡CSNP-630¬°²Ä¤@¥NSNP-610ªºÀu¤Æ¡A¨ã¦³§óÀuªºÃİʾǤÎÃľǯS©Ê¡A¤µ¦~±N¥[³t¬r²z¸ÕÅç¡A¥Ø«e¥Ó½ÐFDA IND¶i¦æ²Ä¤@´ÁÁ{§É¹êÅç¡B§Ö³t³q¹D(first track)¤Î¬ð¯}©ÊªvÀø(breakthrough therapy)ªº»{©w¡C ............................................................................................ www.fda.gov/regulatory-information/food-and-drug-administration-safety-and-innovation-act-fdasia/frequently-asked-questions-breakthrough-therapies Frequently Asked Questions: Breakthrough Therapies 5.Is there a deadline for a sponsor to submit a request for breakthrough therapy designation? The Food Drug and Cosmetic Act (21 USC 356) states that a request for a breakthrough therapy designation may be made concurrently with, or at any time after, the submission of an application for [the IND]. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/6 ¤U¤È 07:41:01²Ä 738 ½g¦^À³
|
³Ì¦³§Æ±æÀò±o²Ä1¤äNASH¤W¥«ÃÄÃÒªºOcaliva (Intercept)¡A¥Ó½ÐÃÄÃҮɳQâ¿ð3¦¸³Ì«á¦º¦b[¨x¬r©Ê]!!! -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/7/8 ¤U¤È 09:11:21²Ä 74 ½g¦^À³ ¦Û Ocaliva ¤W¥«¥H¨Ó¡AUS FDA ¤w±µÀò»P Ocaliva ¬ÛÃöªº 19 ¨Ò¦º¤`©M 11 ¨ÒÄY«¨x·l¶Ë®×¨Ò¡C [¦w¥þ©Ê]¤£°÷©ú½T [¦w¥þ©Ê]¤£°÷©ú½T [¦w¥þ©Ê]¤£°÷©ú½T ....................................................................................... ¬ü°ê®É¶¡29¤é¡AIntercept Pharmaceuticals«Å¥¬¨ä«D°sºë©Ê¯×ªÕ©Ê¨xª¢(NASH)·sÃÄ¡X¡X¶ø¨©Áx»Ä(obeticholic acid, OCA)¡A¤w¾D¬ü°ê¹«~ÃĪ«ºÞ²z§½(FDA)©Úµ´§åã¡FOCA´¿³Q»{¬°±N¬Oº´ÚÀò§åªºNASHÃĪ«¡A³Æ¨ü¦U¬É¬Ý¦n¡CIntercept¶g¤@ªÑ»ù¤]¦]¦¹«®À39%¡C FDA¤w¦VInterceptµo¥¬§¹¥þµªÂЮÑ(CRL)µ²ªG¡Aªí¥Ü¦]¬°¸ÓÃĪ«¤´µL½T¤Áªº¹w´Á¯q³B¡A¥B¹ï©óNASH±wªÌªº[¦w¥þ©Ê]¤£°÷©ú½T¡A¦]¦¹©Úµ´¨ä·sÃĥӽСC -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/7/3 ¤W¤È 07:29:29²Ä 33 ½g¦^À³ §ó¥¿InterceptªºOCA¤£¬O¦º¦b³Ì«á¤@¨è¡A¦Ó¬OºG¾Dâ¿ð3¦¸«á¤~¦º! ¯à¤£¯à¦º¦Ó´_¥Í¤£ª¾! Ocaliva(OCA¡A奥贝胆»Ä)¦b¬ü国审¬d²Ä3¦¸±À迟¡A¥þ²yº个NASH药ª«¦³±æ获§å¡I zhuanlan.zhihu.com/p/143640237 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/6 ¤U¤È 07:24:40²Ä 737 ½g¦^À³
|
¤£n§zÔ¬§]´Ç¡C 17»õ¬O¨ÖÁʤ½¥q¥þ¦Y¡A¤£¬O³æ¤@ÃĪ«±ÂÅvª÷¡C Allergan to Acquire Tobira for Up to $1.695B www.genengnews.com/news/allergan-to-acquire-tobira-for-up-to-1-695b/ Tobira±Mªù±q¨Æ«D°sºë©Ê¯×ªÕ©Ê¨xª¢¡]NASH¡^©M¨ä¥L¨xŦ¯e¯fªºªvÀø¤èªkªº¶}µo©M°Ó·~¤Æ¡C |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/6 ¤U¤È 05:12:10²Ä 736 ½g¦^À³
|
www.gbimonthly.com/2018/09/31737/ tw.stock.yahoo.com/news/%E8%88%88%E6%AB%83-%E9%9D%9E%E9%85%92%E7%B2%BE%E6%80%A7%E6%8C%87%E8%82%AA%E8%82%9D%E7%82%8E%E6%88%90%E8%97%A5%E5%BB%A0%E6%96%B0%E9%A1%AF%E5%AD%B8-%E6%99%AF%E5%87%B1-6549-jkb121%E9%A0%98%E5%85%88%E9%80%B2%E5%85%A5fda%E8%87%A8%E5%BA%8A%E4%BA%8C%E6%9C%9F-045413619.html www.gbimonthly.com/2018/11/36246/ tw.stock.yahoo.com/news/%E6%8B%93%E8%87%BB%E7%94%9F%E7%89%A9%E5%AE%A3%E5%B8%83%E5%85%B6%E9%9D%9E%E9%85%92%E7%B2%BE%E6%80%A7%E8%84%82%E8%82%AA%E6%80%A7%E8%82%9D%E7%82%8E-nash-%E5%80%99%E9%81%B8%E8%97%A5%E7%89%A9tern-101%E7%9A%84-a%E6%9C%9F%E8%87%A8%E5%BA%8A%E8%A9%A6%E9%A9%97-055700189.html n.yam.com/Article/20201012720058 www.sinewpharma.com/news_detail.php?nwno=34 www.sinewpharma.com/news_detail.php?nwno=34 |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/6 ¤U¤È 04:22:25²Ä 735 ½g¦^À³
|
ªYÄ£¥ÍÂåºô¶- ·s»D¤¤¤ß109/10 ªYÄ£·sÃÄÁ{§É¤G´Á´Á¤¤¤ÀªRµ²ªG«G²´ ¡A´¡ºX¡u°ê®a¥Í§Þ¬ã¨s¶é°Ï¡v §ù¿·»T/¥x¥_³ø¾É ªYÄ£¥ÍÂå(6634) 17¤é«Å¥¬¡A¬ãµo«D°sºë©Ê¯×ªÕ¨xª¢(NASH)·sÃÄSNP-6¡AÄ~¨ú±o¦h¶µ°ê»Úµo©ú±M§Q«á¡A¤G´ÁÁ{§É¸ÕÅç´Á¤¤¤ÀªRµ²ªG«G²´¡A¥Ø«e¤w¦³5®a°ê»Ú¤jÃļt¡A¿n·¥°Ó½Í¦X§@±ÂÅv¤¤¡C ¸³¨Æªø¦¶³Í¥Áªí¥Ü¡GªYÄ£¥ÍÂå¬ãµo·sÃÄSNP-6¨t¦CªvÀø«D°sºë©Ê¯×ªÕ¨xª¢(NASH)¤§²Ä¤G´ÁÁ{§É¸ÕÅç¤w§¹¦¨°ª¡B§C¨â¾¯¶q²Õ¦@ 36¦W¨ü¸ÕªÌ¡A´Á¤¤¤ÀªRµ²ªGÅã¥Ü¡ASNP-6·sÃĦbÁ{§ÉÀø®Ä«ü¼Ð»P¥¼ªAÃÄ«e¤ñ¸û¡A§e²{·¥ÅãµÛªvÀø®ÄªG¡A¦¨¥\¹F¦¨SNP-6·sÃĦb¯×ªÕ¨xª¢ªvÀø¤Wªº¥Ø¼Ð¡C NASH¥«³õ³v¦~«ùÄòÂX¤j¡A¥þ²y¥«³õ«o¬OµL¼Ð·ÇªvÀøÃÄ¥i¥H¨ÑªvÀø¡C¾ÚGlobal Data 2017¦~5¤ëªº³ø§i¡A¼w·N§Ó»È¦æ¤ÎEvaluate Pharmaªº¹w´ú¡A¥þ²yNASHÃĪ«ªº¥«³õ³W¼Ò¦b2025¦~¤W¬Ý350»õ~400»õ¬ü¤¸¡C¥]¬A¬ü°ê¡A¼Ú·ù©M¤é¥»ªºNASH¥«³õ¡A¦b¥¼¨Ó¤Q¦~ªº½Æ¦X¦~¼Wªø²v¹F45¢H¡C °£¦¹¤§¥~¡AªYÄ£¤wº§åÀò¿ï¨Ãp¹º©ó¤µ¦~¤Q¤@¤ë¾E¤J«n´ä°ê®a¥Í§Þ¬ã¨s¶é°Ï¡A°ê®a¥Í§Þ¬ã¨s¶é°Ï«Y¥H³Ð·s¬ãµo¬°¾É¦V¡Fµ²¦X¤F¤¤¥¡¬ã¨s°|¤Î¨ä¥L¾Ç¬ã³æ¦ì¤§³Ð·s¬ã¨s¡B¬ì§Þ³¡¡u°ê®a¹êÅç¬ã¨s°|¹êÅç°Êª«¤¤¤ß¡]NLAC¡^¡v¡B¸gÀÙ³¡¡u¥Íª«§Þ³N¶}µo¤¤¤ß¡]DCB¡^¡v¤Î½Ã¥ÍºÖ§Q³¡¡u¹«~ÃĪ«ºÞ²z¸p¡]TFDA¡^¡vµ¥¸ó³¡·|¾÷ºc¡A²£¥Í¸s»E®ÄÀ³¡A¦¨¥\¨ã¦³µo®i°ê»Ú·sÃĪº¥Í§Þ¼t°Ó¡A¥[³t«Øºc§Ú°ê¥Í§Þ²£·~¤§°Ê¯à¡A´£¤É°ê®a¾ãÅéÄvª§Àu¶Õ¡C ¥H¤U³o¤@¤p¬q³ø¾É¤º®e¨£½Ñ¸gÀÙ¤é³ø109/6/22¡AªYÄ£¥ÍÂåºô¶¨Ã¥¼¤Þz---¤wª¾ªº³æµ§±ÂÅv¬ö¿ýªñ17»õ¬ü¤¸¡C |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/6 ¤U¤È 04:07:08²Ä 734 ½g¦^À³
|
2020-06-22 02:00¸gÀÙ¤é³ø °OªÌ³¯®ÑÂ{¡þ¥x¥_³ø¾É |
|
|
·|û¡GRock00910149258 µoªí®É¶¡:2021/2/6 ¤U¤È 03:47:28²Ä 733 ½g¦^À³
|
½Ð°Ý¤p¨È¤j ±z³o¨Ç°T®§¬O¦h¤[«eªº¸ê°T¡H ¡X¡X¡X¡X¡X¡X¡X¡X¡X¡X¡X¡X¡X¡X- ªYÄ£ºX¤UªºSNP-6¡A¤G´ÁÁ{§É¸ÕÅç´Á¤¤¤ÀªRµ²ªG«G²´¡A¥Ø«e¤w¸g¦³¤®a°ê»Ú¤jÃļt¡A¿n·¥°Ó½Í¦X§@±ÂÅv¤¤¡C ¾Ú¼w·N§Ó»È¦æ¤ÎEvaluate Pharmaªº¹w´ú¡A¥þ²yNASHÃĪ«ªº¥«³õ³W¼Ò¦b2025¦~¤W¬Ý400»õ¬ü¤¸¡A¤wª¾ªº³æµ§±ÂÅv¬ö¿ýªñ17»õ¬ü¤¸¡C |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/6 ¤U¤È 12:30:15²Ä 732 ½g¦^À³
|
ªYÄ£ºX¤UªºSNP-6¡A¤G´ÁÁ{§É¸ÕÅç´Á¤¤¤ÀªRµ²ªG«G²´¡A¥Ø«e¤w¸g¦³¤®a°ê»Ú¤jÃļt¡A¿n·¥°Ó½Í¦X§@±ÂÅv¤¤¡C ¾Ú¼w·N§Ó»È¦æ¤ÎEvaluate Pharmaªº¹w´ú¡A¥þ²yNASHÃĪ«ªº¥«³õ³W¼Ò¦b2025¦~¤W¬Ý400»õ¬ü¤¸¡A¤wª¾ªº³æµ§±ÂÅv¬ö¿ýªñ17»õ¬ü¤¸¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/6 ¤W¤È 09:30:22²Ä 731 ½g¦^À³
|
FDA¥]¥Í¡]¼f®Ö·sÃÄ¡^¡A¤]¥]¦º¡]¤U¬[¦^¦¬ÃĪ«¡^¡C ·íµL¨x¬rSNP-810¯à¨ú¥N¦³¨x¬rAPAP®É¡A¨S¦³²z¥ÑÄ~Äò«_ÀI¨Ï¥Î¦³¨x¬rAPAP¡C (ªü´µ¤ÇÆFNSAIDÃĪ«¡A¦³G¼ìºÅ¥X¦å·ÀIµLªk¨ú¥NAPAP) ---------------------------------------------------------------------------------------------- APAP¨x¬r©Ê: ¬ü°ê¨C¦~¦]¨Ï¥Î¤AñQÓi×ô¹L¶q¤¤¬r«æ¶E®×¨Ò¶W¹L¤¸U¤»¤d¤H¡A¦í°|¤G¸U¤»¤d¤H¡A¦º¤`¤H¼Æ¹F¥|¤¡³¤H¥H¤W¡C VS 21»õ¬ü¤¸ªº Troglitazone (Rezulin¡A1997¤W¥«2000¦~¦]¨x¬r©Ê¤U¥«) ±q1997¦~3¤ë¨ì2000¦~2¤ë¡A¤j¬ù192¸U±wªÌ±µ¨ü¤F¦±®æ¦CପvÀø...49¨Ò¡§¥i¯à¡¥possibly¡¨¡]<50¢H¡^©Î¡§¥i¯àprobably¡]> 50¢H¡^¡¨Âk¦]©ó¦±®æ¦CଡC ÁöµMµo¥Í²v¦~¦~¤U°(¦]¬°¤wª`·N¨x¬r©Ê)--¦ýÁÙ¬O³QFDA¤U¬[(¦]¬°¦³´À¥N©ÊÃĪ«¥X²{¦Ó¥BµL¨x¬r) onlinelibrary.wiley.com/doi/abs/10.1002/pds.652 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/6 ¤W¤È 06:59:34²Ä 730 ½g¦^À³
|
Ĺ: ã÷®Ø William M. Lee ³o½g¤å:www.journal-of-hepatology.eu/article/S0168-8278(17)32148-7/fulltext (³oºØ·s«¬ÂíµhÃĪº¦^³ø±N¬O¥¨¤jªº!)¥H¯÷ªí´Æg¹|! ¿é: ¥h¬ü°ê©îWilliam M. Leeªº¦ª´Î ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/7/17 ¤U¤È 10:45:23²Ä 166 ½g¦^À³ SNP-810±N¥þ±¨ú¥N¤£§t¦³¦w¥þ¦¨¤Àªº´¶®³¯k,®õ¿ÕTylenol! 2017¦~7¤ë19¤é-¹ï¤A酰®ò°ò×ô¡]APAP,´¶®³¯k,®õ¿ÕTylenol¡^¨x¬r©Ê-APAP®ø¥¢¤F¶Ü¡H ¥þ¤å¦b:www.journal-of-hepatology.eu/article/S0168-8278(17)32148-7/fulltext ...... 4. What about a totally new pain pill? (SNP-810= APAP+¯S©w¦w¥þ¦¨¤À)°µ¨ì¯S©Ê»PAPAP¬Û¦P¡A¦ý¨S¦³¬r©Ê¡C ³Ì¦³§Æ±æªºµ¦²¤¬O§ä¨ì¤@ºØ·sªº¤îµhÃÄ¡A¸Ó¤îµhÃĪº¯S©Ê»PAPAP¬Û¦P¡A¦ý¨S¦³¬r©Ê¡C ¡K¡K³oºØ·s«¬ÂíµhÃĪº¦^³ø±N¬O¥¨¤jªº¡I ...§Ú·Q¨ìªº¤@Ó¬Û¦ü¤§³B¬O¤Ú¤ñ§´Ãþ¦w¯vÃÄ¡A¸Ó¦w¯vÃĦb1960¦~¥N©M70¦~¥N«D±`¬y¦æ¡A¦ý³y¦¨¤FµL¼Æ¹L¶qªº¦º¤`¡C f¤G´á¨ôÃþÃĪ«°Ý¥@«á¡A¤Ú¤ñ§´ÃþÃĪ«¨³³t®ø¥¢¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/6 ¤W¤È 06:19:31²Ä 729 ½g¦^À³
|
¤@°ï¤H§N¼J¼ö¿Ø¤U¥«ªº¨È·à±d¡AÁà¤pÀn²×©óÅܤÑÃZÅo! ²´¥úµR§Q¦ý¤â¹B¦³®É¤]¤£¨Î¡A¤@±ÑÃĵءC ªYÄ£´Nn¤@½¨âÀü²´¶}µP©w¿éĹ! --------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2019/12/1 ¤U¤È 12:45:32²Ä 1730 ½g¦^À³ §C»ù¤J¤â³q±`¦ñÀH«Ü°ª·ÀI¬O¨S¿ù,¦ý¦³®É¤§«áªº¶W°ª³ø¹S²v«o·|Åý¤H§ãµÃ¤£¤w!!! 10¦~«e³Ì¤j³Q°Ê¤¸¥ó¼t¬O«È¤á,3¤¸¥i¶R¨ì,¦p¤µ·Q·Q«Ü±{¹Ä! ·í®É§Ún¬O¦³¶R100¸U´N¦n,²{¦b¥i¶Rªk©Ô§Q.(¨º®É¶¢¿ú®³¥h¶R200¸U+¨®¤l¨É¨ü«C¬KOrz.) ----------------------------------------------------------------------------------------------- [·|û¡GROGER588910148151 µoªí®É¶¡:2019/8/13 ¤U¤È 05:26:13²Ä 1190 ½g¦^À³ [..as well as results from our ASLAN004 .... Based on this exciting new data, we amended the agreement with CSL Limited to include full global rights to develop, manufacture, and commercialise this first in class therapeutic antibody for atopic dermatitis and other indications. ]®ÇÆ[¤w¤[,·Pı¥H¤W®×±¡¤£³æ¯Â,»ù¦ì±q64©¹¤Uªø¹F16Ó¤ë,À³¸Ó¬O°µ¹Ú³£·|¯º¿ôªº¾÷·|°ª¤@¨Ç! ¦~©³«e³°Äò¤½¥¬¤@¨ÇÁ{§Éµ²ªG,¤pÀ£¤â®ðÅo!] -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2019/11/28 ¤W¤È 09:43:04²Ä 1658 ½g¦^À³ °l·¥S¦pªG±z¶R¤J»ù¦b3.86¨º°÷µR§Q¤F! «¥Ã¨µ¥3¥H¤U¥[½X¤@¨Ç¦a.... ·|û¡GROGER588910148151 µoªí®É¶¡:2019/11/23 ¤W¤È 05:56:39²Ä 1602 ½g¦^À³ ¥un¤U¥«·ÀI¸Ñ°£,«¥·|¦ø¾÷¥[½XÅu¥! µ¥«Ý¥X²{ÄéÄx°ª¤âªº¬y¤t·¬»PÄå¤ìªá¹D(003/004),´Nºâ³Ì«á¤@¨è¤]¯à¤Ï±Ñ¬°³Ó!!! [·|û¡GROGER588910148151 µoªí®É¶¡:2019/11/13 ¤U¤È 03:44:08²Ä 1541 ½g¦^À³ ¦¨¥»12¤¸! [·|û¡GROGER588910148151 µoªí®É¶¡:2019/11/11 ¤U¤È 04:33:19²Ä 1500 ½g¦^À³ ¥¢±Ñ¨Ã¤£¥i©È¡A¤ßºA¨M©w¤F§ÚÌ·|¦p¦ó¦^À³!§ë¸êµJÂI»P§ë¤J»ù¦ì¤£¦P¡A©Ò¯à©Ó¨üÀ£¤O´N¤£¤@P¡C «¥10¶ôªì§ë¤J¡A¬OÀ£µ¥«½SÃĪ«ASLAN004½µP!©ó«¥¨Ó»¡¡A©ú¦~¤~¬O¨£¯u³¹Â_¥Í¦º®É¨è¡C] ¦^ÂÐ¥»¤å ¦^¤W¥«Âd°Q½×°Ï1¶ ·|û¡G¦N¦Ì10148522 µoªí®É¶¡:2019/11/13 ¤U¤È 03:37:28²Ä 1540 ½g¦^À³ ¦n©_½Ð°ÝROGER5889¤j ©M¤Ñ©R¤j §A̤â¤WÁÙ«ù¦³¨È·àªÑ²¼¶Ü? ¦pªG¦³¡AªÑ»ù¶^¨ì²{¦b¡A¦p¦¹¯ëªº¥¿±«ä¦Ò¡A¥O¤H´Ü¨Ø! ] ·|û¡GROGER588910148151 µoªí®É¶¡:2019/11/13 ¤U¤È 02:49:13²Ä 1539 ½g¦^À³ ASLAN004»PDupilumab¨ì©³¨º¤@¤ä¤~¬O¥Ì½©ËµÛ¦Y·|¶V¨Ó¶V²¢!? ©ú¦~§Y¨£¯u³¹¡C ·|û¡GROGER588910148151 µoªí®É¶¡:2019/11/11 ¤U¤È 10:51:03²Ä 1517 ½g¦^À³ §ë¸ê§O¤£©ú¨s²z¸òÀH¨ä¥L¤H¨B¥ï! »`¶°¸ê®Æ«á,¸g¹L¦Û¤vÅçÃÒ«ä¦Òªº¸ê°T¤~¯u¥¿ÄÝ©ó¦Û¤v©Ò¦³. ©ú¦~004¼Æ¾Ú¦p¹w´Á,¨º»ò¨È·à±d±N±qÁà¤pÀnÅܤÑÃZ! [·|û¡G«Ó°¶10144972 µoªí®É¶¡:2019/11/11 ¤U¤È 09:54:28²Ä 1516 ½g¦^À³ ¬Ý¥²´I§ë¸ê¥_·¥¬PÅý§ÚÁȤF100¸U¬Ý¥²´I§ë¸ê¨È·à±dÅý§Ú½ß¦^¥hÁÙ˶K(50±i§¡»ù43¦h)----] ¦^ÂÐ¥»¤å ¦^¤W¥«Âd°Q½×°Ï1¶ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/6 ¤W¤È 05:49:12²Ä 3624 ½g¦^À³ ¦³¤H«Ü·Q§Ú??????? ´±¦M¾÷¤J¥«5¤¸¶R¤J¡A Áx¤j¤ß²Ó¡A±z§Y±N·|ÁȽ!!! ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/5/8 ¤W¤È 10:13:24²Ä 2530 ½g¦^À³ ³oÓ»ù¦ì±þµL¦×¡A±ó¤§¥i±¤! Á«¬O¤@¿,ÁÈ«h¬O´X¤Q¿¬Æ¦Ü¦Ê¿. ºÝ¬Ý004¬O¤£¬O¦n°sÅo!? ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/6/18 ¤W¤È 08:31:35²Ä 2755 ½g¦^À³ ¥Õ®ö·Ê·Ê§Ú¤£©È;´I¶Q¥»¬OÀI¤¤¨D. ........................................................................................... ·|û¡GROGER588910148151 µoªí®É¶¡:2020/5/8 ¤W¤È 10:41:11²Ä 2532 ½g¦^À³ Ãø«O³oÓ¦ÑÁ󤣷|¤]¥X¤U¥«³oºØ¶ø¨B? ´¦¶}³¯®õ»Ê±N°ê¥¨¤U¥«¤º¹õ¡þ¤j¦ÑÁ󪺳¥ÆZª÷¿ú¹CÀ¸ stock.pchome.com.tw/magazine/report/po/businesstoday/4299/130262400027479004001.htm ............................................................................................ ·|û¡GROGER588910148151 µoªí®É¶¡:2020/4/20 ¤W¤È 08:24:11²Ä 2469 ½g¦^À³ ·|û¡G¤Ñ©R10141925 µoªí®É¶¡:2020/4/20 ¤W¤È 07:34:49²Ä 2468 ½g¦^À³ ¥xÆW¤U¥«¤£¥NªíASLAN004 ´N¬OªÅ¡C .......................................................................... ¨S¿ù+1 2018Áp¥Ín¤U¥«,¤½¥q¬£25¤¸¦¬,¶^¨ì20¤¸¤§¤U,²V¤ô¤¤«¥ºN¤F´X±ø³½! ¤£¹L¦b2019-04/18Áp¥ÍÃĪvÀø·R´þ¯f§ÜÅé·sÃÄUB-421Á{§ÉII´Á¸ÕÅçµ²ªG ºaÀò¥Zµn©ó·s^®æÄõÂå¾Ç´Á¥Z«á, «¥·P¨ì«á®¬¤Ï¦ÓnÄ~Äò«ù¦³! www.unitedbiopharma.com/tw/news_detail.php?id=251 ·|û¡GROGER588910148151 µoªí®É¶¡:2020/5/8 ¤W¤È 10:52:39²Ä 2533 ½g¦^À³ ¯à²q³z¦ÑÁ󪺫äºû? 2019-12-03 05:30 ¤O´¹¶°¹Î¸³¨Æªø¶À±R¤¯¡]¥k¡^¹wp©ú¦~¥H¤O¿n¹q¤§¦W¥Ó½Ðµn¿ý¿³Âd¡A³W¹º«·s¤W¥« ¡C ec.ltn.com.tw/article/paper/1336373 ....... ¤O´¹2012¦~´¿¤j´T´î¸ê¡A¤@¨Ç´î¸ê«á¥H§C»ù¤j¶R¤O´¹ªº¤pªÑªF¡A¤£¥F«ù¦³¤W¸U©Î´X¤d±i¡Aªñ´X¦~»â¨ìªºªÑ§Q§¡¤Q¤ÀÅå¤H¡C¤£¹L¡A¤]¦³¤U¥««e©Î´î¸ê«e«ù¦³ªº¤pªÑªF¡AºG½ß¦Ü¤µ¡A´Á±æ¤O´¹¥H¤O¿n¹q¤§¦W¦¤é«ªð¤W¥«¤§¸ô¡C |
|
|
·|û¡GRock00910149258 µoªí®É¶¡:2021/2/5 ¤U¤È 09:24:01²Ä 728 ½g¦^À³
|
Roger¤j ¤p§Ì§Ú¤£³g¤ß SNP-810 ¨C¦~©T©w¦¬EPS 240 ªÑ»ù4800 SNP-610 ¨C¦~©T©w¦¬EPS 120 ªÑ»ù2400 4800+2400=7200 ¤û¦~¨ì¤F³Õ§g¤@¯º¿±¿±· §j§j¤û ¶}¤ß¹L¦n¦~🤣🤣🤣 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/5 ¤U¤È 08:37:18²Ä 727 ½g¦^À³
|
¤p¨È¤j¡A¤åµ§¬Û·í¦n¡C¥i¬O§ÚÌÁÙ·Qª¾¹D¥[¤WSNP-610«á¯à¦A§j¦h°ª? ------------------------------------------------------------------------------------------------ ³æ¤@ÅT¬¶SNP-810¡A¸ò¥xªÑ¦Ü´LªÑ¤ýÄ_®y¬O¤@¨B¤§»»;n¬OÂùÅT¬¶¡A1ÅTSNP-610¡A¤GÅTSNP-810¡A¨¬¥i礦ܴLªÑ¤ýÄ_®y! |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2021/2/5 ¤U¤È 08:30:06²Ä 726 ½g¦^À³
|
¤p¨È¤j 240x20=4800 ¤j®a·s¦~§Ö¼Ö |
|
|
·|û¡G¤p¨È10135608 µoªí®É¶¡:2021/2/5 ¤U¤È 08:19:48²Ä 725 ½g¦^À³
|
§Ú¤]¥[¤J¤û¦~§j¤û¤jÁÉ¡A¨Ó°Q½×R¤j§jªº¦Ü´LªÑ¤ýªÑ»ù¤£暁±o·|öt¦h°ª¡H¥xªÑªÑ¤ý¤j²É¥ú´¿¸g³Ð¤U6075¤Ñ»ù¡A¤µ¤Ñ¦¬½L¤´¦³300.5¸U¡Aªí²{¥O¤H©Q¦Þ¡A·sÃĪѥ»¯q¤ñ¦V¨Ó°ª©ó¹q¤lªÑªºIC³]pªÑ¡A¦]¦¹¡A©Ò¿×¦Ü´LªÑ¤ýÀ³¸Ó§ó¤j²É¤~¹ï¡C¥u¤£¹L¥Í§ÞªÑªºªÑ»ù¦æ±¡ªí²{¯à¤£¯à¦p§ÚÌ©ÒÄ@©O¡H§ÚÌ®³¦X¤@¿}§¿¯f¨¬ºC©Ê¶Ë¤f¼ìºÅ (DFU)·sÃÄ ON101ÅQ¤ý¯Å±ÂÅvªº¹ê¨Ò¨Ó±´°Q¤@¤U¡A¦X¤@»P¤¦³Á¦Ê¦~¥Ö½§Âå¾ÇÃĤj¼t§Q¶ø»sÃÄ(LEO Pharma)ñ¸p²§¦ì©Ê¥Ö½§ª¢·sÃÄFB825±ÂÅv¡Añ¬ùª÷¦Xp¨½µ{ª÷¦@¬ù5.3»õ¬ü¤¸¡A¥«½Õ¿}§¿¯f¨¬ºC©Ê¶Ë¤f¼ìºÅ (DFU)·sÃÄ ON101¦b¥þ¬ü¦³130»õ¬ü¤¸¥«³õ°Ó¾÷¡A¬ù¥i¨ú±o 25-30% ¥«¦û²v¡A¬ù·í39»õ¬ü¤¸¡A¤À¼íª÷¦ô¦b10%¡A¬ù·í120»õ·s¥x¹ô/¦~¡A³o¨Ç¼Æ¾Ú»PRock¤j±À¦ôªYÄ£ªº±ÂÅv©M¥«³õ¤À¼íª÷ÃB´X¥G¬Û·í¡A¨âªÌ°ß¤@®t§O¥u¦b©óªÑ¥»¤j¤p¡A¦X¤@37.71»õ¡AªYÄ£5.2»õ¡AªYÄ£ªÑ¥»¬Û¹ï»´¬Õ¡BÄw½X¶°¤¤¦n©Ô©ï¡A¦p¦³ªk¤H¤¶¤JªÑ»ùªí²{·|°ª©ó¦X¤@¿¼Æ¡C§Ú̦^ÀY¬Ý¤@¬Ý¦X¤@¦bµo§G±ÂÅv«á¨Ã¥B¦³3360¸U¬ü¤¸Ã±¬ùª÷¹ê»Ú¤J±b«áªºªÑ»ùªí²{¦p¦ó¡H109¦~7¤ë¦X¤@³Ð¤U476.5°ª»ù¡CRock¤j±À¦ôªYÄ£ªºµL¼ÄSNP-810¦b¥þ¬ü¦³40E¬üª÷¥«³õ¡Aµ¥©ó1200E¥x¡A¤À¼í10%=120E¥xªÑ¥»5EªºªYÄ£¡A¨C¦~¨S¨Æ·F¤]¯à®³¨ìEPS240ªº¤ô·ÇÁÙ¤£§tÅv§Qª÷¦¬¤J¡B¥¼¨ÓªºSNP-610µ¥µ¥µ¥¡A¯u¬O¥O¤H¤®¾Ä¦Ü·¥¡A¥HEPS240´«ºâ¥»¯q¤ñ20¿ªºªÑ»ù´NÀ³¸Ó¦³2800ªí²{¡A280¸U®@¡I¤£¹L¨Æ¹ê¤W¥i¯à¹ê²{¶Ü¡H§ÚÁ|¦X¤@ªºªí²{´N»¡©ú¬O·|¦³¸¨®tªº¡A·íµM§Ú̳£´Á«Ý2800ªº«GÄRªí²{¦³¤@¤Ñ·|¹ê²{¡A¤û¦~§j§j¤û¡B°µ°µ²¢»e¬ü¹Ú¡A¹LÓ¦n¦~¤]¤£¿ù¡H |
|
|
·|û¡GRock10135634 µoªí®É¶¡:2021/2/5 ¤U¤È 07:51:03²Ä 724 ½g¦^À³
|
°Ý¹L±Mºë¥Í§Þ·sÃļƾڪº«e½ú§iª¾ ³o¨Ç¼Æ¾Ú....«D±`¦n |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/2/5 ¤U¤È 05:50:09²Ä 723 ½g¦^À³
|
High dose (n=17) GLU (¡Â 19.9 ¡Ó 30.3 mg/dL, p = 0.016) Low dose (n=8) GLU (¡Â 10.9 ¡Ó 22.1 mg/dL, p = 0.206) ALL HIGH DOSE-->Significantly decreases??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/5 ¤U¤È 02:52:03²Ä 722 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/5 ¤U¤È 12:05:47²Ä 710 ½g¦^À³ ¤@¥¹·s»D³ø¾Éªº±ÂÅvª÷ÃB¨ê·s¥xÆW·sÃĬö¿ý¦¨¯u¡A§¤¤W¥xªÑ¦Ü´LªÑ¤ýÄ_®y´N¬O¤@¨B¤§»»! ----------------------------------------------------------------------------------------- ¤û¦~ÂùÅT¬¶¡A1ÅTSNP-610¡A¤GÅTSNP-810¡C ³o2¤ä±ÂÅvÅT¬¶¤@¥¹¾_¤Ñ»ùÅT¡A¨¬¥i礦ܴLªÑ¤ýÄ_®y! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/5 ¤U¤È 02:40:03²Ä 721 ½g¦^À³
|
¤û¦~ÂùÅT¬¶¡A1ÅTSNP-610¡A¤GÅTSNP-810¡C SNP-610´Á¤¤¼Æ¾Ú: mops.twse.com.tw/nas/STR/663420190724M001.pdf ¦Û¤v¬Ý¬Ý¤jÃļt¦³¨S¦³¿³½ì??? -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/31 ¤W¤È 09:03:12²Ä 645 ½g¦^À³ SNP-610[¬°°t¦X°ê»Ú¤jÃļt¤§¦X§@¡B§ÞÂà¡B±ÂÅv¤§»Ýn ]¨Æ¥ó®É¶¡¶b 1. 2018-09-21 ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/20 ¤W¤È 05:26:34²Ä 525 ½g¦^À³ 2018-09-21 [¾Ú¤F¸Ñ¡A¤¤°ê±Æ¦W«e¤T¤jÃļt¤w¸g©MªYÄ£¶i¤@¨B¬¢½Í¡C]??? www.gbimonthly.com/2018/09/32593/ ....ªYÄ£Á`¸g²z¦¶³Í¥ÁÂå®vªí¥Ü¡ASNP-6¨ã¦³¦h«§@¥Î¾÷Âà... 2. 2020¦~7¤ë ´Á¤¤¤ÀªRµ²ªG¥¿¦V SNP-610¶}©ñ¦¡Á{§É¤G´Á¬ã¨s¤wÀò±oÅãµÛ¤HÅéÀø®ÄÃÒ¾Ú¡C¾Ú109¦~7¤ë´Á¤¤¤ÀªRµ²ªG¡A35¦ì NASH¯f¤H¡A¥]§t17¦ì°ª¾¯¶q²Õ©M18¦ì¤¤¾¯¶q²Õ¡A¸g12¶gªvÀø«á¡A¥DnÀø®Ä«ü¼Ð¨xŦ¾¢Ói»Ä¤þ଻ÄÂà®ò°ò»Ã¯À(ALT)¦b°ª¾¯¶q²ÕÅãµÛ°§C¹F -29.5¡Ó33.0 U/L, p=0.002¡A¤¤¾¯¶q²ÕÅãµÛ°§C¹F -18.9¡Ó27.3 U/L, p=0.009¡C¨ä¥LÀø®Ä«ü¼Ð¦p¾¢Ói»Äf¾L»ÄÂà®ò°ò»Ã¯À(AST)¡B¨Å»Ä²æ²B酶¡]LDH¡^¡BÁͤƦ]¤lCCL2/CCL5¡BCasepase-3¡BªÅ¸¡¦å¿}ȵ¥¡A¥ç¬ÒÅãµÛ°§C¡CSNP-610´Á¤¤¤ÀªR¦³¨xŦÅÖºû±½´y»öFibroscan data¡A°ò¦Ȱª(F4)ªº²Õ¡AªvÀø«e«á¦³ÅãµÛ®t²§¡C¯×ªÕ¨x¡A¦b§C¾¯¶q²ÕªvÀø«á¦³¶i¨B¡C¥Ø«e¤´¦b¶i¦æ¤¤¡A¹wp¨ì109¦~©³¡C ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/7/3 ¤W¤È 08:05:38²Ä 35 ½g¦^À³ 108/07/24 Bio-Asia¨È¬w¥Í§Þ¤j®iÁ|¿ì¤§¤½¥q®i±æ»¡©ú·| mops.twse.com.tw/nas/STR/663420190724M001.pdf |
|
|
|